|
Omni Bridgeway is an alternative asset manager specializing in legal assets, providing litigation and arbitration funding, legal enforcement, and asset recovery services. The company invests in legal claims, judgments, awards, and non-performing loans by entering financing, purchase, or risk-sharing agreements with claimants, law firms, banks, and creditors. Its operations span the Americas, APAC, and EMEA regions, serving individual claimants, corporations, sovereigns, and multilateral institutions. The group acts as an investment advisor to multiple funds, generating management fees, transaction fees, and carried interests. Core activities include funding high-value commercial disputes, class actions, and international arbitrations, as well as the enforcement of judgments and recovery of distressed assets in complex cross-border scenarios. The company also offers bankruptcy litigation financing and monetization of law firm fee income. Omni Bridgeway was formed in November 2019 through the acquisition of Omni Bridgeway by IMF Bentham, combining entities with roots dating back to 1986 in the Netherlands and the late 1990s in Australia. Summarised from the company's own disclosures, fiscal year ended Jun 2026 |
Industry Financial Services | Homepage omnibridgeway.com |
| Sector Financial Services | IR page omnibridgeway.com/investors | |
|
Tags
litigation funding, dispute finance, legal asset recovery, non-performing loans, arbitration finance, judgment enforcement, bankruptcy financing, asset tracing, cross-border recovery, legal risk management, IMF Bentham, ROLAND ProzessFinanz, IFC, Fund 1, Fund 2, Fund 3, Fund 4, Fund 5, Fund 6, Fund 9
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | A$ 499.633M |
| Market cap (USD) | $ 364.182M |
| P/E | 9.46 |
| PEG | — |
| P/BV | 0.50 |
| P/S | 5.19 |
| P/OCF | -27.24 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 5.3% |
| ROI | 5.1% |
| ROIC | 5.1% |
| Profit margin | 47.7% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | 4.1% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 25.0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Podcast Mentions
Announcements lodged with ASX, newest first, routine forms (director and substantial-holding notices, daily buy-back and quotation notices) included. The link opens the announcement on ASX. Press releases from the company's own website, newest first.
ASX Announcement 27 OCTOBER 2026
Addresses of Chairman and Managing Director to Shareholders of Omni Bridgeway Limited at 2026 Annual General Meeting In accordance with Listing Rule 3.13.3, please refer to the following attached documents: • PART ONE: Chairman’s address to the Annual General Meeting • PART TWO: Managing Director’s address to the Annual General Meeting This announcement is authorised for release to the market by the Disclosure Committee.
INVESTOR ENQUIRIES: Nathan Kandapper Global Head of Investor Relations [email protected]
Omni Bridgeway Limited | ABN 45 067 298 088 | GPO Box 5457 | Sydney NSW 2001 | Freecall 1800 016 464
Annual General Meeting 27 October 2026
Board
Michael Green
Karen Phin
Non-Executive Director and Chairman
Non-Executive Director
Christine Feldmanis
Raymond van Hulst
Non-Executive Director
Managing Director & CEO
Annual General Meeting| 27 October 2026
Chairman’s Address
Michael Green
Non-Executive Director and Chairman
Annual General Meeting| 27 October 2026
Capital allocation approach •
As the company generates incremental free cash flow, the following guidelines established by management and the Board will drive liquidity, capital allocation and distribution decisions.
•
These guidelines will be reviewed semi-annually by management and the Board.
•
OBL aims to maintain Net Liquidity between 12 and 24 months of forecasted Net Opex 1 and OBL-only deployments.
•
Net Liquidity = Net Cash + Net Receivables.
•
Net Receivables = Gross Current Receivables – Gross Current Liabilities.
< 12 months •
Net Liquidity below the 12-month threshold will in principle be fully retained.
•
OBL level cash will continue to be invested in investment grade instruments with short duration.
24 months
12-24 months •
Net Liquidity within the 12-to-24-month threshold may be retained or distributed.
•
Based on management assessment and discretion, taking into account overall portfolio maturity and possible exceptional circumstances.
•
Net Liquidity exceeding the 24-month threshold will in principle be returned to shareholders.
•
Returns to shareholders will in principle be structured as share buy-backs.
•
Subject to exceptional circumstances (e.g. COVID, M&A, exceptional balance sheet investment opportunities, etc.).
Annual General Meeting| 27 October 2026
Share price performance •
OBL’s share price is up 41% since the start of FY25, but continues to trade at a material discount to its book value per share.
•
Closing this gap through sustained delivery, and the capital allocation approach on the previous slide, remains a key focus for the Board.
Share price performance since the start of FY25
Share price 2
OBL closing share price (A$); indices rebased to OBL’s A$1.11 at 30 June 2024 OBL
A$2.00
S&P/ASX 300
OBL
S&P/ASX Small Ordinaries 2025 AGM A$1.61
A$1.75
Fund 9 announced
A$1.57
ASX 300 Small Ords
FY25
+20.7%
+9.9%
+9.2%
FY26
+23.1%
+2.8%
+5.5%
Since 30 Jun 2024
+41.4%
+13.0%
+4.0%
A$1.50
Price to book value
A$1.25
0.53x
A$1.00 A$0.75 Jun-24
2024 AGM A$1.01 Oct-24
Feb-25
Jun-25
Oct-25
Feb-26
Jun-26
Oct-26
Share price of A$1.57 vs FY26 book value per share of A$2.96 3
Share price returns and price to book as at 26 Oct 2026.
Annual General Meeting| 27 October 2026
Address by Non-Executive Director & Chairman, Michael Green, to the Annual General Meeting 27 October 2026
Ladies and gentlemen, this year Omni Bridgeway marks forty years of leadership in legal finance. Forty years is a significant achievement by any measure. When we were founded, the industry did not exist in its current form. That legal finance has grown from a niche pursuit into a globally recognised asset class is owed, in no
We entered FY26 with a fully deleveraged balance sheet following the Fund 9 transaction with Ares Management, and a validated fair value framework. That fundamentally changed the risk profile of the business. Raymond will take you through the FY26 results in detail, so I will make only some key points. Statutory profit after
small part, to the track record of pioneers like Omni Bridgeway. That legacy is not incidental to where we stand today. It is the foundation on which everything we are
tax was A$45.9 million, compared with A$416.8 million last year. The difference is the one-off gain from the Fund 9 transaction in FY25, not a weaker underlying business. The
building rests.
fee income has grown 17% year on year to A$35.4 million while the cash operating expenses decreased by 20% to A$67.1 million, improving our cost coverage ratio.
I am particularly pleased to welcome Edward de Jager, who founded Omni Bridgeway in 1986. Over the forty years since, the company has been through several leadership transitions, and each time it has kept its investment discipline, its track record and its culture intact. Managing leadership transitions successfully is rare among asset managers, and it is one of the reasons fund investors trust us with long-term capital. Edward, thank you. Anniversaries can easily become more backward-looking than they are useful. The Board sees our fortieth year as an opportunity to take stock of what has been built, to draw confidence from it, and to set out clearly why this platform is well placed to continue delivering in the years ahead.
I am pleased with the progress made. This is no longer a business in transition. It is a business in execution. Recognising that distinction is important as shareholders and investors evaluate the outlook for Omni Bridgeway. When I took on the role of Chair following the 2024 AGM, I committed to a more active approach to engagement, with shareholders and, as we become a legal asset management platform, with our fund investors as well.
ASX Announcement 27 OCTOBER 2026
Results of Annual General Meeting In accordance with Listing Rule 3.13.3 and section 251AA of the Corporations Act 2001 (Cth), the results and details of the resolution put to shareholders at the Omni Bridgeway Limited Annual General Meeting held today are set out in the attached table. This announcement is authorised for release to the market by the Disclosure Committee. INVESTOR ENQUIRIES: Nathan Kandapper Global Head of Investor Relations [email protected]
Omni Bridgeway Limited | ABN 45 067 298 088 | GPO Box 5457 | Sydney NSW 2001 | Freecall 1800 016 464
Omni Bridgeway Limited Annual General Meeting Tuesday, 27 October 2026
Results of Meeting
The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2. Resolution details
Resolution
Resolution Type
1 Adoption of the Remuneration Report
Ordinary
2 Re-election of Mr Michael Green as Director
Ordinary
3 Approval of the Managing Director Plan
Ordinary
4 Issue of Managing Director Performance Rights
Ordinary
5 Approval of the Executive Plan
Ordinary
6 Approval of the Right to Equity Settle Team Carried Interest Plan Awards
Ordinary
7 Approval of Indemnified Persons' Deeds of Indemnity, Insurance and Access
Ordinary
Instructions given to validly appointed proxies
Number of votes cast on the poll
Resolution
(as at proxy close)
(where applicable)
For
Against
188,167,568
1,511,635
Proxy's Discretion 69,911
99.16%
0.80%
0.04%
195,260,987
862,672
53,186
99.53%
0.44%
0.03%
188,182,876
1,478,473
53,186
99.19%
0.78%
0.03%
186,909,262
2,761,127
54,146
98.51%
1.46%
0.03%
189,927,566
5,503,805
716,635
96.82%
2.81%
0.37%
189,983,176
6,035,015
107,455
96.86%
3.08%
0.06%
195,449,818
677,242
53,186
99.62%
0.35%
0.03%
Abstain
For
Against
Abstain*
6,459,857
188,343,279
1,511,635
6,459,857
Result Carried / Not Carried Carried
99.20%
0.80%
195,665,685
862,672
239,241
Carried
6,494,436
Carried
6,484,436
Carried
24,411
Carried
46,771
Carried
28,725
Carried
32,126
99.56%
0.44%
188,794,689
1,478,473
99.22%
0.78%
187,522,035
2,761,127
98.55%
1.45%
15,965
191,194,382
5,503,805
97.20%
2.80%
38,325
190,640,812
6,035,015
96.93%
3.07%
196,061,631
677,242
99.66%
0.34%
6,494,436 6,484,436
28,725
- Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.
1/1
Heading Form 604 Corporations Act 2001 Section 671B
Notice of change of interests of substantial holder To: Company Name/Scheme
Omni Bridgeway Limited (OBL)
ACN/ARSN
ACN 067 298 088
- Details of substantial holder (1) Perpetual Limited and its related bodies corporate
Name ACN/ARSN (if applicable)
ACN 000 431 827
There was a change in the interests of the substantial holder on
21/10/2026
The previous notice was given to the company on
22/09/2026
The previous notice was dated
18/09/2026
- Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows: Class of securities (4)
Ordinary
Previous notice
Present notice
Person’s votes
Voting power (5)
Person’s votes
Voting power (5)
44,613,540
15.403%
47,867,256
16.526%
- Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Date of change
Person whose relevant interest changed
Nature of change (6)
Consideration given in relation to change (7)
Class and number of securities affected
Person's votes affected
Refer to annexure A
- Present relevant interests Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows: Holder of relevant interest
Registered holder of securities Refer to annexure B
Person entitled to be registered as holder (8)
Nature of relevant interest (6)
Class and number of securities
Person's votes
- Changes in association The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable)
Nature of association
- Addresses The addresses of persons named in this form are as follows: Name
Address
Perpetual Limited (PPT)
Level 14, 123 Pitt Street, Sydney, NSW 2000
Perpetual Investment Management Limited (PIML)
Level 14, 123 Pitt Street, Sydney, NSW 2000
OMNI BRIDGEWAY LIMITED (OBL)
Level 7, 35 Clarence Street, Sydney, NSW 2000
Signature print name
sign here
Sylvie Dimarco
capacity
Company Secretary
date
23/10/2026
DIRECTIONS (1)
If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.
(2)
See the definition of "associate" in section 9 of the Corporations Act 2001.
(3)
See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(4)
The voting shares of a company constitute one class unless divided into separate classes.
(5)
The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
(6)
Include details of: (a)
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
(b)
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001. (7)
Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
(8)
If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".
(9)
Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
ANNEXURE A This is annexure ‘A’ referred to in Form 604, Notice of change of interests of substantial holder, lodged for Perpetual Limited ACN 000 431 827 Sylvie Dimarco – Company Secretary, Perpetual Limited 23/10/2026
Transaction Type
Consideration (Cash)
Class (Ordinary) and number
Person's vote affected
2026-10-13
Purchase
1,081.80
720
720
2026-10-15
Purchase
8,342.51
5,599
5,599
2026-10-15
Purchase
13,490.46
9,054
9,054
2026-10-21
Purchase
775,000.00
500,000
500,000
2026-10-21
Purchase
311,354.70
200,874
200,874
Entity
Custodian
Date
PIML
HSBC Custody Nominees (Australia) Limited Citicorp Nominees Pty Ltd
PIML PIML PIML PIML
HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited
PIML
Citicorp Nominees Pty Ltd
2026-10-21
Purchase
283,450.05
182,871
182,871
PIML
HSBC Custody Nominees (Australia) Limited
2026-10-21
Purchase
2,435,942.80
1,571,576
1,571,576
PIML
Citicorp Nominees Pty Ltd
2026-10-21
Purchase
258,488.85
166,767
166,767
PIML
UBS Nominees Pty Ltd
2026-10-21
Purchase
955,195.25
616,255
616,255
ANNEXURE B This is annexure ‘B’ referred to in Form 604, Notice of change of interests of substantial holder, lodged for Perpetual Limited ACN 000 431 827 Sylvie Dimarco – Company Secretary, Perpetual Limited 23/10/2026
Holder of relevant interest
Number of securities
Number of votes
7,775,859
7,775,859
8,849,464
8,849,464
Citicorp Nominees Pty Ltd
1,536,595
1,536,595
Citicorp Nominees Pty Ltd
3,801,904
3,801,904
Citicorp Nominees Pty Ltd
Citicorp Nominees Pty Ltd
778,344
778,344
HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited
2,588,876
2,588,876
5,105,982
5,105,982
3,758,527
3,758,527
UBS Nominees Pty Ltd
UBS Nominees Pty Ltd
13,671,705
13,671,705
Registered holder securities
Persons entitled to be registered holder
HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited
PIML
Citicorp Nominees Pty Ltd
PIML
Citicorp Nominees Pty Ltd
PIML
PIML PIML
PIML PIML PIML PIML
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Announcement Summary
Entity name OMNI BRIDGEWAY LIMITED Date of this announcement Wednesday October 07, 2026 The +securities the subject of this notification are: Unquoted options that have been exercised or other unquoted +convertible securities that have been converted Total number of +securities to be issued/transferred
ASX +security code
Security description
OBL
ORDINARY FULLY PAID US PROHIBITED
Total number of +securities to be issued/transferred
Issue date
44,048
30/09/2026
Refer to next page for full details of the announcement
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
1/5
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 1 - Entity and announcement details
1.1 Name of entity OMNI BRIDGEWAY LIMITED We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities. 1.2 Registered number type
Registration number
ABN
45067298088
1.3 ASX issuer code OBL 1.4 The announcement is New announcement 1.5 Date of this announcement 7/10/2026
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
2/5
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 2 - Issue details
2.1 The +securities the subject of this notification are: Unquoted options that have been exercised or other unquoted +convertible securities that have been converted 2.2b The +securities being issued, transferred or re-classified as a result of the options being exercised or other +convertible securities being converted are: securities that have already been quoted on ASX ("existing class")
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
3/5
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B
The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: A transfer of existing +securities The underlying securities being received by the holder are: Already quoted by ASX Existing +securities converting into an existing class FROM (Existing Class) ASX +Security code and description OBLAB : PERFORMANCE RIGHTS
TO (Existing Class) ASX +Security code and description OBL : ORDINARY FULLY PAID US PROHIBITED Please state the number of options that were exercised or other +convertible securities that were converted
The first date the options were exercised or other +convertible securities were converted
The last date the options were exercised or other +convertible securities were converted 30/9/2026
44,048 Is this all of the options or other +convertible securities on issue of that type? No Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No Date the +securities the subject of this notification were issued/transferred 30/9/2026 Any other information the entity wishes to provide about the +securities the subject of this notification
Issue details
Number of +securities 44,048
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
4/5
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 4 - +Securities on issue
Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX) ASX +security code and description
Total number of +securities on issue
OBL : ORDINARY FULLY PAID US PROHIBITED
289,642,218
4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description
Total number of +securities on issue
OBLAB : PERFORMANCE RIGHTS
10,602,252
OBLAC : OPTION EXPIRING 25-FEB-2030 EX $0.9375
37,333,333
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
5/5
-
Press Release
Share
Omni Bridgeway Closes US$1 Billion Legal Finance Fundraise
Final close of Funds 4 and 5 Series 2 takes total capital raised to full target of US$1 billion, with a 99% repeat investment rate.
SYDNEY, 7 October 2026 – Omni Bridgeway Limited (ASX: OBL), the world’s leading alternative asset manager dedicated to legal finance, today confirmed the final close of its Funds 4 and 5 Series 2 capital raise, reaching in full the targeted US$1 billion across both funds.
The Series 2 capital raise further broadens and diversifies Omni Bridgeway’s institutional investor base, while maintaining a strong reinvestment rate. Investors representing 99% of Series 1 commitments have reinvested in Series 2, with over 50% of Series 2 capital committed by Series 1 investors. The investor base comprises global top-tier institutional investors.
The close increases assets under management to A$5.9 billion (US$4.2 billion). It comes as Omni Bridgeway marks its 40th year as a global specialist in legal assets and its 25th year listed on the ASX.
Key facts
- Strategy: Investments in legal assets, diversified globally by jurisdiction, area of law and investment style.
- Total fund size: US$1 billion across Funds 4 and 5 Series 2.
- Alignment: Approximately 20% Omni Bridgeway GP co-investment in Series 2.
- Repeat participation: Investors representing 99% of Series 1 commitments have reinvested, with >50% of Series 2 capital committed by repeat investors.
- Platform track record: As at 30 June 2026, 822 completed investments at a portfolio-wide 2.4x multiple of invested capital (MOIC) across multiple decades and economic cycles.
- Fund-level returns, vintage analysis and the Group's forward capital strategy are set out in Omni Bridgeway's FY26 results presentation and analyst data pack, available at omnibridgeway.com/investors .
Raymond van Hulst, Managing Director and CEO of Omni Bridgeway, said:
_
“In legal finance, institutional capital is consolidating around mature, scaled managers with proprietary origination and work-out capability, and a track record of disciplined underwriting that has performed through multiple economic cycles.”__
“Our successful close, the 99% reinvestment rate, and the sophisticated institutional quality of our investment base reflect our leading position within legal finance.”__
“Funded parties increasingly and rightly focus on capital availability, long-term stability and commitment authority. Every dollar we commit is matched by dedicated fund capital earmarked to that matter. Omni Bridgeway is the sole decision-maker, and the availability of our capital commitment is not exposed to the outcome of other portfolio investments, capital market conditions, third-party underwriting or syndication. Counterparties increasingly recognize and value these differentiators - and accordingly assign a premium to our capital.”__
“The US$1 billion raised in connection with Funds 4 and 5 Series 2 sits alongside a broader capital strategy, with sidecar capital and structured finance solutions continuing to expand alongside our core funds, supporting Omni Bridgeway’s aim of further scaling and diversifying its platform.”
_**
Investor and Media Contacts****
Media**
Naomi Barber, Director, Business Development & Marketing
+61 421 371 844, [email protected]
Management is available for interviewsInvestor Relations
Nathan Kandapper
, Global Head of Corporate Development and Investor Relations
+61 403 941 502, [email protected]
ABOUT OMNI BRIDGEWAY
Omni Bridgeway is the world’s leading alternative asset manager dedicated to legal finance, with over A$5.9 billion in assets under management across multiple funds. Founded in 1986 and listed on the ASX since 2001, Omni Bridgeway has pioneered the industry and has a unique track record of consistent outperformance across multiple decades and economic cycles. With a team of approximately 160 professionals operating in over 20 locations and 15 countries, Omni Bridgeway is the largest and most diversified institutional platform for primary origination, underwriting and management of legal assets and risk, across all relevant jurisdictions and areas of law.
All Press Releases
-
© OmniBridgeway , 2026
-
All Rights Reserved
-
Follow Us
27 October 2026
Investment Portfolio Report at 30 September 2026 (1Q27) Strong start to FY27: 3.9x MOIC on A$135.8 million of proceeds, management fees up 24%, and Funds 4/5 Series II closed at full target of US$1 billion. Omni Bridgeway Limited (ASX: OBL) (Omni Bridgeway, OBL, Group) announces the key investment performance metrics for the three months ended 30 September 2026 (1Q27, Quarter) and for the financial year to date (FY27).
A$135.8m
3.9x
102%
1Q26: A$136.6m
2-year trailing avg: 2.5x
2-year trailing avg: 104%
A$10.7m
A$87.1m
A$416.6m
+24% on 1Q26
+23% on 1Q26
1Q26: A$317.8m
From 20 completions
Management fees 3
MOIC on completions 1
New commitments
Fair value conversion ratio 2
Pipeline: 46 exclusive term sheets
Summary A strong first quarter with elevated completion metrics, continued fee income growth, and a strong pipeline. The Group is tracking at or above all FY27 operational targets. •
Completions: 20 full and partial completions generated A$135.8 million in proceeds, including A$9.7 million OBL-only, at a 3.9x MOIC and 102% fair value conversion. Including a 2011 legacy balance sheet investment, which administratively closed in 1Q27, MOIC was 1.9x.1,2
•
Fee income: management fees of A$10.7 million, up 24% on 1Q26.3 Cash carried interest of A$9.4 million, with a further approximately A$8.6 million accrued on Series II funds and not yet distributed.4
•
Cost discipline: cash opex of A$15.7 million, tracking below the full-year budget range of A$72.5–75.0 million. Cost coverage ratio of 68% for the Quarter.5
•
Commitments: new commitments of A$87.1 million, up 23% on 1Q26, to 9 new investments.6 A$81.2 million in new fair value added. The pipeline of 46 exclusive term sheets represents an estimated A$416.6 million in new commitments.
•
Capital formation: final close of Funds 4/5 Series II at the full US$1 billion target.
•
Balance sheet: OBL-only cash and receivables of A$122.5 million. Total deployments of A$64.1 million, including A$11.9 million OBL-only.
Commenting on the result, Managing Director and CEO Raymond van Hulst said: “Omni Bridgeway has made a strong start to FY27. Completions delivered a 3.9x multiple, management fees grew 24% and the final close of Series II at US$1 billion on improved terms underpins further fee growth. With 46 exclusive term sheets and a significant number of late stage investments in the portfolio, we remain well positioned for the rest of the year.”
omnibridgeway.com
|1
Investment Portfolio at 30 September 2026
Key metrics and developments for the Quarter Quarterly comparison 7 2- year 4Q26 trailing avg 8
1Q27
1Q26
20
17
21
18
135.8
136.6
77.5
79.9
OBL-only investment proceeds (A$m)
9.7
1.1
9.1
9.5
MOIC on completions (x) 1
3.9x
2.3x
2.1x
2.5x
Fair value conversion ratio 2
102%
107%
95%
104%
Management fees (A$m) 3
10.7
8.6
8.4
8.8
New commitments (A$m) 6
87.1
70.7
343.0
147.3
New fair value (A$m)
81.2
72.8
246.5
130.3
Pipeline – est. commitments from exclusive term sheets (A$m)
416.6
317.8
407.8
337.6
Full and partial completions (#) Investment proceeds (A$m)
Income and completions •
During the Quarter, 11 full completions and 9 partial completions were realised, generating A$135.8 million in proceeds, with a provisional combined fair value conversion ratio of 102% and MOIC of 3.9x.1,2
•
A$18.6 million in OBL investment proceeds were recorded for the Quarter. A$8.9 million was applied to Fund 9 returns, with A$9.7 million in OBL-only investment proceeds.
•
An additional A$40.5 million of total investment proceeds was applied to the Funds 2&3 hurdle return.
•
Management fees totalled A$10.7 million for the Quarter, which is 24% above 1Q26 management fees. The final close of the Series II at improved terms is expected to accelerate management fee growth towards the higher end of the range indicated for the year.3
•
A$9.4 million in cash carried interest was received during the Quarter from funds with American waterfalls, with a further approximately A$8.6 million accrued on Series II funds and not yet distributed.4
•
A legacy balance sheet investment, originated in 2011 and unsuccessfully completed in 2022, was administratively closed in the Quarter when the final adverse costs were settled. Including this investment, MOIC for the period and full life to date on completions was 1.9x. FV conversion and other metrics are unchanged.1
Investment performance metrics at 30 September 2026 9 Period
FV conversion (%) 2
Proceeds ($m)
MOIC (x)
Proceeds ($m)
11
3.3x
95%
$82.6m
2.8x
$105.9m
Partially completed
9
5.3x
112%
$53.2m
4.0x
$73.4m
Total 1
20
3.9x
102%
$135.8m
3.2x
$179.3m
Completed 1Q27
Full life to date 10
MOIC (x)
omnibridgeway.com
|2
Investment Portfolio at 30 September 2026
Capital formation and funds management •
Final close of the Funds 4 and 5 Series II capital raise at the full US$1 billion target. Investors representing 99% of Series I commitments reinvested and contributed over 50% of the capital for Series II.
•
Multiple potential sidecar transactions continue to progress.
Investment portfolio update Active investments 1Q27
4Q26
A$m
Gross FV
OBL-only 11
Gross FV
OBL-only 11
Agreed settlements, pending finalisation, approval or payment
12
86
12
14
140
33
In settlement discussions 12
18
191
32
19
238
34
Material positive awards and judgments in set-aside, annulment, appeal or enforcement proceedings
20
581
125
17
552
118
Awards or judgments expected in the next 3 months 13
6
207
NA
4
64
NA
•
This update includes material investments and developments after the end of the Quarter, up to the date of this report.
•
The reduction in agreed settlements primarily reflects the conversion of settlements into completions during 1Q27.
•
None of the above investments has been or will be recorded as completions until the cash has been received or is highly certain and imminent.
New commitments •
New conditional and unconditional commitments of A$87.1 million were made to 9 new investments in the Quarter, as well as to a number of existing investments with increased investment opportunities. This is in line with expectations and reflects normal seasonality.6
•
The fair value associated with these new commitments is A$81.2 million.
•
The pipeline remains elevated, with 46 agreed exclusive term sheets representing an estimated A$416.6 million in new commitments if contracted - supporting continued momentum into FY27 and beyond.
omnibridgeway.com
|3
Investment Portfolio at 30 September 2026
Cash reporting and financial position Cash and receivables at 30 September 2026 A$ million
Cash
Receivables
Total
OBL-only balance sheet
53.4
20.3
73.7
OBL-only portion within consolidated funds 14
9.1
11.1
20.2
OBL-only portion within unconsolidated funds 15
24.7
3.9
28.6
OBL-only total
87.2
35.3
122.5
External fund investors' portion within consolidated funds 16
50.5
58.7
109.2
External fund investors' portion within unconsolidated funds
31.6
0.1
31.7
External fund investors' total
82.1
58.8
140.9
Grand total
169.3
94.1
263.4
•
At 30 September 2026, OBL had approximately A$123 million in OBL-only cash and receivables.
•
OBL-only cash and receivables are in line with expectations.
Outlook •
The pipeline of 46 exclusive term sheets, together with a significant number of late stage investments in the portfolio supports continued momentum into FY27 and beyond.
•
Favourable market and competitive dynamics continue to support a strong pipeline with appropriate risk-adjusted pricing.
•
Management fee growth is expected to accelerate following the Series II final close. Cash opex is expected to increase in later quarters, in line with the FY27 budget.
•
OBL’s Annual General Meeting will be held today, 27 October 2026. The 2Q27 Investment Portfolio Report is expected to be released on 29 January 2027.
omnibridgeway.com
|4
Investment Portfolio at 30 September 2026
Footnotes 1
A balance sheet investment made in 2011 that was ultimately unsuccessful following a negative appeals decision in 2022, leaving a remaining uncertain adverse costs liability, the final tranche of which was settled during the Quarter. It is treated as an extraordinary investment given its size, consistent with the Extraordinary Investments basis presented in prior results presentations. OBL has no remaining balance sheet investments.
2
The fair value conversion ratio indicates the net value of investment deployments and investment proceeds received from investments (partially) completed since the date of the last reported portfolio fair value, divided by the last reported total fair value of the applicable (partial) investments.
3
Management fees are recorded on an accrual basis, and include transaction fees, cost recharges and other administrative fees charged to the funds and sidecars, but exclude any performance fees or carried interest.
4
Our funds have both European waterfalls (back-ended carried interest) and American waterfalls (deal-by-deal carried interest), with periodical full fund catch-ups and possible adjustments for fund management and operating fees. Carried interest received in a period is impacted by which funds had completions, full fund catch-up calculations and timing thereof. As carried interest is subject to potential claw-back based on subsequent completions and catch-ups, accrued carried interest is not booked as a receivable.
5
Cost coverage ratio is fee income (excluding carried interest or performance fees) as a percentage of cash operating expenses.
6
New commitments remain conditional until any confirmatory diligence points have been completed, and an LFA is signed.
7
Prior period figures may change slightly as income and costs associated with completions are recognised in subsequent periods.
8
The 2-year average represents the trailing 8-quarter average, inclusive of the current quarter.
9
All metrics presented are on a full investment basis, excluding the impact of co-investments or partial secondary sales. Figures disclosed in prior quarters may change slightly, due to income and costs associated with completions being recognised in subsequent periods. Matters co-funded between funds, i.e. invested across 2 or more funds, are counted separately (and proportionally) to align with fund reporting.
10 Full life-to-date metrics include any partial completions in prior periods for the investments involved. 11 OBL-only amounts are estimated proceeds. 12 Settlement discussions may or may not progress to agreed settlements and carry significant uncertainty. 13 The outcome and timing of awards or judgments remain uncertain. 14 Includes cash invested by OBL in Fund 6 and Fund 8, which has not yet been deployed and is available to meet future deployment requirements. 15 Includes cash invested by OBL in Funds 2&3, Funds 4/5 Series I and Series II, and Fund 9, which is not consolidated within the Group Consolidated Financial Statements, and has not yet been deployed and is available to meet future deployment requirements. 16 Includes Fund 6 and Fund 8 and represents the external investors' portion of each respective fund.
omnibridgeway.com
|5
Investment Portfolio at 30 September 2026
Further information Further information on terms used in this announcement is available in our Glossary: https://omnibridgeway.com/investors/omni-bridgeway-glossary (Glossary) The Glossary contains important information, including definitions of key concepts, and should be read in conjunction with this announcement. Commitments include conditional, and investment committee approved investments. This report includes a number of concepts, such as fair value and OBL-only, which are classified as a non-IFRS financial measure under ASIC Regulatory Guide 230 “Disclosing non-IFRS financial information”. Management believes that these measures are useful for investors to understand the operations and financial condition of the group. Unless expressly stated, this non-IFRS financial information has not been subject to audit or review by BDO in accordance with IFRS. The figures presented in this document are based on preliminary data and have not been audited. While every effort has been made to ensure the accuracy of the information, these figures are subject to change and should not be considered final. The content of this report does not constitute earnings guidance for OBL for the current or future periods. This report is provided for OBL’s public shareholders and is not connected in any way with any offering of any private fund. This report may contain certain forward–looking statements that can generally be identified using forward looking words such as, “expect”, “anticipate”, “likely”, “intend”, “should”, “could”, “may”, “predict”, “plan”, “propose”, “will”, “believe”, “forecast”, “estimate”, “target” and other similar expressions. Forward-looking statements may involve known and unknown risks, uncertainties, assumptions, and contingencies which are subject to change and are provided as a general guide only and should not be relied upon as an indication or guarantee of future performance. Actual results, performance or achievements may vary materially from any forward- looking statements. Except as required by law or regulation, Omni Bridgeway disclaims all obligations to update publicly any forward-looking statements, whether as a result of new information, future events, or results or otherwise.
This announcement is authorised for release to the market by the Disclosure Committee. INVESTOR ENQUIRIES: Nathan Kandapper Global Head of Investor Relations [email protected] About Omni Bridgeway Omni Bridgeway is the world’s leading alternative asset manager dedicated to legal finance, with over A$5.9 billion in assets under management across multiple funds. Founded in 1986 and listed on the ASX since 2001, Omni Bridgeway has pioneered the industry and has a unique track record of consistent outperformance across multiple decades and economic cycles. With a team of approximately 160 professionals operating in over 20 locations and 15 countries, Omni Bridgeway is the largest and most diversified institutional platform for primary origination, underwriting and management of legal assets and risk, across all relevant jurisdictions and areas of law.
omnibridgeway.com
|6
Sorry, the page you requested has been moved or deleted.
Perhaps you could:
-
Use the site navigation (top of page) to locate the page you are looking for.
-
Search the site using the search box in the top right hand corner of the site.
-
Contact Us for further assistance.
-
Return to the Home Page .
-
© OmniBridgeway , 2026
-
All Rights Reserved
-
Follow Us
Privacy Preference Center
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. More information
Allow All
Manage Consent Preferences
Performance Cookies
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Functional Cookies
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Strictly Necessary Cookies
Always Active
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Confirm My Choices
Performance Cookies
Vendor Search Search Icon Filter Icon
Information storage and access
Apply
Consent Leg.Interest
All Consent Allowed
Select All Vendors
Select All Vendors
All Consent Allowed
-
[ ]
33Across
host description
View Cookies
REPLACE-WITH-DYANMIC-HOST-ID
-
Name
cookie name
-
-
[ ]
33Across
3 Purposes
REPLACE-WITH-DYANMIC-VENDOR-ID
Arrow
Consent Purposes
Location Based Ads
Consent Allowed
Legitimate Interest Purposes
Personalize
Special Purposes
Location Based Ads
Features
Location Based Ads
Special Features
Location Based Ads
Confirm My Choices
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Announcement Summary
Entity name OMNI BRIDGEWAY LIMITED Date of this announcement Friday September 25, 2026 The +securities the subject of this notification are: +Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX Total number of +securities to be issued/transferred
ASX +security code
Security description
OBLAB
PERFORMANCE RIGHTS
Total number of +securities to be issued/transferred
Issue date
2,041,859
21/09/2026
Refer to next page for full details of the announcement
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
1/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 1 - Entity and announcement details
1.1 Name of entity OMNI BRIDGEWAY LIMITED We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities. 1.2 Registered number type
Registration number
ABN
45067298088
1.3 ASX issuer code OBL 1.4 The announcement is New announcement 1.5 Date of this announcement 25/9/2026
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
2/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 2 - Issue details
2.1 The +securities the subject of this notification are: +Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX 2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which: has an existing ASX security code ("existing class")
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
3/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B
ASX +security code and description OBLAB : PERFORMANCE RIGHTS Date the +securities the subject of this notification were issued 21/9/2026 Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate? Yes Provide details of the KMP or +associates being issued +securities. Name of KMP
Name of registered holder
Number of +securities
Raymond van Hulst
Raymond van Hulst
1,395,705
Jeremy Sambrook
Jeremy Sambrook
479,342
David Breeney
David Breeney
166,812
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms Refer to the November 2024 Notice of Meeting https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/fil e/2924-02868693-6A1232062&v=4a466cc3f899e00730cfbfcd5ab8940c41f474b6 Any other information the entity wishes to provide about the +securities the subject of this notification
Issue details
Number of +securities 2,041,859
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
4/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 4 - +Securities on issue
Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX) ASX +security code and description
Total number of +securities on issue
OBL : ORDINARY FULLY PAID US PROHIBITED
289,642,218
4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description
Total number of +securities on issue
OBLAB : PERFORMANCE RIGHTS
10,646,300
OBLAC : OPTION EXPIRING 25-FEB-2030 EX $0.9375
37,333,333
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
5/6
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
Part 5 - Other Listing Rule requirements
5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes 5.1a Select the number of the applicable exception in Listing Rule 7.2 13
Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities
6/6
Notice of Annual General Meeting and Explanatory Memorandum The annual general meeting of Omni Bridgeway Limited will be held at the Amora Jamison Hotel, 11 Jamison St, Sydney NSW 2000, Australia on Tuesday, 27 October 2026 at 10:00am (AEDT).
This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their accountant, solicitor or other professional adviser prior to voting.
Should you wish to discuss any matter please do not hesitate to contact the Company Secretary by email at [email protected]
Notice of Annual General Meeting Notice is hereby given that the annual general meeting of shareholders of Omni Bridgeway Limited (Company) will be held at the Amora Jamison Hotel, 11 Jamison St, Sydney NSW 2000 on Tuesday, 27 October 2026 at 10:00am (AEDT) (Meeting). The Explanatory Memorandum provides additional information on matters to be considered at the Meeting. The Explanatory Memorandum and the Proxy Form are part of this Notice. We recommend Shareholders read the Explanatory Memorandum in relation to the proposed Resolutions. The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered as Shareholders on Sunday, 25 October 2026 at 7.00pm (AEDT). Terms and abbreviations used in this Notice (including the Explanatory Memorandum) are defined in Schedule 1.
Omni Bridgeway Limited | ACN 067 298 088
|2
Agenda ANNUAL REPORT
2
To consider the Annual Report of the Company and its controlled entities, which includes the Financial Report, Directors' Report and Auditor's Report for the year ended 30 June 2026.
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following:
1
RESOLUTION 1 – ADOPTION OF THE REMUNERATION REPORT
To consider and, if thought fit, to pass with or without amendment, as a non-binding ordinary resolution the following:
RESOLUTION 2 – RE-ELECTION OF MR MICHAEL GREEN AS DIRECTOR
That, pursuant to and in accordance with Listing Rule 14.4, Listing Rule 14.5, article 6.3 of the Constitution and for all other purposes, Mr Michael Green, retires and being eligible, is re-elected as a Director, on the terms and conditions in the Explanatory Memorandum.
That, pursuant to and in accordance with section 250R(2) of the Corporations Act and for all other purposes, approval is given by the Shareholders for the adoption of the Remuneration Report, on the terms and conditions in the Explanatory Memorandum.
3
Voting Prohibition
That, for the purposes of Listing Rule 7.2 Exception 13 and for all other purposes, Shareholders authorise and approve the Company’s managing director performance rights plan known as the “Omni Bridgeway MD LTIP” (Managing Director Plan), and the issue of up to a maximum of 4,000,000 Performance Rights under the Managing Director Plan, on the terms and conditions described in the Explanatory Memorandum.
A vote on this Resolution must not be cast (in any capacity) by or on behalf of any of the following persons: (a)
a member of the Key Management Personnel details of whose remuneration are included in the Remuneration Report; or
(b)
a Closely Related Party of such a member.
However, a person described above may cast a vote on this Resolution as a proxy if the vote is not cast on behalf of a person described in subparagraphs (a) or (b) above and either: (a)
(b)
the person is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or the person is the Chairman and the appointment of the Chairman as proxy does not specify the way the proxy is to vote on this Resolution but expressly authorises the Chairman to exercise the proxy, even though this Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel for the Company (or its consolidated group).
Omni Bridgeway Limited | ACN 067 298 088
RESOLUTION 3 – APPROVAL OF THE MANAGING DIRECTOR PLAN
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following:
Voting Exclusion The Company will disregard any votes cast in favour of this Resolution by or on behalf of: (a)
a person who is eligible to participate in the Managing Director Plan; or
(b)
an associate of that person or those persons.
However, this does not apply to a vote cast in favour of this Resolution by: (a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with directions given to the proxy or attorney to vote on this Resolution in that way; or
|3
(b)
(c)
the Chairman as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with a direction given to the Chairman to vote on this Resolution as the Chairman decides; or a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i)
(ii)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on this Resolution; and the holder votes on this Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
Voting Prohibition In accordance with section 250BD of the Corporations Act, a vote on this Resolution must not be cast by a person appointed as a proxy, where that person is either a member of the Key Management Personnel or a Closely Related Party of such member. However, a vote may be cast by such person if the vote is not cast on behalf of a person who is otherwise excluded from voting, and (a)
(b)
4
the person is appointed as a proxy and the appointment specifies how the proxy is to vote; or the person appointed as proxy is the Chairman and the appointment does not specify how the Chairman is to vote but expressly authorises the Chairman to exercise the proxy even if the Resolution is connected with the remuneration of a member of the Key Management Personnel.
RESOLUTION 4 – ISSUE OF MANAGING DIRECTOR PERFORMANCE RIGHTS
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following:
Omni Bridgeway Limited | ACN 067 298 088
That, subject to Resolution 3 being passed, pursuant to and in accordance with Listing Rule 10.14 and for all other purposes, Shareholders approve: (a)
the issue of Performance Rights to Mr Raymond van Hulst (and/or his nominee) over a three-year period (being, FY27, FY28 and FY29) in accordance with the Allocation Formula and his employment terms; and
(b)
the issue, transfer or allocation of, and acquisition by Mr Raymond van Hulst (and/or his nominee) of, Shares in respect of those Performance Rights,
under the Managing Director Plan and on the terms and conditions in the Explanatory Memorandum. Voting Exclusion The Company will disregard any votes cast in favour of this Resolution by or on behalf of: (a)
a person referred to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Managing Director Plan; or
(b)
an associate of that person or those persons.
However, this does not apply to a vote cast in favour of this Resolution by: (a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with directions given to the proxy or attorney to vote on this Resolution in that way; or
(b)
the Chairman as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with a direction given to the Chairman to vote on this Resolution as the Chairman decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on this Resolution; and
(ii)
the holder votes on this Resolution in accordance with directions given by
|4
the beneficiary to the holder to vote in that way.
(a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with directions given to the proxy or attorney to vote on this Resolution in that way; or
(b)
the Chairman as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with a direction given to the Chairman to vote on this Resolution as the Chairman decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:
Voting Prohibition In accordance with section 250BD of the Corporations Act, a vote on this Resolution must not be cast by a person appointed as a proxy, where that person is either a member of the Key Management Personnel or a Closely Related Party of such member. However, a vote may be cast by such person if the vote is not cast on behalf of a person who is otherwise excluded from voting, and (a)
(b)
5
the person is appointed as a proxy and the appointment specifies how the proxy is to vote; or the person appointed as proxy is the Chairman and the appointment does not specify how the Chairman is to vote but expressly authorises the Chairman to exercise the proxy even if the Resolution is connected with the remuneration of a member of the Key Management Personnel.
RESOLUTION 5 – APPROVAL OF THE EXECUTIVE PLAN
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: That, for the purposes of Listing Rule 7.2 Exception 13 and for all other purposes, Shareholders authorise and approve the Company’s executive performance rights plan known as the “Omni Bridgeway Executive Plan” (Executive Plan), and the issue of up to a maximum of 10,000,000 Performance Rights under the Executive Plan, on the terms and conditions described in the Explanatory Memorandum. Voting Exclusion The Company will disregard any votes cast in favour of this Resolution by or on behalf of: (a)
a person who is eligible to participate in the Executive Plan; or
(b)
an associate of that person or those persons.
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on this Resolution; and
(ii)
the holder votes on this Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
Voting Prohibition In accordance with section 250BD of the Corporations Act, a vote on this Resolution must not be cast by a person appointed as a proxy, where that person is either a member of the Key Management Personnel or a Closely Related Party of such member. However, a vote may be cast by such person if the vote is not cast on behalf of a person who is otherwise excluded from voting, and (a)
the person is appointed as a proxy and the appointment specifies how the proxy is to vote; or
(b)
the person appointed as proxy is the Chairman and the appointment does not specify how the Chairman is to vote but expressly authorises the Chairman to exercise the proxy even if the Resolution is connected with the remuneration of a member of the Key Management Personnel.
However, this does not apply to a vote cast in favour of this Resolution by:
Omni Bridgeway Limited | ACN 067 298 088
|5
6
RESOLUTION 6 – APPROVAL OF THE RIGHT TO EQUITY SETTLE TEAM CARRIED INTEREST PLAN AWARDS
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: That, for the purposes of Listing Rule 7.2 Exception 13 and for all other purposes, Shareholders authorise and approve the equity settlement component of the Team Carried Interest Plan (TCI Equity Settlement), and the issue of up to a maximum of 15,000,000 Shares by way of TCI Equity Settlement, on the terms and conditions described in the Explanatory Memorandum.
the beneficiary to the holder to vote in that way. Voting Prohibition In accordance with section 250BD of the Corporations Act, a vote on this Resolution must not be cast by a person appointed as a proxy, where that person is either a member of the Key Management Personnel or a Closely Related Party of such member. However, a vote may be cast by such person if the vote is not cast on behalf of a person who is otherwise excluded from voting, and (a)
the person is appointed as a proxy and the appointment specifies how the proxy is to vote; or
(b)
the person appointed as proxy is the Chairman and the appointment does not specify how the Chairman is to vote but expressly authorises the Chairman to exercise the proxy even if the Resolution is connected with the remuneration of a member of the Key Management Personnel.
Voting Exclusion The Company will disregard any votes cast in favour of this Resolution by or on behalf of: (a)
a person who is eligible to participate in the Team Carried Interest Plan; or
(b)
an associate of that person or those persons.
However, this does not apply to a vote cast in favour of this Resolution by: (a)
(b)
(c)
a person as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with directions given to the proxy or attorney to vote on this Resolution in that way; or the Chairman as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with a direction given to the Chairman to vote on this Resolution as the Chairman decides; or a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on this Resolution; and
(ii)
the holder votes on this Resolution in accordance with directions given by
Omni Bridgeway Limited | ACN 067 298 088
7
RESOLUTION 7 – APPROVAL OF INDEMNIFIED PERSONS' DEEDS OF INDEMNITY, INSURANCE AND ACCESS
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: That, pursuant to and in accordance with Chapter 2D of the Corporations Act and for all other purposes approval be given to the Company to: (a)
indemnify each Indemnified Person during their Office and after the cessation of that Office, in respect of certain claims made against the Indemnified Persons in relation to the period of their Office;
(b)
use its reasonable endeavours to procure an insurance policy and pay the premiums of insurance as assessed at market rates for Indemnified Persons in respect of certain claims made against Indemnified Persons in relation to the period of their Office (except to the extent such insurance cannot be procured at a reasonable cost or is otherwise unavailable to the Company);
|6
(c)
(d)
use its reasonable endeavours to ensure that Indemnified Persons are at all times covered under an insurance policy for the period of seven years from the date that Indemnified Persons cease to hold Office (Insurance Run Off Period), which will be on terms not materially less favourable to Indemnified Persons than the terms of insurance applicable at the date of termination of their Office, and to continue to pay those premiums during that Insurance Run Off Period (except to the extent such insurance cannot be procured at a reasonable cost or is otherwise unavailable to the Company); and provide Indemnified Persons with access, upon the termination of their Office, for a period of not less than seven years following that termination, to any Company records which are either prepared or provided by them during the period of their Office,
However, a vote may be cast by such person if the vote is not cast on behalf of a person who is otherwise excluded from voting on this Resolution, and: (a)
the person is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or
(b)
the person appointed as proxy is the Chairman and the written appointment of the Chairman does not specify the way the Chairman is to vote on this Resolution but expressly authorises the Chairman to exercise the proxy even if this Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel.
Dated: 25 September 2026 By order of the Board
on the terms and conditions in the Explanatory Memorandum. Voting Prohibition The Company will disregard any votes cast in favour of this Resolution by or on behalf of an Indemnified Person or any of their associates.
Mr Jeremy Sambrook Global General Counsel and Company Secretary
The Company will not disregard a vote if: (a)
it is cast by a person as a proxy appointed in writing that specifies how the proxy is to vote on this Resolution; and
(b)
it is not cast on behalf of an Indemnified Person or any of their associates.
In accordance with section 250BD of the Corporations Act, a vote on this Resolution must not be cast by a person appointed as a proxy, where that person is either a member of the Key Management Personnel or a Closely Related Party of such member.
Omni Bridgeway Limited | ACN 067 298 088
|7
Explanatory Memorandum 1
INTRODUCTION This Explanatory Memorandum has been prepared to provide Shareholders with important information regarding the items of business to be conducted at the Meeting to be held on Tuesday, 27 October 2026 at 10:00am (AEDT). This Explanatory Memorandum should be read in conjunction with and forms part of the Notice. The purpose of this Explanatory Memorandum is to provide information to Shareholders in deciding whether or not to pass the Resolutions. This Explanatory Memorandum includes the following information to assist Shareholders in deciding how to vote on the Resolutions: Section 2
Action to be taken by Shareholders
Section 3
Annual Report
Section 4
Resolution 1 – Adoption of the Remuneration Report
Section 5
Resolution 2 – Re-election of Mr Michael Green as Director
Section 6
Resolution 3 – Approval of the Managing Director Plan
Section 7
Resolution 4 – Issue of Managing Director Performance Rights
Section 8
Resolution 5 – Approval of the Executive Plan
Section 9
Resolution 6 – Approval of the Right to Equity Settle Team Carried Interest Plan Awards
Section 10
Resolution 7 – Approval of Indemnified Persons' Deeds of Indemnity, Insurance and Access
Schedule 1
Definitions
Schedule 2
Summary of the Managing Director Plan and Executive Plan
Schedule 3
Terms and Conditions of the Managing Director Performance Rights
Schedule 4
Indemnified Persons
A Proxy Form is attached to the Notice.
2
ACTION TO BE TAKEN BY SHAREHOLDERS Shareholders should read the Notice, including this Explanatory Memorandum, carefully before deciding how to vote on the Resolutions. A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited to attend the Meeting in
Omni Bridgeway Limited | ACN 067 298 088
|8
person or, if they are unable to attend in person, sign and return the Proxy Form to the Company in accordance with the instructions thereon. Returning the Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in person. Please note that: (a)
a member of the Company entitled to attend and vote at the Meeting is entitled to appoint a proxy;
(b)
a proxy need not be a member of the Company; and
(c)
a member of the Company entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. Where the proportion or number is not specified, each proxy may exercise half of the votes.
The Proxy Form provides further details on appointing proxies and lodging Proxy Forms. Shareholders who choose to lodge a Proxy Form should follow the instructions on the Proxy Form. For your proxy appointment to be effective it must be received by 10:00am (AEDT) on Sunday, 25 October 2026.
Attendance at Meeting in person If you attend the Meeting, please bring your personalised Proxy Form with you to assist with registration and (if possible) arrive at the venue 15 to 30 minutes before the start of the Meeting. Representatives from the Share Registry will verify your shareholding against the Company's share register and note your attendance. If you do not bring your Proxy Form with you, you will still be able to attend the Meeting, but you will need to verify your identity. The Company has elected for this year's Meeting to be held in person rather than online. The costs involved in holding a hybrid meeting in previous years have been disproportionate to the very limited level of online participation of Shareholders. All Resolutions will be conducted by poll. At the Meeting, Shareholders will be offered the opportunity to: (a)
discuss the Annual Report which is available online at https://omnibridgeway.com/investors/annual-general-meeting;
(b)
ask questions about, or comment on, the management of the Company; and
(c)
ask the auditor questions about the conduct of the audit and the preparation and content of the Auditor's Report.
In addition to taking questions at the Meeting, written questions to the Chairman or to the Company's auditor may be submitted no later than five business days before the Meeting by emailing them to [email protected]. Please note that each question will not necessarily be individually addressed at the Meeting or answered individually after the Meeting.
3
ANNUAL REPORT In accordance with section 317(1) of the Corporations Act, the Annual Report must be laid before the annual general meeting. There is no requirement for Shareholders to approve the Annual Report. Please note that if you have elected to continue to receive a hard copy of the Annual Report, it will be mailed to you no later than 21 days before the Meeting.
Omni Bridgeway Limited | ACN 067 298 088
|9
However, if you did not elect to continue to receive a hard copy of the Annual Report and now (or at some time in the future) wish to receive a hard copy of the Annual Report, please contact the Company, who will arrange to mail you a hard copy.
4
RESOLUTION 1 – ADOPTION OF THE REMUNERATION REPORT
4.1
General In accordance with section 250R(2) of the Corporations Act, the Company must put the Remuneration Report to the vote of Shareholders. The Remuneration Report is set out in pages 28 to 37 of the Annual Report and outlines the Company’s remuneration framework which is designed to attract, incentivise and retain highly skilled employees in order for the business to thrive and achieve its potential. It consists of both fixed and “at risk” components, depending on the particular role and seniority of the employee. The Board’s conviction is that remuneration and incentive programs must support disciplined longterm value creation and realisation rather than short-term effort or unsustainable growth. The Company’s business is characterised by multi-year investment cycles, uncertain timing of realisations, and the need for highly specialised teams capable of originating, underwriting, managing and realising complex legal assets across multiple jurisdictions. The Board believes that reward should follow realised cash: participants should benefit alongside fund investors and shareholders when investments complete successfully, generating investment returns for fund investors and co-investment returns and fund carried interest for the Company. The Board also recognises that Omni Bridgeway competes for capital and investment talent with the asset management sector and carried interest is the standard and expected form of long-term alignment in that market. During FY26, Omni Bridgeway introduced its Team Carried Interest Plan (detailed in Section 4.2) and finalised proposals to introduce its Executive Plan from FY27, subject to shareholder approval at this AGM. Remuneration for KMP, senior executives, investment professionals and other senior staff comprises a fixed component and an “at risk” component. Fixed remuneration is market based, benchmarked primarily against the asset management industry in each of our various operating regions. The Directors refer you to the Remuneration Report for further information.
4.2
Variable Remuneration The "at risk" or variable remuneration framework now comprises the following elements: (a)
Managing Director Plan: This is the sole at-risk element of the Managing Director’s remuneration and, in accordance with the terms of the Managing Director’s employment contract of 2023, comprises an entitlement to receive an annual award of Performance Rights equal to 125% of the Managing Director’s Total Fixed Remuneration. The vesting of the Managing Director Performance Rights is subject to the Company’s TSR performance relative to the Comparator Group. The vesting matrix provides for 50% vesting at the 50th percentile, pro rata straight-line vesting between 50% and 100% for performance between the 50th and 75th percentile, and 100% vesting at or above the 75th percentile. Vesting is tested at the end of the three-year period and rights that do not vest lapse. Unvested rights lapse on cessation of employment, subject to good leaver treatment, and are subject to malus and clawback clauses. The Directors consider that the Managing Director Plan is a cost effective and efficient reward to appropriately incentivise the performance of the Managing Director and is consistent with the strategic goals and targets of the Company.
Omni Bridgeway Limited | ACN 067 298 088
| 10
(b)
Team Carried Interest Plan: This is the principal at-risk element for investment professionals and senior staff. Participants hold Carried Interest Points (CIP) entitling them to a share (capped at 25%) of the carried interest the Company actually receives from its Funds, with the remaining 75% retained for the Company and its Shareholders. Unvested CIP attach to specific investments and are granted at initial commitment proportionate to the fair value of the investment, and convert to vested CIP only on realisation of the investment, and then in proportion to the realised fair value achieved measured against the initial fair value. Distributions are made on vested points only, with any carried interest on unvested points retained until and subject to vesting. The Team Carried Interest Plan rewards genuine long-term value creation and realisation. Participant entitlements track the carried interest the Company itself receives and follow the Company’s co-investment performance. This creates a clear connection between employee reward, investment performance, fund investor outcomes and shareholder value, and aligns the Company's remuneration structure with the alternative asset management industry. The Team Carried Interest Plan is also structured so that participants are rewarded for the performance of the portfolio and of the firm, and not merely for their own matters. CIPs are allocated as a mix across personal, specific portfolio and companywide portfolio investments, and any participant’s entitlement depends on outcomes wider than the investments they manage themselves. This is aimed at aligning the pursuit of individual, team and Company goals and promoting global collaboration. Unlike many examples in the asset management industry, the Team Carried Interest Plan is deliberately broad based. All investment roles and senior non-investment roles are eligible to participate. The Team Carried Interest Plan is also relatively flat, with limited divergence in eligibility for the most senior participants and the most junior participants. The Nomination and Remuneration Committee will assess annual allocations of the newly generated unvested CIPs with reference to a combination of eligibility and personal KPI scores. Seniority only sets the starting point for an allocation, and performance determines the outcome, with high performing junior participants able to exceed senior participants in annual allocation. The Team Carried Interest Plan’s eligibility framework and every individual allocation are recommended by management and approved by the Nomination and Remuneration Committee annually. Up to a quarter of the CIPs created each year are withheld in an unallocated reserve, from which the Nomination and Remuneration Committee may make allocations to, for example, new employees. As participants and CIP share in a fixed proportion of carried interest actually received, the cost of the Team Carried Interest Plan cannot exceed that proportion and cannot dilute the share of carried interest retained for Shareholders. Consistent with good governance practices, the Team Carried Interest Plan rules give the Board express powers to prevent inappropriate reward. Three mechanisms operate, and they are distinct. The first is automatic and requires no exercise of discretion: unvested points convert on realisation only in proportion to the value actually realised against the underwritten fair value, so that a matter realised below carrying value converts fewer points than were allocated to it and the shortfall expires. The second addresses the risk that carried interest paid early in a Fund’s life must later be returned to that Fund because of subsequent underperformance. The Nomination and Remuneration Committee sets a retention percentage annually for each Fund, with higher retention where a Fund’s outcome remains uncertain and reducing as performance is established, and the retained amounts are held in escrow rather than distributed. The Company is therefore able to meet a Fund-level clawback obligation without having to pursue recovery from individuals. The third is the Board’s power to determine that a participant has engaged in a malus event which, among other things, includes deliberately engaging in fraudulent or dishonest conduct, or in conduct resulting in material reputational damage to the Group. In malus circumstances,
Omni Bridgeway Limited | ACN 067 298 088
| 11
the Board may cancel both vested and unvested CIPs and may demand repayment of amounts already received in respect of vested CIPs, net of tax. A participant treated as a Bad Leaver forfeits all points, vested and unvested; a Good Leaver retains only the amounts already held in escrow for their vested points at departure, and only for so long as they continue to observe the post-departure conditions of the Team Carried Interest Plan. (c)
Executive Plan. This is a performance rights plan with a narrow and senior executive scope focussed on the global leadership team (excluding the Managing Director) and potential successors. It is intended to deliver the enterprise-wide accountability and direct equity alignment appropriate to those responsible for the Company as a whole. Participants have plan eligibility levels and, based on their performance against personal KPIs in the award year, they will receive performance rights relative to their eligibility and performance levels. The vesting of these rights is then subject to the following three Company performance metrics measured over the 3-year period from the start of the first plan year as follows: (i)
50% of the total award is determined by the Company's total shareholder return relative to the constituents of the Comparator Group, measured using the Company’s VWAP over the 90-trading days ending on the first and last day of the Performance Period respectively, with no vesting below the 50th percentile, 50% vesting at the 50th percentile, full vesting at or above the 75th percentile and straight-line vesting in between;
(ii)
25% of the total award is determined by the Company's return on equity measured as a three-year average, with no vesting below 12.5%, 50% vesting at 12.5%, full vesting at or above 17.5% and straight-line vesting in between; and
(iii)
25% of the total award is determined by the Company's growth in assets under management also measured as the compound annual growth rate over the Performance Period, with no vesting below 10%, 50% vesting at 10%, full vesting at or above 15% and straight-line vesting in between.
Each measure is tested once, at the end of the three-year period and rights that do not vest lapse. Unvested rights lapse on cessation of employment, subject to Good Leaver treatment, and are subject to malus and clawback clauses. (d)
4.3
Discretionary cash bonus. A discretionary bonus of up to 20% of gross salary remains available to staff who do not participate in the Team Carried Interest Plan or the Executive Plan. Awards depend on annual personal performance and on the Company’s performance for the year.
Fixed Remuneration The "at risk" remuneration is intended to complement the fixed component of the Company’s remuneration framework. The fixed remuneration component for Key Management Personnel and senior employees is reviewed annually against the applicable markets in which the Group operates, and taking into account any Team Carried Interest Plan and Executive Plan awards.
4.4
Effect of the vote In accordance with section 250R(3) of the Corporations Act, the vote on Resolution 1 is advisory only and does not bind the Directors or the Company. If Resolution 1 is not passed, the Directors will not be required to alter any of the arrangements in the Remuneration Report. Shareholders will have the opportunity to remove the whole Board, except the Managing Director, if the Remuneration Report receives a 'no' vote of 25% or more (Strike) at two consecutive annual general meetings. Where a resolution on the Remuneration Report receives a Strike at two consecutive annual general meetings, the Company will be required to put to Shareholders at the second annual general
Omni Bridgeway Limited | ACN 067 298 088
| 12
meeting a resolution on whether another meeting should be held (within 90 days) at which all Directors (other than the Managing Director) who were in office at the date of approval of the applicable Directors' Report must stand for re-election. The Remuneration Report did not receive a Strike at the 2025 annual general meeting. Please note, if the Remuneration Report receives a Strike at this Meeting, and if a second Strike is received at the 2027 annual general meeting, this may result in the re-election of all the Directors (other than the Managing Director). The Chairman will allow reasonable opportunity for Shareholders to ask questions about or comment on the Remuneration Report. Resolution 1 is a non-binding ordinary resolution. The Chairman intends to exercise all available proxies in favour of Resolution 1. If the Chairman is appointed as your proxy and you have not specified the way the Chairman is to vote on Resolution 1, by signing and returning the Proxy Form, you are considered to have provided the Chairman with an express authorisation for the Chairman to vote the proxy in accordance with the Chairman's intention, even though Resolution 1 is connected directly or indirectly with the remuneration of a member of the Key Management Personnel.
5
RESOLUTION 2 – RE-ELECTION OF MR MICHAEL GREEN AS DIRECTOR
5.1
Background In accordance with Listing Rule 14.4, a director must not hold office (without re-election) past the third annual general meeting following the director's appointment, or three years, whichever is longer. In accordance with Listing Rule 14.5, an entity which has directors must hold an election of directors at each annual general meeting. Article 6.3(c) of the Constitution requires one third of all Directors, or if their number is not a multiple of three, then the number nearest one-third (rounded down to the nearest whole number) to retire at each annual general meeting. Article 6.3(f) of the Constitution states that a Director who retires under article 6.3 is eligible for re-election. The Director (other than the Managing Director) with the longest time from election or re-election is Mr Michael Green, who has been a non-executive director of the Company since April 2023. Mr Green has over 20 years’ experience in the global investment industry. Mr Green was previously International Chief Executive Officer for both Morgan Stanley Investment Management and for American Century Investments where he was a member of their respective Executive Management Committees and was a board member for a number of local entities and global fund structures. Mr Green has held the role of the Chair and Independent Trustee of Lloyd’s of London Pension Scheme since his appointment in 2007. From 2020 to 2023, Mr Green became a co-opted non-executive member of the Investment Oversight Committee for the London CIV, the local government pension fund asset pooling company. Mr Green holds a Bachelor of Arts (Honours) in Economics from the University of Exeter in the UK. Resolution 2 provides that Mr Green retires by rotation and seeks re-election as Director. If Resolution 2 is passed, Mr Green will be entitled to be a Director of the Company for the next three years and if the Resolution 2 is not passed, Mr Green will cease to be a Director of the Company.
Omni Bridgeway Limited | ACN 067 298 088
| 13
Resolution 2 is an ordinary resolution and the Chairman intends to exercise all available proxies in favour of Resolution 2.
5.2
Board Recommendation The Board (excluding Mr Green) supports the re-election of Mr Green and recommends that Shareholders vote in favour of Resolution 2.
6
RESOLUTION 3 – APPROVAL OF MANAGING DIRECTOR PLAN
6.1
General Background Resolution 3 seeks Shareholder approval, pursuant to Listing Rule 7.2, Exception 13(b), to adopt the Managing Director Plan and to facilitate the issuance of incentive securities in the form of Performance Rights (and Shares issued upon the exercise of Performance Rights) to the current Chief Executive Officer and Managing Director (Eligible Participant). Shareholders first approved long-term incentive arrangements for the current Chief Executive Officer and Managing Director in November 2024. The Managing Director Plan continues those arrangements for a further three-year period. The Managing Director Plan governs the award of long-term incentive Performance Rights to the current Chief Executive Officer and Managing Director and the terms and conditions that apply to such Performance Rights. It aims to align the interests of the Chief Executive Officer and Managing Director with those of the Company and its Shareholders, increasing Shareholder value by motivating the Chief Executive Officer and Managing Director and providing an opportunity to share in the success of the Company by acquiring an ownership interest in it. A summary of the material terms of the Managing Director Plan is set out in Schedule 2. The Directors (excluding Mr van Hulst) consider that the Managing Director Plan is an attractive and efficient means of incentivising and retaining the required calibre of executive to lead and manage the Group. Resolution 3 is an ordinary resolution and the Chairman intends to exercise all available proxies in favour of Resolution 3. If the Chairman is appointed as your proxy and you have not specified the way the Chairman is to vote on Resolution 3, by signing and returning the Proxy Form, you are considered to have provided the Chairman with an express authorisation for the Chairman to vote the proxy in accordance with the Chairman’s intention, even though Resolution 3 is connected directly or indirectly with the remuneration of Key Management Personnel.
6.2
Listing Rule 7.1 and Listing Rule 7.2, Exception 13(b) Subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a public company can issue, without obtaining shareholder approval, over any 12-month period to 15% of the fully paid ordinary issued securities on issue at the start of the period (15% Placement Capacity). Listing Rule 7.2, Exception 13(b) sets out an exception to this rule by providing that issues of Equity Securities under an employee incentive scheme approved by shareholders within the last three years are not included in a company’s 15% Placement Capacity. If Resolution 3 is passed, the Company will be able to issue Performance Rights under the Managing Director Plan to the Eligible Participant over a period of three years from the date of the Meeting without impacting the Company’s 15% Placement Capacity and without requiring Shareholder approval under Listing Rule 7.1. If Resolution 3 is not passed, and subject to the passing of Resolution 4 and any future approvals required under Listing Rule 10.14, the Company will still be able to proceed with the issue of the Performance Rights under the Managing Director Plan, however such issues will count towards the Company’s 15% Placement Capacity.
Omni Bridgeway Limited | ACN 067 298 088
| 14
Shareholder approval is required for the purposes of Listing Rule 10.14 before any Director can be issued Performance Rights under the Managing Director Plan.
6.3
Specific information required by Listing Rule 7.2, Exception 13(b) The following additional information in relation to Resolution 3 is provided to Shareholders for the purposes of Listing Rule 7.2, Exception 13(b):
6.4
(a)
a summary of the material terms of the Managing Director Plan is set out in Schedule 2;
(b)
the Company has not issued any Equity Securities under the Managing Director Plan as this is the first time that Shareholder approval is being sought for the adoption of the Managing Director Plan;
(c)
the maximum number of Equity Securities proposed to be issued across the three-year period comprising FY27, FY28 and FY29 under the Managing Director Plan following Shareholder approval is 4,000,000 Performance Rights. This amounts to approximately 1.38% of the current issued share capital of the Company as at 25 September 2026. There is no obligation on the Company to, or guarantee that the Company will, issue the maximum number of Equity Securities. The maximum number of Equity Securities simply sets a "cap" for the purposes of Shareholder approval. The cap has been calculated taking into account the Company’s VWAP over the 90-trading day period ending on 1 July 2026 and the terms of the Managing Director Plan. Given the maximum award to the Eligible Participant under the Managing Director Plan is derived from the fixed remuneration of the Managing Director, if the Share price exceeds the 90-trading day VWAP then the number of Performance Rights awarded, and therefore the level of dilution to existing Shareholders, will reduce proportionally; and
(d)
a voting exclusion statement has been included in the Notice for Resolution 3.
Directors' Recommendation The Board (excluding Mr van Hulst) recommends that Shareholders vote in favour of Resolution 3.
7
RESOLUTION 4 – ISSUE OF MANAGING DIRECTOR PERFORMANCE RIGHTS
7.1
General Resolution 4 is subject to Resolution 3 being passed. Resolution 4 seeks Shareholder approval in accordance with Listing Rule 10.14, and all other purposes, for the grant of Performance Rights in accordance with the Managing Director Plan to Mr Raymond van Hulst over the three-year period commencing from the date of the Meeting, which will cover awards for FY27, FY28 and FY29 (Managing Director Performance Rights). Mr van Hulst was appointed as Managing Director and Chief Executive Officer of the Company effective from 26 October 2023 and the terms of his employment contract were announced to the ASX on 19 October 2023. In accordance with those terms, Mr van Hulst is eligible to participate in the Company’s long-term incentive plan for an annual amount equal to 125% of his Total Fixed Remuneration. The Board has determined that the long-term incentive rights to which Mr van Hulst is contractually entitled under his employment contract will be granted to him under, and governed by the terms of, the Managing Director Plan. Shareholders first approved long-term incentive arrangements for the Chief Executive Officer and Managing Director in November 2024. The Managing Director Plan continues those arrangements for a further three-year period. The number of Managing Director Performance Rights to be granted to Mr van Hulst under the Managing Director Plan will be determined by dividing 125% of his Total Fixed Remuneration by the
Omni Bridgeway Limited | ACN 067 298 088
| 15
Company VWAP over the 90-trading day period ending on the first day of the relevant Performance Period (Allocation Formula). The number of Managing Director Performance Rights that may be issued to Mr van Hulst (or his nominee) in respect of FY27, FY 28 and FY29 is as follows: Table A:
Participant
Entitlement
Raymond van Hulst
FY27
125% of Total Fixed Remuneration
Company VWAP
No. of Managing Director Performance Rights
CHF 875,000 (equivalent to A$ 1,562,500)1
A$1.642
952,744
Notes:
- Based on an exchange rate of CHF 0.56 to A$1 as at 30 June 2026.
- 90-trading day VWAP ending on 1 July 2026.
As at the date of this Notice, it is not possible to determine in respect of FY28 and FY29 the applicable Company VWAP and therefore the maximum number of Managing Director Performance Rights to be issued to Mr van Hulst for that period. For the purposes of this calculation, the Total Fixed Remuneration will be Mr van Hulst’s FY26 Total Fixed Remuneration of CHF 700,000 (equivalent to A$1,250,000). Set out below are worked examples of the number of Managing Director Performance Rights that may be issued to Mr van Hulst (or his nominees) for FY28 and FY29 based on hypothetical Company VWAP prices of A$1.50, A$1.75 and A$2.00 and the dilutionary effect on Shareholders based on the following assumptions: (a)
Managing Director Performance Rights are issued based on the assumed VWAP and foreign exchange rate;
(b)
the Performance Conditions under the Managing Director Plan are met in full and all of the Managing Director Performance Rights vest and are exercised;
(c)
dilution effect calculations are based on 289,642,218 Shares being the current number of Shares on issue as at 25 September 2026 and does not take into account any Performance Rights on issue that are unvested; and
(d)
no further Shares are issued.
125% of Total Fixed Remuneration (CHF)
Assumed FX Rate (CHF)1
Assumed VWAP (A$)
Maximum number of Managing Director Performance Rights participant is entitled to apply for 2
Number of Shares issued if Managing Director Performance Rights vest 3
Dilution effect on existing Shareholders
875,000
0.56
1.50
1,041,667
1,041,667
0.360%
875,000
0.56
1.75
892,857
892,857
0.308%
875,000
0.56
2.00
781,250
781,250
0.270%
Notes:
- Based on an exchange rate of CHF 0.56 to A$1 as at 30 June 2026.
- Subject to rounding.
Omni Bridgeway Limited | ACN 067 298 088
| 16
- Subject to rounding and any applicable deductions for tax if required.
Vesting of Managing Director Performance Rights is variable dependent on performance against the Company's TSR performance against the Comparator Group over a three-year period. At the end of the Performance Period, the Board will: (a)
determine in its sole discretion whether and, if so, the extent to which, the Performance Conditions applicable to that Performance Period have been satisfied;
(b)
if the Performance Conditions have been satisfied, determine whether a Managing Director Performance Right has vested or lapsed by application of the vesting matrix as detailed below:
Company Percentile Ranking
Percentage of Managing Director Performance Rights Vesting
Below 50th percentile
0%
Equal to the 50th percentile
50%
Between the 50th and 75th percentile
Between 50% and 100%, determined on a straight line basis
Equal to the 75th percentile or above
100%
(c)
(d)
advise the Eligible Participant in writing: (i)
of the applicable number of vested Managing Director Performance Rights now held by that Eligible Participant; and
(ii)
of the applicable number of Managing Director Performance Rights that have lapsed; and
amend the register to reflect the vesting or lapse of the Managing Director Performance Rights.
Under the default terms of the Managing Director Plan and assuming Mr van Hulst is a Good Leaver for the purposes of the Managing Director Plan, upon the cessation of Mr van Hulst’s employment with the Group and subject to Mr van Hulst continuing to be a Good Leaver, he will be entitled to hold his vested Performance Rights in accordance with the Managing Director Plan and will forfeit all of his rights, title and interest in all unvested Performance Rights for no monetary consideration on the date he becomes a Good Leaver, unless the Nomination and Remuneration Committee resolves otherwise. The Board (excluding Mr van Hulst) considers that the grant of Managing Director Performance Rights to Mr van Hulst in accordance with the Managing Director Plan is a cost effective and efficient reward for the Company to make to appropriately incentivise his continued performance and is consistent with the strategic goals and targets of the Company and the terms of his employment contract. A summary of the Managing Director Plan is in Schedule 2 and a summary of the Managing Director Performance Rights is in Schedule 3. Resolution 4 is an ordinary resolution. The Chairman intends to exercise all available proxies in favour of Resolution 4. If the Chairman is appointed as your proxy and you have not specified the way the Chairman is to vote on Resolution 4, by signing and returning the Proxy Form, you are considered to have provided the Chairman with an express authorisation for the Chairman to vote the proxy in accordance with the Chairman's intention, even though Resolution 4 is connected directly or indirectly with the remuneration of a member of the Key Management Personnel.
Omni Bridgeway Limited | ACN 067 298 088
| 17
7.2
Chapter 2E of the Corporations Act The issue of Managing Director Performance Rights to Mr van Hulst constitutes giving a financial benefit to a related party of the Company by virtue of his position as a Director. Absent an available exception, Chapter 2E of the Corporations Act would require the Company to obtain the approval of Shareholders for this financial benefit. The Board has resolved that the reasonable remuneration exception provided by section 211 of the Corporations Act applies to the issue of the Managing Director Performance Rights to Mr van Hulst and the Company will not seek approval for the issue of the Managing Director Performance Rights pursuant to section 208 of the Corporations Act.
7.3
Listing Rule 10.14 Listing Rule 10.14 requires shareholder approval to be obtained where an entity issues, or agrees to issue, Equity Securities under an employee incentive scheme to a director of the entity. If approval is obtained under Listing Rule 10.14, the issue of the Managing Director Performance Rights to Mr van Hulst will not be included in the 15% Placement Capacity. Resolution 4 is being put to Shareholders to seek approval for the issue of Managing Director Performance Rights to Mr van Hulst pursuant to Listing Rule 10.14. Resolution 4 is conditional upon Resolution 3 being passed. If Resolutions 3 or 4 are not passed, the Company will not be able to issue the Managing Director Performance Rights to Mr van Hulst for the FY27, FY28 and FY29 under the Managing Director Plan, and Mr van Hulst will have the right to resign upon the provision of 3 months’ notice as an exception to his general requirement to provide 12 months’ notice. If Shareholder approval for Resolution 4 is obtained, the Company will be permitted to issue Managing Director Performance Rights to Mr van Hulst for FY27, FY28 and FY29 under the Managing Director Plan.
7.4
Specific information required by Listing Rule 10.15 The following additional information in relation to Resolution 4 is provided to Shareholders for the purposes of Listing Rule 10.15: (a)
Subject to the terms of the Managing Director Plan, Managing Director Performance Rights will be granted to Mr van Hulst, who is a Director of the Company, falling within the category of Listing Rule 10.14.1. Any party that Mr van Hulst nominates to receive Managing Director Performance Rights would be expected to fall within the category in Listing Rule 10.14.2 as an associate of Mr van Hulst.
(b)
Pursuant to the terms of the Managing Director Plan, the maximum number of Managing Director Performance Rights Mr van Hulst may be invited to apply for is determined in accordance with the Allocation Formula (refer to Section 7.1 for further details).
(c)
The number of Managing Director Performance Rights that may be issued to Mr van Hulst in respect of FY27 is set out in Table A at Section 7.1. At the date of this Notice, the number of Managing Director Performance Rights that may be issued for FY28 and FY29 cannot be calculated because the Company VWAP in respect of that year will not be known until the conclusion of the relevant Financial Year. The Total Fixed Remuneration will remain unchanged from the figures provided in Table A at Section 7.1 for the purpose of calculating the number of Managing Director Performance Rights to be issued to Mr van Hulst in respect of FY28 and FY29.
Omni Bridgeway Limited | ACN 067 298 088
| 18
7.5
(d)
The current total remuneration package Mr van Hulst is entitled to in respect of FY27 is set out in Table A at Section 7.1.
(e)
Mr van Hulst has previously been granted 428,870 Performance Rights and 1,395,705 Performance Rights under the Employee Incentive Plan adopted by Shareholders at the 2024 Annual General Meeting on 19 November 2024 for FY24 and FY25 respectively.
(f)
The summary of the terms of the Managing Director Plan is contained in Schedule 2 and a summary of the terms of the Managing Director Performance Rights is contained in Schedule 3.
(g)
The Board considers that the grant of Managing Director Performance Rights to Mr van Hulst in accordance with the Managing Director Plan is a cost effective and efficient reward for the Company to make to appropriately incentivise his continued performance and is consistent with the strategic goals and targets of the Company. The value of the Managing Director Performance Rights issued to Mr van Hulst is equal to the VWAP of the Company's Shares at the time of issue multiplied by the number of Managing Director Performance Rights issued (without any discount being applied for time or the uncertainty of whether the relevant Performance Conditions are satisfied).
(h)
The Company will grant the Managing Director Performance Rights to Mr van Hulst no later than three years after the date of the Meeting (or such later date to the extent permitted by any ASX waiver or modification of the Listing Rules).
(i)
Subject to the terms of the Managing Director Plan, the Managing Director Performance Rights to be issued to Mr van Hulst will be granted for no consideration and will have no exercise price.
(j)
No loan will be made to Mr van Hulst in relation to the acquisition of Managing Director Performance Rights or Shares under the Managing Director Plan.
(k)
Each annual report of the Company relating to a period in which Managing Director Performance Rights or Shares have been issued to, or acquired by, a Director, an associate of a Director or other person referred to in Listing Rule 10.14 under the Managing Director Plan will include: (i)
details of any such issue or acquisition; and
(ii)
a statement that approval for the issue or acquisition of those Performance Rights or Shares to those persons was obtained under Listing Rule 10.14.
(l)
Any additional persons referred to in Listing Rule 10.14 who become entitled to participate in the Managing Director Plan after Resolution 4 is approved and who are not named in this Notice will not participate until approval is obtained under Listing Rule 10.14.
(m)
A voting exclusion statement is included in the Notice for Resolution 4.
Board Recommendation The Board (excluding Mr van Hulst) recommend that Shareholders vote in favour of Resolution 4.
8
RESOLUTION 5 – APPROVAL OF EXECUTIVE PLAN
8.1
General Background Resolution 5 seeks Shareholder approval, pursuant to Listing Rule 7.2, Exception 13(b), to adopt the Executive Plan and to facilitate the issuance of incentive securities in the form of Performance Rights
Omni Bridgeway Limited | ACN 067 298 088
| 19
(and Shares issued upon the exercise of Performance Rights) to eligible employees, directors and other parties eligible for participation in the Executive Plan (Participants). The Executive Plan is a new incentive plan for global leadership team members and potential successors designed to align the interests of Participants with the interests of Shareholders by providing an opportunity for Participants to acquire and retain an equity interest in the Company and therefore directly participate in the future success of the Company over the medium to long-term. A summary of the material terms of the Executive Plan is set out in Schedule 2. The Directors consider that the Executive Plan, in conjunction with the Team Carried Interest Plan, is a cost effective and efficient means for the Company to incentivise global leadership and is preferable to alternative forms of incentives such as increased fixed remuneration or cash bonuses. The Executive Plan is designed to deliver enterprise-wide accountability and incentivise sustained high-quality performance by aligning the total remuneration outcomes of Participants with the growth in the Company's earnings and value. Any such grants would be made on such terms as the Board determines appropriate. This limb is designed to provide the Board with discretion to recognise exceptional performance or to incentivise new or senior leadership and is strictly subject to the overall cap on the number of Equity Securities which can be issued under the Executive Plan. Resolution 5 is an ordinary resolution and the Chairman intends to exercise all available proxies in favour of Resolution 5. If the Chairman is appointed as your proxy and you have not specified the way the Chairman is to vote on Resolution 5, by signing and returning the Proxy Form, you are considered to have provided the Chairman with an express authorisation for the Chairman to vote the proxy in accordance with the Chairman’s intention, even though Resolution 5 is connected directly or indirectly with the remuneration of Key Management Personnel.
8.2
Listing Rule 7.1 and Listing Rule 7.2, Exception 13(b) Refer to Section 6.2 for a summary of Listing Rule 7.1 and Listing Rule 7.2, Exception 13(b). If Resolution 5 is passed, the Company will be able to issue Performance Rights under the Executive Plan to eligible Participants over a period of three years from the date of the Meeting without impacting the Company’s 15% Placement Capacity and without requiring Shareholder approval under Listing Rule 7.1. If Resolution 5 is not passed, the Company will still be able to proceed with the issue of the Performance Rights under the Executive Plan, however such issues will count towards the Company’s 15% Placement Capacity. Shareholder approval is required before any Director can be issued Performance Rights under the Executive Plan.
8.3
Specific information required by Listing Rule 7.2, Exception 13(b) The following additional information in relation to Resolution 5 is provided to Shareholders for the purposes of Listing Rule 7.2, Exception 13(b): (a)
a summary of the material terms of the Executive Plan is set out in Schedule 2;
(b)
the Company has not issued any Equity Securities under the Executive Plan as this is the first time that Shareholder approval is being sought for the adoption of the Executive Plan;
(c)
the maximum number of Equity Securities proposed to be issued under the Executive Plan following Shareholder approval is 10,000,000 Performance Rights. This amounts to approximately 3.45% of the current issued share capital of the Company as at 25 September 2026. There is no obligation on the Company to, or guarantee that the Company will, issue the maximum number of Equity Securities. The maximum number of Equity Securities simply sets a "cap" for the purposes of Shareholder approval; and
Omni Bridgeway Limited | ACN 067 298 088
| 20
(d)
8.4
a voting exclusion statement has been included in the Notice for Resolution 5.
Directors' Recommendation The Directors are excluded from voting on Resolution 5 pursuant to the Listing Rules as they are eligible to participate in the Executive Plan. Accordingly, the Directors decline to make a recommendation to Shareholders on Resolution 5.
9
RESOLUTION 6 – APPROVAL OF THE RIGHT TO EQUITY SETTLE TEAM CARRIED INTEREST PLAN AWARDS
9.1
General Background Resolution 6 seeks Shareholder approval, pursuant to Listing Rule 7.2, Exception 13(b), for the Company to have the right to satisfy some or all of the Team Carried Interest Plan eligible participants' (TCI Participants) payout by procuring the issue or transfer of Shares instead of cash (TCI Equity Settlement). The Team Carried Interest Plan governs the terms upon which Participants hold Carried Interest Points, entitling them to a share (capped at 25%) of the carried interest the Company actually receives from its Funds, with the remaining 75% retained for the Company and its Shareholders. Distributions under the Team Carried Interest Plan are by default to be paid in cash. However, as part of its ongoing liquidity management, the Company is seeking the flexibility to be able to settle distributions in Shares from time to time, and thereby release the corresponding cash reserved for such distributions to fund general corporate activities. The number of Shares to be issued for this purpose would be determined by the Nomination and Remuneration Committee using the Company's VWAP over an appropriate period. Cash settlement would remain the default. The approval sought is enabling only: it does not commit the Company to settling any distribution in Shares, and the Company would do so only where it considers this beneficial to its liquidity management at the relevant time. Resolution 6 is an ordinary resolution and the Chairman intends to exercise all available proxies in favour of Resolution 6. If the Chairman is appointed as your proxy and you have not specified the way the Chairman is to vote on Resolution 6, by signing and returning the Proxy Form, you are considered to have provided the Chairman with an express authorisation for the Chairman to vote the proxy in accordance with the Chairman’s intention, even though Resolution 6 is connected directly or indirectly with the remuneration of Key Management Personnel.
9.2
Listing Rule 7.1 and Listing Rule 7.2, Exception 13(b) Refer to Section 6.2 for a summary of Listing Rule 7.1 and Listing Rule 7.2, Exception 13(b). If Resolution 6 is passed, the Company will be able to issue or transfer Shares to satisfy Team Carried Interest Plan payouts over a period of three years from the date of the Meeting without impacting the Company’s 15% Placement Capacity and without requiring Shareholder approval under Listing Rule 7.1. If Resolution 6 is not passed, TCI payouts will continue to be satisfied in cash and the Company will not be able to equity settle those payouts without such issues counting towards the Company’s 15% Placement Capacity. Shareholder approval is required before any Director can be issued Shares under TCI Equity Settlement arrangements.
Omni Bridgeway Limited | ACN 067 298 088
| 21
9.3
Specific information required by Listing Rule 7.2, Exception 13(b) The following additional information in relation to Resolution 6 is provided to Shareholders for the purposes of Listing Rule 7.2, Exception 13(b):
9.4
(a)
A summary of the key terms of the Team Carried Interest Plan is set out in Section 4.2(b);
(b)
the Company has not issued any Shares to satisfy Team Carried Interest Plan payouts as this is the first time that Shareholder approval is being sought for TCI Equity Settlement arrangements;
(c)
the maximum number of Shares proposed to be issued or transferred to satisfy Team Carried Interest Plan payouts following Shareholder approval is 15,000,000 Shares. This amounts to approximately 5.18% of the current issued share capital of the Company as at 25 September 2026. There is no obligation on the Company to, or guarantee that the Company will, issue the maximum number of Shares. The maximum number of Shares simply sets a "cap" for the purposes of Shareholder approval; and
(d)
a voting exclusion statement has been included in the Notice for Resolution 6.
Directors' Recommendation The Directors are excluded from voting on Resolution 6 pursuant to the Listing Rules as they are eligible to participate in the Team Carried Interest Plan. Accordingly, the Directors decline to make a recommendation to Shareholders on Resolution 6.
10
RESOLUTION 7 – APPROVAL OF INDEMNIFIED PERSONS' DEEDS OF INDEMNITY, INSURANCE AND ACCESS
10.1 General Each of the persons listed in Schedule 4 (Indemnified Persons) are senior employees who have entered into a deed of indemnity, insurance and access with the Company (Deed of Indemnity, Insurance and Access) prior to the Meeting. It is generally recognised that an officer or former officer of a company may face considerable difficulty in properly answering or defending any claim made against them, particularly, as is often the case, where the claim is brought after the person ceases to hold office. Difficulties may arise by reason of the following: (a)
No indemnity after cessation of Office While a company's constitution provides officers with an indemnity in respect of claims made while they hold office, the indemnity arguably ceases if they cease to hold office and does not extend to cover roles as an officer of a body corporate associated with the company. Without the benefit of an indemnity, the cost of defending such a claim in respect of the actions of an officer or former officer, even if the claim is ultimately proven to be without merit, can be considerable and beyond the financial resources of the individual officer.
(b)
Maintenance of insurance policies Officers' insurance policies generally only provide cover for claims made during the currency of the insurance policy. Generally, unless insurance premiums continue to be paid after the time the officer ceases to hold office, claims made after cessation of office will not be covered by the insurance policy. The cost to a former officer of personally maintaining insurance cover after ceasing to hold office can be prohibitive, particularly given the number of years for which insurance must be maintained and given the former officer is unlikely to be receiving income from the company.
Omni Bridgeway Limited | ACN 067 298 088
| 22
(c)
Access to Board papers In accordance with section 198F of the Corporations Act, officers have a right to inspect the books of the company:
(i)
whilst they hold office; and
(ii)
for seven years after ceasing to hold office, at all reasonable times for the purposes of a legal proceeding to which the person is a party, that the person proposes in good faith to bring or that the person has reason to believe will be brought against them.
Despite this statutory right, officers may require access to company documents which are relevant to the officer's office and not strictly required for the purpose of anticipated, threatened or commenced legal proceedings. Furthermore, although a proceeding may be instituted within six years after a cause of action arises, that six-year period is calculated from the date the damage is found to have occurred – this may be long after the conduct which allegedly caused the damage occurred. Given these difficulties, a person may be unwilling to become or to remain as an officer of a company without suitable protection being provided by the company. The benefit to such company in providing such protection is that it will continue to be able to attract persons of suitable expertise and experience to act as officers. Resolution 7 is an ordinary resolution. The Chairman intends to exercise all available proxies in favour of Resolution 7.
10.2 Summary of the Deed of Indemnity, Insurance and Access The Company has entered into Deeds of Indemnity, Insurance and Access, which require: (a)
the Company to indemnify the Indemnified Persons during their Office and after the cessation of that Office, in respect of certain claims made against the Indemnified Persons in relation to the period of their Office to the extent allowable under the Corporations Act;
(b)
the Company to use its reasonable endeavours (subject to cost and availability) to maintain an insurance policy and pay the premiums of insurance as assessed at market rates for each Indemnified Person to the extent available under the Corporations Act, in respect of certain claims made against him or her in relation to the period of his or her Office (except to the extent such insurance cannot be procured at a reasonable cost or is otherwise unavailable to the Company) and to continue to pay those premiums for a period of up to seven years following the termination of their Office; and
(c)
the Company to provide each Indemnified Person with access, upon ceasing to hold Office and for a period of up to seven years following that cessation, to any Group Company records which are either prepared by or provided to the Indemnified Person during the period which the person held Office.
10.3 Summary of indemnity and insurance provisions in the Corporations Act In considering Resolution 7, please note the following limitations in the Corporations Act concerning the provision of indemnities and insurance to Company officers. The Deeds of Indemnity, Insurance and Access for which Shareholder approval is sought under Resolution 7 comply with these limitations. (a)
Section 199A of the Corporations Act
Omni Bridgeway Limited | ACN 067 298 088
| 23
The Corporations Act sets out specific prohibitions to the Company's ability to grant indemnities for liabilities and legal costs. The Company is prohibited from indemnifying its Officers against a liability if it is a liability: (i)
to the Company and any of its related bodies corporate;
(ii)
to a third party that arose out of conduct involving a lack of good faith; or
(iii)
for a pecuniary penalty order or a compensation order under the Corporations Act (such orders being made for breaches such as breaches of director's duties, the related party rules and insolvent trading rules). The Company is also prohibited from indemnifying its officers against legal costs incurred: (i)
in defending actions where an officer is found liable for a matter for which they cannot be indemnified by the Company as set out immediately above;
(ii)
in defending criminal proceedings where the officer is found guilty;
(iii)
in defending proceedings brought by the ASIC or a liquidator for a court order if the grounds for making the order are found by the court to be established; or
(iv)
in connection with proceedings for relief to the director under the Corporations Act where the court denies the relief.
(b)
Section 199B of the Corporations Act If the Company, or a related body corporate of the Company, pays the premium on an insurance policy in favour of a Director, section 199B of the Corporations Act requires the Company to ensure that the relevant contract of insurance does not cover liabilities incurred by the officer arising out of conduct involving either:
(i)
a wilful breach of duty in relation to the Company; or
(ii)
contravention of the provisions relating to an officer making improper use of information or improper use of their position for their advantage or gain, or to the detriment of the Company.
10.4 Section 200B of the Corporations Act In accordance with section 200B of the Corporations Act, to give a benefit in connection with a person's retirement from an office, the Company must obtain Shareholder approval in the manner set out in section 200E of the Corporations Act. The Directors consider that as the: (a)
proposed payment of insurance premiums;
(b)
benefit of the indemnity in relation to liabilities incurred during the period an Officer holds office; and
(c)
Officer's access to Group entity records,
continue for a period of up to seven years after the Officer ceases to hold Office, each may be viewed as the provision of a benefit given "in connection with" the officer’s retirement for the purposes of section 200B of the Corporations Act.
Omni Bridgeway Limited | ACN 067 298 088
| 24
10.5 Board Recommendation The Board recommends that Shareholders vote in favour of Resolution 7. Neither the Directors nor the Company are aware of any other information that would be reasonably required by Shareholders to make a decision in relation to the benefits contemplated by Resolution 7.
Omni Bridgeway Limited | ACN 067 298 088
| 25
Schedule 1 – Definitions In the Notice and the Explanatory Memorandum, words importing the singular include the plural and vice versa. $ means Australian Dollars 15% Placement Capacity has the meaning given in Section 6.2. AEDT means Australian Eastern Daylight Time. Allocation Formula has the meaning given in Section 7.1. Annual Report means the Directors' Report, the Financial Report and the Auditor's Report in respect to the Financial Year ended 30 June 2026. ASIC means the Australian Securities and Investments Commission. ASX means ASX Limited (ACN 008 624 691) and, where the context permits, the Australian Securities Exchange operated by ASX. Auditor's Report means the independent auditor’s report on the Financial Report and a report on the Remuneration Report. Bad Leaver has the meaning given in Schedule 2. Board means the board of Directors of the Company. Chairman means the person appointed to chair the Meeting, or any part of the Meeting, convened by the Notice. Change of Control Event: means the occurrence of a Company announcement that its shareholders have at a Court convened meeting of shareholders voted in favour, by the necessary majority, of a proposed scheme of arrangement (excluding a merger by way of scheme of arrangement for the purposes of a corporate restructure (including change of domicile, or any reconstruction, consolidation, sub-division, reduction or return) of the issued capital of the Company) and the Court, by order, approves the scheme of arrangement; a Takeover Bid is announced, has become unconditional; and the person making the Takeover Bid has a Relevant Interest in 50% or more of the issued Shares; or any person acquires a Relevant Interest in 50.1% or more of the issued Shares by any other means. Carried Interest Point (CIP) has the meaning given in Section 4.2(b). Closely Related Party has the meaning given in section 9 of the Corporations Act. Company means Omni Bridgeway Limited (ACN 067 298 088). Company's TSR means the total shareholder return of the Company over the Performance Period calculated as follows:
((End date share price - start date share price) + gross dividends) ----------------------------------------------------------Start date share price
x 100
Comparator Group means a benchmark group comprising those constituents of the S&P/ASX Small Ordinaries Index (XSO) that are classified in the GICS Financials sector, determined as at the first day of the performance period.
Omni Bridgeway Limited | ACN 067 298 088
| 26
Constitution means the constitution of the Company, as amended from time to time. Corporations Act means the Corporations Act 2001 (Cth). Deed of Indemnity, Insurance and Access has the meaning given in Section 10.1. Director means a director of the Company. Directors' Report means the annual directors' report prepared under Chapter 2M of the Corporations Act for the Company and its controlled entities. Employee Share Trust means any employee share trust established by or on behalf of the Company from time to time. Eligible Participant has the meaning given in Section 6.1. Equity Security has the same meaning as in the Listing Rules. Executive Plan has the meaning given in Resolution 5. Explanatory Memorandum means the explanatory memorandum which forms part of the Notice. Financial Report means the annual financial report prepared under Chapter 2M of the Corporations Act for the Company. Financial Year means a period from 1 July in any year to 30 June in the following year. Fund means a fund or investment structure of which a Group Company is the appointed investment advisor or investment manager or service provider. FY means the financial year of the Company ending on 30 June in that year, for example for FY26 on 30 June 2026. Good Leaver has the meaning given in Schedule 2. Group means the Company and each Group Company. Group Company means any one of the Company or a related body corporate (as defined in the Corporations Act) of the Company. Indemnified Persons has the meaning given in Section 10.1. Insurance Run Off Period has the meaning given in Resolution 7. Invitation means an invitation made to an Eligible Participant to participate in the Managing Director Plan or Executive Plan and be issued Performance Rights in accordance with that Plan. Key Management Personnel or KMP has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group. Listing Rules means the listing rules of ASX. Managing Director Plan has the meaning given in Resolution 3. Managing Director Performance Rights has the meaning given in Section 7.1. Meeting has the meaning in the introductory paragraph of the Notice.
Omni Bridgeway Limited | ACN 067 298 088
| 27
Nomination and Remuneration Committee means the Nomination and Remuneration Committee of the Board as established from time to time. Notice means the notice of meeting which comprises of the notice, agenda, Explanatory Memorandum and Proxy Form. Office means an office as an Officer. Officer has the same meaning, as the context requires, given in paragraphs (a) and (b) of the definition of “officer” of a corporation, or in paragraphs (a) and (b) of the definition of “officer” of an entity that is neither an individual nor a corporation, in each case in section 9 of the Corporations Act. Participants has the meaning given in Section 8.1. Performance Condition means, in relation to each Performance Right, the performance related conditions which must be satisfied or circumstances which must exist before a Performance Right can be exercised. Performance Period in respect of a Performance Right means the period commencing on 1 July of the Financial Year in which the applicable invitation is made to a participant and ending 36 months later. Performance Rights means a performance right which converts into a Share on satisfaction of a specified milestone. Proxy Form means the proxy form attached to the Notice. Relevant Interest has the meaning given in the Corporations Act. Remuneration Report means the remuneration report of the Company contained in the Directors' Report in respect to the Financial Year ended 30 June 2026. Resolution means a resolution detailed in the Notice. Schedule means a schedule to this Explanatory Memorandum. Section means a section of this Explanatory Memorandum. Share means a fully paid ordinary share in the capital of the Company. Shareholder means a holder of Shares in the Company. Share Registry means Computershare Investor Services Pty Limited. Strike has the meaning given in Section 4.4. Takeover Bid has the meaning given in the Corporations Act. Total Fixed Remuneration means in respect of an Eligible Participant, the fixed base gross annual salary plus, if applicable, annual superannuation entitlement but for the avoidance of doubt excluding any other monetary entitlements including to any incentive awards under any Employee Incentive Plan or any other plans operated by a Group Company from time to time, save that if: (a) the applicable Eligible Participant was not an Eligible Participant on the first day of the Financial Year; or (b) the base salary payable to the applicable Eligible Participant has been varied during the applicable Financial Year, such amount shall be adjusted proportionately and determined by the Nomination and Remuneration Committee.
Omni Bridgeway Limited | ACN 067 298 088
| 28
Team Carried Interest Plan means the team carried interest plan adopted by the Company on 7 August 2026 as detailed in Section 4.2(b). TCI Co has the meaning given in Section 9.1. TCI Co Board has the meaning given in Section 9.1. TCI Equity Settlement has the meaning given in Resolution 6. TCI Participants has the meaning given in Section 9.1. VWAP means volume weighted average price as defined in the Listing Rules.
Omni Bridgeway Limited | ACN 067 298 088
| 29
Schedule 2 – Summary of the Managing Director Plan and Executive Plan A summary of the terms of the Managing Director Plan and Executive Plan is set out below. For the purposes of this Schedule 2, a reference to "the Plan" is a reference to the Managing Director Plan or the Executive Plan (as the context requires). The full terms of the Managing Director Plan and Executive Plan may be inspected at the registered office of the Company during normal business hours. 1
Purpose: The Managing Director Plan governs the award of long-term incentive Performance Rights to the Chief Executive Officer and Managing Director and the terms and conditions that apply to such Performance Rights. It aims to align the interests of the Chief Executive Officer and Managing Director with those of the Company and its Shareholders, increasing Shareholder value by motivating the Chief Executive Officer and Managing Director and providing an opportunity to share in the success of the Company by acquiring an ownership interest in it. The Executive Plan is a long-term incentive plan aimed at attracting, incentivising and retaining Eligible Participants (defined below), aligning the interests of Eligible Participants with those of the Company and its Shareholders, increasing Shareholder value by motivating Eligible Participants and providing Eligible Participants with an opportunity to share in the success of the Company by acquiring an ownership interest in it.
2
Eligible Participant: The Chief Executive Officer and Managing Director as determined by the Nomination and Remuneration Committee to be eligible to participate in the Managing Director Plan. Members of the global leadership team (excluding the Managing Director) and potential successors determined by the Nomination and Remuneration Committee to be eligible to participate in the Executive Plan
3
Invitation: The Nomination and Remuneration Committee may, from time to time, in its absolute discretion, invite any Eligible Participant to apply for up to a specified number of Performance Rights in such proportion or number of tranches determined by the Nomination and Remuneration Committee, subject to the terms set out in the Plan (Invitation).
4
Grant of Performance Rights: The Nomination and Remuneration Committee may resolve to issue Performance Rights to Eligible Participants under the Plan, in accordance with the Plan rules, the Corporations Act and the ASX Listing Rules. The Nomination and Remuneration Committee will, in respect of the Eligible Participant, or (where applicable) his or her nominee (Participant), issue the Performance Rights which are the subject of the relevant application to such person.
5
Satisfaction of Performance Conditions: The Board, on recommendation from the Nomination and Remuneration Committee will determine the Performance Conditions attaching to the Performance Rights which will be specified in the Invitation. The Nomination and Remuneration Committee shall recommend to the Board whether a Performance Right shall vest in accordance with the terms of the Invitation and the Plan and, following the Board determination, the Company shall issue to the Participant a written notice which sets out the number of the Participant's Performance Rights that have vested and the number of the Participant's Performance Rights that have lapsed. The Performance Conditions attaching to the Performance Rights: (a)
the vesting of the Performance Rights issued under the Managing Director Plan depends on the Company’s TSR performance relative to a Comparator Group over a three-year period. The vesting matrix provides for 50% vesting at the 50th percentile, pro rata straight-line vesting between 50% and 100% for performance between the 50th and 75th percentile, and 100% vesting at or above the 75th percentile; and
(b)
the vesting of the Performance Rights issued under the Executive Plan depends on three Company performance metrics measured over a 3-year period from the start of the first plan year as follows:
Omni Bridgeway Limited | ACN 067 298 088
| 30
(i)
50% of the total award is determined by the Company's total shareholder return relative to the constituents of the Comparator Group, measured using the Company’s VWAP over the 90-trading days ending on the first and last day of the Performance Period respectively, 50% vesting at the 50th percentile, pro rata straight-line vesting between 50% and 100% for performance between the 50th and 75th percentile, and 100% vesting at or above the 75th percentile;
(ii)
25% of the total award is determined by the Company's return on equity measured as a three-year average, with no vesting below 12.5%, 50% vesting at 12.5%, full vesting at or above 17.5% and straight-line vesting in between; and
(iii)
25% of the total award is determined by the Company's growth in assets under management also measured as the compound annual growth rate over the Performance Period, with no vesting below 10%, 50% vesting at 10%, full vesting at or above 15% and straight-line vesting in between.
6
Exercise on Vesting: Depending upon the jurisdiction of residence of the applicable Participant, a vested Performance Right may be exercised from the date of vesting up to the expiry date or will automatically be exercised upon vesting.
7
Ceasing to be Eligible Participant: unless the Nomination and Remuneration Committee resolves otherwise, any Participant who ceases to be an Eligible Participant: (c)
who is a Bad Leaver will automatically forfeit all of his or her rights, title and interest in all unvested and vested Performance Rights held directly or via a nominee for no monetary consideration on the date the Participant becomes a Bad Leaver;
(d)
who is a Good Leaver will:
(e)
(i)
automatically forfeit all of his or her rights, title and interest in all unvested Performance Rights for no monetary consideration on the date the Participant becomes a Good Leaver; and
(ii)
subject at all times to continuing to be a Good Leaver, continue to hold his or her vested Performance Rights in accordance with the Plan.
Bad Leaver means a Participant who has: (i)
been given notice of termination of his or her employment or office or other applicable contractual arrangement with the Group; or
(ii)
given notice of resignation or termination of the same, (each, a Departure) and in either case, the Nomination and Remuneration Committee determines to be a Bad Leaver, either at the time of Departure or at any time thereafter.
(f)
Without fettering in any way the discretion of the Nomination and Remuneration Committee to determine a Participant to be a Bad Leaver: (i)
it is anticipated that a Participant whose Departure follows the occurrence of one or more of the following circumstances shall be determined to be a Bad Leaver: (a)
anything which entitles a Group Company to dismiss or terminate the Participant's contractual arrangements on immediate notice;
(b)
an act or omission of the Participant which may give rise to an indictable or criminal offence;
(c)
an act or omission of the Participant determined by the Board to be wilful misconduct, negligence, defalcation or breach of law; or
Omni Bridgeway Limited | ACN 067 298 088
| 31
(d)
(ii)
8
an act or omission of the Participant determined by the Board to be a material breach of the Participant's contractual or other legal or equitable duties as an employee or officer or service provider of a Group Company or to bring such entity into disrepute; and
it is anticipated that a Participant whose Departure results from their death, permanent disability or genuine retirement shall not be determined to be a Bad Leaver subject, in the case of retirement, to such Participant remaining in the reasonable opinion of the Nomination and Remuneration Committee to be retired.
(g)
Good Leaver means a Participant in respect of whom a Departure has occurred, in circumstances other than as a Bad Leaver.
(h)
A Good Leaver will be deemed to breach the Good Leaver post Departure conditions in any of the following circumstances if, following their Departure but prior to the receipt by the Good Leaver of all of their remaining entitlements pursuant to any vested Performance Rights, the Nomination and Remuneration Committee determines that the Good Leaver: (i)
failed to comply with any ongoing contractual obligations to any member of the Group;
(ii)
in any capacity whatsoever carries on, operates or is engaged, interested or employed in any business operated in any format which carries on an activity the same as or similar to or competitive with any business of the Group;
(iii)
interferes with or disrupts directly or indirectly (or attempts to interfere or disrupt) the relationship, contractual or otherwise, between any member of the Group or a Fund and any of its existing or prospective investors or counterparties;
(iv)
induces, solicits (or attempts to induce or solicit) any existing or prospective investors or counterparties of a member of the Group or a Fund to deal with the Good Leaver directly or indirectly;
(v)
induces, encourages or solicits directly or indirectly any person employed or otherwise engaged by a member of the Group but excluding any person employed or engaged in an administrative, clerical, manual or secretarial capacity, to leave the employment or agency of or to cease providing services to the Group;
(vi)
employs or engages any person or entity who was previously employed or engaged by a member of the Group but shall not include any employee employed in an administrative, clerical, manual or secretarial capacity; or
(vii)
directly or indirectly through others, makes any statement that disparages or criticises a member of the Group or a Fund or any of its or their officers, directors, members, managers, employees or agents, or which causes or is calculated or likely to cause damage or harm to the business interests or reputation of the Group or a Fund or any of its or their officers, directors, members, managers, employees or agents.
Malus and Clawback: Malus If any Participant or former Participant is determined by the Nomination and Remuneration Committee to have, whether alone or in conjunction with others: (a)
wilfully or deliberately engaged in conduct which:
Omni Bridgeway Limited | ACN 067 298 088
| 32
(i)
was fraudulent or dishonest in connection to the business of a Group Company; or
(ii)
has resulted in material: (a)
reputational damage to any Group Company; or
(b)
misstatements or omissions in the financial statements of the Company,
save where such conduct was in compliance with the Group's risk management processes, procedures and authorisations as in force at the applicable time; (b)
committed gross misconduct; or
(c)
been convicted of an offence or has an adverse judgment entered against them in connection with the affairs of any Group Company which is of a serious nature, (each a Malus Event), the Nomination and Remuneration Committee may take any action it considers appropriate with respect to the unvested Performance Rights held by such Participant, including declaring: (i)
such Performance Rights to immediately expire for no consideration; and/or
(ii)
the applicable terms and conditions, including the Performance Conditions, to be amended in such manner as the Board may determine in its absolute discretion (subject to compliance with the Listing Rules).
Clawback If a Clawback Participant is determined by the Nomination and Remuneration Committee to have, during the Clawback Period, whether alone or in conjunction with others: (a)
wilfully or deliberately engaged in conduct which: (i)
was fraudulent or dishonest in connection to the business of a Group Company; or
(ii)
has resulted in material: (a)
reputational damage to any Group Company; or
(b)
misstatements or omissions in the financial statements of the Company,
save where such conduct was in compliance with the Group's risk management processes, procedures and authorisations as in force at the applicable time; or (b)
committed gross misconduct;
(each a Clawback Event), the Nomination and Remuneration Committee may determine that: (c)
any unvested Performance Rights held by the Clawback Participant lapse;
(d)
any Clawback Vested Performance Rights lapse;
(e)
the Clawback Participant is required to repay the Company as a debt an amount not exceeding the higher of (i) the value of Shares issued under the Plan or in respect of Clawback Vested Performance Rights and (ii) the amount received by the Clawback Participant upon sale of such Shares, in both cases, after accounting for any tax expenses or taxes paid and any applicable costs of sale of Shares such as brokerage costs; and/or
(f)
take any other action that the Nomination and Remuneration Committee considers appropriate and which is agreed with the relevant Clawback Participant.
Omni Bridgeway Limited | ACN 067 298 088
| 33
The following terms apply for the purposes of the malus and clawback provisions of the Plans: Clawback Participant means an Eligible Participant, or where a participant is a nominee, the Eligible Participant by virtue of whom such nominee holds Performance Rights. Clawback Period means a period commencing on the date the applicable Clawback Participant became a Participant and ending on the earlier of (i) a Change of Control Event and (ii) the date which is 12 months from when the applicable Clawback Participant ceased to be an Eligible Participant. Clawback Vested Performance Rights means any Performance Rights held by a Clawback Participant which vested in the Relevant Period. Relevant Period means the period commencing on the date the Nomination and Remuneration Committee determines the Clawback Event to have first commenced and ending on the expiry of the Clawback Period. The malus and clawback provisions can apply to former Participants. 9
Lapsing of Performance Rights: A Performance Right lapses: (a)
in the case of a vested Performance Right, on the expiry date; and
(b)
in the case of an unvested Performance Right, on the earlier of: (i)
the date of the issue of a notice of lapse by the Company; or
(ii)
otherwise in accordance with the Plan.
10
Issue of Shares on vesting of Performance Rights: Subject to the Corporations Act, the Listing Rules and the Plan, the Company must issue to, or procure the transfer to, the Participant (or to the trustee of the Employee Share Trust to be held on behalf of the Participant) the number of Shares the Participant is entitled to be issued in respect of vested Performance Rights that are exercised.
11
Share ranking: All Shares issued under the Plans upon the exercise of vested Performance Rights will rank equally with all other issued Shares.
12
Change of Control: All unvested Performance Rights automatically vest and are deemed to have been exercised automatically where one of the following events has occurred or, in the opinion of the Board, will occur: (a)
the Company announces that its Shareholders have at a Court convened meeting of shareholders voted in favour, by the necessary majority, of a proposed scheme of arrangement (excluding a merger by way of scheme of arrangement for the purposes of a corporate restructure (including change of domicile, consolidation, sub-division, reduction or return) of the issued capital of the Company) and the Court, by order, approves the scheme of arrangement;
(b)
a Takeover Bid:
(c) 13
(i)
is announced;
(ii)
has become unconditional; and
(iii)
the person making the Takeover Bid has a Relevant Interest in 50% or more of the Shares; or
any person acquires a Relevant Interest in 50% or more of the Shares by any other means.
Transferability: A Participant may not transfer, assign, novate, grant a security interest or otherwise dispose of or deal with a Performance Right or any interest in them other than in respect of the
Omni Bridgeway Limited | ACN 067 298 088
| 34
transmission of a Performance Right to a Participant's legal representative upon death or legal incapacity, with the prior approval of the Nomination and Remuneration Committee or as required by law, and any purported disposal or dealing will not be recognised in any capacity by the Company and shall, unless otherwise determined by the Nomination and Remuneration Committee, result in the affected Performance Rights lapsing immediately. 14
General Provisions: Whenever the number or type of securities issuable upon exercise of a Performance Right is adjusted pursuant to the Plan, the Company shall give notice of the adjustment to the Participant and the ASX, as required, together with calculations on which the adjustment is based.
15
Amendments: Subject to the Plan and the Listing Rules, the Board may from time to time amend or supplement the rules of a Plan in any respect. However, in respect of an issued Performance Right no amendment made to the terms and conditions of the Plan or the Performance Rights shall bind a Participant in respect of such Performance Rights unless such amendment: (a)
is consented to in writing by a Participant; or
(b)
is introduced for complying with, or conforming to, the Listing Rules, or State or Commonwealth legislation governing or regulating the maintenance or operation of the Plan or similar plans.
Omni Bridgeway Limited | ACN 067 298 088
| 35
Schedule 3 - Terms and Conditions of the Managing Director Performance Rights 1
Issue Price: Managing Director Performance Rights issued or granted under the Managing Director Plan to Mr Raymond van Hulst (or his nominee) (Holder) will be issued for no consideration and shall have no exercise price.
2
Expiry Date: means the day ending at 5.00pm (AEDT) on the date 15 years after the date of issue or such earlier date as may be notified to the Holder by the Nomination and Remuneration Committee following a change in applicable law or upon the direction of an applicable regulatory authority (including ASX), save that such date shall be at least 20 business days after: (a)
the date of notification of the change to the Expiry Date; or
(b)
if the End Date (being, the last day of a Performance Period) occurs during the period referred to in (a), the date of issue of a vesting notice or a lapse notice; or
(c)
if the End Date occurs before the period referred to in (a) but no vesting notice or lapse notice has been issued as the Nomination and Remuneration Committee is still determining whether the Performance Condition has been satisfied, the date of a vesting notice or a lapse notice.
3
Determination of Performance Conditions: The Managing Director Performance Rights will vest subject to the Company’s TSR performance relative to a Comparator Group over a three-year period. The vesting matrix provides for 50% vesting at the 50th percentile, pro rata straight-line vesting between 50% and 100% for performance between the 50th and 75th percentile, and 100% vesting at or above the 75th percentile.
4
Satisfaction of Performance Conditions: At the end of each Performance Period, the Nomination and Remuneration Committee will: (a)
determine in its sole discretion whether and, if so, the extent to which, the Performance Conditions applicable to that Performance Period have been satisfied;
(b)
if the Performance Conditions have been satisfied, determine whether a Managing Director Performance Right has vested or lapsed;
(c)
advise the Holder in writing:
(d)
(i)
of the applicable number of vested Managing Director Performance Rights now held by the Holder; or
(ii)
of the applicable number of Managing Director Performance Rights that have lapsed; and
amend the register to reflect the vesting or lapse of the Managing Director Performance Rights.
5
Exercise on Vesting: A vested Managing Director Performance Right may be exercised from the date of vesting up the Expiry Date.
6
Ceasing to be Eligible Participant: If the Holder ceases to be an Eligible Participant and is: (a)
a Bad Leaver, he will automatically forfeit all of his rights, title and interest in all unvested and vested Performance Rights held directly or via a nominee for no monetary consideration on the date the Holder becomes a Bad Leaver;
(b)
a Good Leaver, he will: (i)
automatically forfeit all of his rights, title and interest in all unvested Performance Rights for no monetary consideration on the date the Holder becomes a Good Leaver; and
Omni Bridgeway Limited | ACN 067 298 088
| 36
(ii)
(c)
subject at all times to continuing to be a Good Leaver, continue to hold his vested Performance Rights in accordance with the Managing Director Plan.
Bad Leaver means a Participant who has: (i)
been given notice of termination of his or her employment or office or other applicable contractual arrangement with the Group; or
(ii)
given notice of resignation or termination of the same, (each, a Departure) and in either case, the Nomination and Remuneration Committee determines to be a Bad Leaver, either at the time of Departure or at any time thereafter.
(d)
Without fettering in any way the discretion of the Nomination and Remuneration Committee to determine a Participant to be a Bad Leaver: (i)
(ii)
it is anticipated that a Participant whose Departure follows the occurrence of one or more of the following circumstances shall be determined to be a Bad Leaver: (a)
anything which entitles a Group Company to dismiss or terminate the Participant's contractual arrangements on immediate notice;
(b)
an act or omission of the Participant which may give rise to an indictable or criminal offence;
(c)
an act or omission of the Participant determined by the Board to be wilful misconduct, negligence, defalcation or breach of law; or
(d)
an act or omission of the Participant determined by the Board to be a material breach of the Participant's contractual or other legal or equitable duties as an employee or officer or service provider of a Group Company or to bring such entity into disrepute; and
it is anticipated that a Participant whose Departure results from their death, permanent disability or genuine retirement shall not be determined to be a Bad Leaver subject, in the case of retirement, to such Participant remaining in the reasonable opinion of the Nomination and Remuneration Committee to be retired.
(e)
Good Leaver means a Participant in respect of whom a Departure has occurred, in circumstances other than as a Bad Leaver.
(f)
A Good Leaver will be deemed to breach the Good Leaver post Departure conditions in any of the following circumstances if, following their Departure but prior to the receipt by the Good Leaver of all of their remaining entitlements pursuant to any vested Performance Rights, the Nomination and Remuneration Committee determines that the Good Leaver: (i)
failed to comply with any ongoing contractual obligations to any member of the Group;
(ii)
in any capacity whatsoever carries on, operates or is engaged, interested or employed in any business operated in any format which carries on an activity the same as or similar to or competitive with any business of the Group;
(iii)
interferes with or disrupts directly or indirectly (or attempts to interfere or disrupt) the relationship, contractual or otherwise, between any member of the Group or a Fund and any of its existing or prospective investors or counterparties;
Omni Bridgeway Limited | ACN 067 298 088
| 37
7
(iv)
induces, solicits (or attempts to induce or solicit) any existing or prospective investors or counterparties of a member of the Group or a Fund to deal with the Good Leaver directly or indirectly;
(v)
induces, encourages or solicits directly or indirectly any person employed or otherwise engaged by a member of the Group but excluding any person employed or engaged in an administrative, clerical, manual or secretarial capacity, to leave the employment or agency of or to cease providing services to the Group;
(vi)
employs or engages any person or entity who was previously employed or engaged by a member of the Group but shall not include any employee employed in an administrative, clerical, manual or secretarial capacity; or
(vii)
directly or indirectly through others, makes any statement that disparages or criticises a member of the Group or a Fund or any of its or their officers, directors, members, managers, employees or agents, or which causes or is calculated or likely to cause damage or harm to the business interests or reputation of the Group or a Fund or any of its or their officers, directors, members, managers, employees or agents.
Malus and Clawback: Malus If the Holder is determined by the Nomination and Remuneration Committee to have, whether alone or in conjunction with others: (a)
wilfully or deliberately engaged in conduct which: (i)
was fraudulent or dishonest in connection to the business of a Group Company; or
(ii)
has resulted in material: (a)
reputational damage to any Group Company; or
(b)
misstatements or omissions in the financial statements of the Company,
save where such conduct was in compliance with the Group's risk management processes, procedures and authorisations as in force at the applicable time; (b)
committed gross misconduct; or
(c)
been convicted of an offence or has an adverse judgment entered against them in connection with the affairs of any Group Company which is of a serious nature, (each a Malus Event), the Nomination and Remuneration Committee may take any action it considers appropriate with respect to the unvested Managing Director Performance Rights held by the Holder, including declaring: (i)
such Managing Director Performance Rights to immediately expire for no consideration; and/or
(ii)
the applicable terms and conditions, including the Performance Conditions, to be amended in such manner as the Board may determine in its absolute discretion (subject to compliance with the Listing Rules).
Omni Bridgeway Limited | ACN 067 298 088
| 38
Clawback If the Holder is determined by the Nomination and Remuneration Committee to have, during the Clawback Period, whether alone or in conjunction with others: (a)
wilfully or deliberately engaged in conduct which: (i)
was fraudulent or dishonest in connection to the business of a Group Company; or
(ii)
has resulted in material: (a)
reputational damage to any Group Company; or
(b)
misstatements or omissions in the financial statements of the Company,
save where such conduct was in compliance with the Group's risk management processes, procedures and authorisations as in force at the applicable time; or (b)
committed gross misconduct;
(each a Clawback Event), the Nomination and Remuneration Committee may determine that: (a)
any unvested Managing Director Performance Rights held by the Holder lapse;
(b)
any Clawback Vested Performance Rights lapse;
(c)
the Holder is required to repay the Company as a debt an amount not exceeding the higher of (i) the value of Shares issued under the Managing Director Plan or in respect of Clawback Vested Managing Director Performance Rights and (ii) the amount received by the Holder upon sale of such Shares, in both cases, after account for any tax expenses or taxes paid and any applicable costs of sale of Shares such as brokerage costs; and/or
(d)
take any other action that the Nomination and Remuneration Committee considers appropriate and which is agreed with the Holder.
The following terms apply for the purposes of the malus and clawback provisions: Clawback Period means a period commencing on the date the Holder became a participant in the Managing Director Plan and ending on the earlier of (i) a Change of Control Event and (ii) the date which is 12 months from when the Holder ceased to be an Eligible Participant for the purposes of the Managing Director Plan. Clawback Vested Performance Rights means any Managing Director Performance Rights held by the Holder which vested in the Relevant Period. Relevant Period means the period commencing on the date the Nomination and Remuneration Committee determines the Clawback Event to have first commenced and ending on the expiry of the Clawback Period. 8
9
Lapsing of Performance Rights: A Managing Director Performance Right lapses: (a)
in the case of a vested Managing Director Performance Right, on the Expiry Date; and
(b)
in the case of an unvested Managing Director Performance Right, on the earlier of: (i)
the date of the issue of a notice of lapse by the Company; or
(ii)
otherwise in accordance with the Managing Director Plan.
Issue of Shares on vesting of Performance Rights: Subject to the Corporations Act, the Listing Rules and the Managing Director Plan, the Company must issue to, or procure the transfer to, the Holder (or
Omni Bridgeway Limited | ACN 067 298 088
| 39
to the trustee of the Employee Share Trust to be held on behalf of the Holder) the number of Shares the Holder is entitled to be issued in respect of vested Managing Director Performance Rights that are exercised. 10
Share ranking: All Shares issued under the Managing Director Plan will rank equally with all other issued Shares.
11
Listing of shares on ASX: The Company will use its best endeavours to obtain official quotation of all Shares issued under the Managing Director Plan on ASX.
12
Change of Control: All unvested Managing Director Performance Rights automatically vest and are deemed to have been exercised automatically where one of the following events has occurred or, in the opinion of the Board, will occur: (a)
the Company announces that its Shareholders have at a Court convened meeting of shareholders voted in favour, by the necessary majority, of a proposed scheme of arrangement (excluding a merger by way of scheme of arrangement for the purposes of a corporate restructure (including change of domicile, consolidation, sub-division, reduction or return) of the issued capital of the Company) and the Court, by order, approves the scheme of arrangement;
(b)
a Takeover Bid:
(c)
(i)
is announced;
(ii)
has become unconditional; and
(iii)
the person making the Takeover Bid has a Relevant Interest in 50% or more of the Shares; or
any person acquires a Relevant Interest in 50.1% or more of the Shares by any other means.
13
Adjustment for bonus issues: If Shares are issued pro rata to Shareholders generally by way of bonus issue, the number of Managing Director Performance Rights to which the Holder is entitled shall be increased by that number of securities which the Holder would have been issued if the Managing Director Performance Rights then held by the Holder were exercised immediately prior to the record date of the bonus issue.
14
Pro rata issues: If during the term of any Managing Director Performance Right, the Company makes a pro rata issue of securities to Shareholders by way of a rights issue, the Holder shall not be entitled to participate in the rights issue in respect of any Managing Director Performance Rights. The Holder will not be entitled to any adjustment to the number of Shares issued under the Managing Director Plan that he is entitled to or adjustment to any Performance Condition which is based, in whole or part, on the Company's share price, as a result of the Company undertaking a rights issue.
15
Adjustment for reconstruction: In the event of any reconstruction (including consolidation, subdivision, reduction or return) of the issued capital of the Company, the number of Managing Director Performance Rights to which the Holder is entitled shall be reconstructed (as appropriate) in accordance with the Listing Rules and in a manner determined by the Board to ensure that no advantage or disadvantage accrues to the Holder as a result of such corporate actions.
16
Hedging transactions: The Holder is prohibited from entering into any transactions (whether through the use of derivatives or otherwise) which seek to mitigate any economic risk or exposure in relation to any Managing Director Performance Rights, including, without limitation, entering into a put option (or similar transaction) in respect of Shares which may become issued pursuant to Managing Director Performance Rights to mitigate the risk of a change in the price of the Shares between the date of the put option and the date the Shares may become issued.
Omni Bridgeway Limited | ACN 067 298 088
| 40
17
18
Amendments: Subject to the Managing Director Plan and the Listing Rules, the Board may from time to time amend or supplement the Managing Director Plan rules in any respect. However, in respect of an issued Managing Director Performance Right no amendment made to the terms and conditions of the Managing Director Plan or the Managing Director Performance Rights shall bind the Holder in respect of such Managing Director Performance Rights unless such amendment: (a)
is consented to in writing by the Holder; or
(b)
is introduced for complying with, or conforming to, the Listing Rules, or State or Commonwealth legislation governing or regulating the maintenance or operation of the Managing Director Plan or similar plans.
Managing Director Plan: The Managing Director Performance Rights are otherwise subject to the terms and conditions of the Managing Director Plan.
Omni Bridgeway Limited | ACN 067 298 088
| 41
Schedule 4 – Indemnified Persons 1.
David Breeney
Omni Bridgeway Limited | ACN 067 298 088
| 42
Need assistance? Omni Bridgeway Limited ABN 45 067 298 088
Phone: 1300 850 505 (within Australia) +61 3 9415 4000 (outside Australia) Online: www.investorcentre.com/contact
YOUR VOTE IS IMPORTANT For your proxy appointment to be effective it must be received by 10:00am (AEDT) on Sunday, 25 October 2026.
Proxy Form How to Vote on Items of Business
Lodge your Proxy Form:
All your securities will be voted in accordance with your directions.
APPOINTMENT OF PROXY
Online:
Voting 100% of your holding: Direct your proxy how to vote by marking one of the boxes opposite each item of business. If you do not mark a box your proxy may vote or abstain as they choose (to the extent permitted by law). If you mark more than one box on an item your vote will be invalid on that item.
Lodge your vote online at www.investorvote.com.au using your secure access information or use your mobile device to scan the personalised QR code.
Voting a portion of your holding: Indicate a portion of your voting rights by inserting the percentage or number of securities you wish to vote in the For, Against or Abstain box or boxes. The sum of the votes cast must not exceed your voting entitlement or 100%.
Your secure access information is
Appointing a second proxy: You are entitled to appoint up to two proxies to attend the meeting and vote on a poll. If you appoint two proxies you must specify the percentage of votes or number of securities for each proxy, otherwise each proxy may exercise half of the votes. When appointing a second proxy write both names and the percentage of votes or number of securities for each in Step 1 overleaf. A proxy need not be a securityholder of the Company.
Control Number: 189035 SRN/HIN:
For Intermediary Online subscribers (custodians) go to www.intermediaryonline.com
SIGNING INSTRUCTIONS FOR POSTAL FORMS Individual: Where the holding is in one name, the securityholder must sign. Joint Holding: Where the holding is in more than one name, all of the securityholders should sign. Power of Attorney: If you have not already lodged the Power of Attorney with the registry, please attach a certified photocopy of the Power of Attorney to this form when you return it. Companies: Where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please sign in the appropriate place to indicate the office held. Delete titles as applicable.
By Mail: Computershare Investor Services Pty Limited GPO Box 242 Melbourne VIC 3001 Australia
By Fax: 1800 783 447 within Australia or +61 3 9473 2555 outside Australia
PARTICIPATING IN THE MEETING Corporate Representative If a representative of a corporate securityholder or proxy is to participate in the meeting you will need to provide the appropriate “Appointment of Corporate Representative”. A form may be obtained from Computershare or online at www.investorcentre.com/au and select "Printable Forms".
PLEASE NOTE: For security reasons it is important that you keep your SRN/HIN confidential. You may elect to receive meeting-related documents, or request a particular one, in electronic or physical form and may elect not to receive annual reports. To do so,
Sorry, the page you requested has been moved or deleted.
Perhaps you could:
-
Use the site navigation (top of page) to locate the page you are looking for.
-
Search the site using the search box in the top right hand corner of the site.
-
Contact Us for further assistance.
-
Return to the Home Page .
-
© OmniBridgeway , 2026
-
All Rights Reserved
-
Follow Us
Heading Form 604 Corporations Act 2001 Section 671B
Notice of change of interests of substantial holder To: Company Name/Scheme
Omni Bridgeway Limited (OBL)
ACN/ARSN
ACN 067 298 088
- Details of substantial holder (1) Perpetual Limited and its related bodies corporate
Name ACN/ARSN (if applicable)
ACN 000 431 827
There was a change in the interests of the substantial holder on
18/09/2026
The previous notice was given to the company on
13/04/2026
The previous notice was dated
09/04/2026
- Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows: Class of securities (4)
Ordinary
Previous notice
Present notice
Person’s votes
Voting power (5)
Person’s votes
Voting power (5)
41,291,970
14.256%
44,613,540
15.403%
- Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Date of change
Person whose relevant interest changed
Nature of change (6)
Consideration given in relation to change (7)
Class and number of securities affected
Person's votes affected
Refer to annexure A
- Present relevant interests Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows: Holder of relevant interest
Registered holder of securities Refer to annexure B
Person entitled to be registered as holder (8)
Nature of relevant interest (6)
Class and number of securities
Person's votes
- Changes in association The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable)
Nature of association
- Addresses The addresses of persons named in this form are as follows: Name
Address
Perpetual Limited (PPT)
Level 14, 123 Pitt Street Sydney, NSW 2000
Perpetual Investment Management Limited (PIML)
Level 14, 123 Pitt Street Sydney, NSW 2000
OMNI BRIDGEWAY LIMITED (OBL)
Level 7, 35 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
Signature print name
sign here
Sylvie Dimarco
capacity
Company Secretary
date
22/09/2026
DIRECTIONS (1)
If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.
(2)
See the definition of "associate" in section 9 of the Corporations Act 2001.
(3)
See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(4)
The voting shares of a company constitute one class unless divided into separate classes.
(5)
The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
(6)
Include details of: (a)
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
(b)
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001. (7)
Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
(8)
If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".
(9)
Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
ANNEXURE A This is annexure ‘A’ referred to in Form 604, Notice of change of interests of substantial holder, lodged for Perpetual Limited ACN 000 431 827 Sylvie Dimarco – Company Secretary, Perpetual Limited 22/09/2026
Transaction Type
Consideration (Cash)
Class (Ordinary) and number
Person's vote affected
2026-06-16
Sale
-6,727.10
-4,080
-4,080
Citicorp Nominees Pty Ltd
2026-06-19
Sale
-381.15
-231
-231
Citicorp Nominees Pty Ltd
2026-06-24
Sale
-18,721.22
-11,484
-11,484
PIML
Citicorp Nominees Pty Ltd
2026-07-10
Sale
-22,433.76
-13,848
-13,848
PIML
Citicorp Nominees Pty Ltd
2026-08-27
Purchase
10,984.56
7,796
7,796
PIML
Citicorp Nominees Pty Ltd
2026-08-28
Purchase
82,232.78
58,633
58,633
PIML
Citicorp Nominees Pty Ltd
2026-09-15
Purchase
29,478.88
19,560
19,560
PIML
Citicorp Nominees Pty Ltd
2026-09-16
Purchase
69,262.69
45,982
45,982
PIML
Citicorp Nominees Pty Ltd
2026-09-17
Purchase
10,666.32
7,256
7,256
Citicorp Nominees Pty Ltd
2026-09-18
Purchase
80,852.80
57,752
57,752
2026-06-12
Sale
-893.798
-547
-547
2026-06-12
Sale
-5,982.07
-3,661
-3,661
2026-06-18
Sale
-5,709.90
-3,497
-3,497
2026-07-29
Purchase
13,542.76
8,898
8,898
2026-07-29
Purchase
6,503.51
4,273
4,273
2026-08-27
Purchase
86,747.90
61,567
61,567
2026-08-27
Purchase
166,115.46
117,896
117,896
2026-08-27
Purchase
58,745.44
41,693
41,693
2026-08-27
Purchase
81,869.95
58,105
58,105
2026-08-27
Purchase
34,218.97
24,286
24,286
2026-08-28
Purchase
156,711.14
111,737
111,737
2026-08-28
Purchase
106,118.76
75,664
75,664
2026-08-28
Purchase
300,078.90
213,960
213,960
2026-08-28
Purchase
61,694.57
43,989
43,989
2026-08-28
Purchase
147,900.64
105,455
105,455
2026-09-11
Purchase
8,749.99
5,627
5,627
2026-09-14
Purchase
7,475.00
5,000
5,000
2026-09-14
Purchase
269,931.75
180,279
180,279
2026-09-15
Purchase
130,448.55
86,556
86,556
2026-09-16
Purchase
306,501.92
203,480
203,480
2026-09-17
Purchase
47,204.64
32,112
32,112
2026-09-18
Purchase
234,697.40
167,641
167,641
2026-09-18
Purchase
1,165,698.80
832,642
832,642
Entity
Custodian
Date
PIML
Citicorp Nominees Pty Ltd
PIML PIML
PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML PIML
HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited HSBC Custody Nominees (Australia) Limited
PIML
National Nominees Pty Ltd
2026-05-29
Purchase
66,316.56
39,350
39,350
PIML
National Nominees Pty Ltd
2026-08-27
Purchase
7,212.67
5,119
5,119
PIML
National Nominees Pty Ltd
2026-08-28
Purchase
13,027.82
9,289
9,289
PIML
UBS Nominees Pty Ltd
2026-08-27
Purchase
109,345.45
77,605
77,605
PIML
UBS Nominees Pty Ltd
2026-08-28
Purchase
182,278.72
129,967
129,967
PIML
UBS Nominees Pty Ltd
2026-09-18
Purchase
727,648.60
519,749
519,749
ANNEXURE B This is annexure ‘B’ referred to in Form 604, Notice of change of interests of substantial holder, lodged for Perpetual Limited ACN 000 431 827 Sylvie Dimarco – Company Secretary, Perpetual Limited 22/09/2026
Holder of relevant interest
Registered holder securities
Persons entitled to be registered holder
Number of securities
Number of votes
PIML
Citicorp Nominees Pty Ltd
Citicorp Nominees Pty Ltd
1,348,125
1,348,125
PIML
Citicorp Nominees Pty Ltd
Citicorp Nominees Pty Ltd
3,801,904
3,801,904
PIML
HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia) Limited
7,775,859
7,775,859
PIML
HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia) Limited
7,277,888
7,277,888
PIML
HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia) Limited
2,588,876
2,588,876
PIML
HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia) Limited
4,905,108
4,905,108
PIML
HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia) Limited
3,248,753
3,248,753
PIML
National Nominees Pty Ltd
National Nominees Pty Ltd
611,577
611,577
PIML
UBS Nominees Pty Ltd
UBS Nominees Pty Ltd
13,055,450
13,055,450
-
Press Release
Share
Omni Bridgeway reports record FY26 results in its 40th year
SYDNEY, 27 August 2026 – Omni Bridgeway Limited (ASX: OBL), the leading global alternative asset manager dedicated to legal assets, today released its results for the 12 months ended 30 June 2026 (FY26), reporting record cash investment proceeds and record new commitments, and achieving or exceeding each of the targets set for the year.
Highlights
- A milestone year: FY26 marks 40 years since the founding of the business and 25 years since listing on the ASX, underscoring Omni Bridgeway’s long-standing track record, deep sector expertise and globally scaled platform, which has realised strong uncorrelated returns across several market cycles.
- Fund capital formation: Achieved the US$1 billion Funds 4 and 5 Series II capital raise, with A$862 million of new third-party capital added during FY26.
- Record new commitments: A$712.2 million in new commitments, up 38% on FY25, expected to add A$564.4 million in fair value over their life.
- Record investment proceeds: Cash investment proceeds of A$350.5 million, up 49% on FY25, from 80 full and partial completions at a 2.3x MOIC and a 105% fair value conversion ratio.
- AUM growth: Assets under management grew to A$5.9 billion, a 14% compound annual growth rate since FY24.
- Financial results: Statutory NPAT of A$45.9 million; OBL-only EBIT of A$49.4 million and net cash generation of A$22.4 million.
- Operational discipline: Cash operating expenses of A$67.1 million were 16% below the A$80 million budget and 20% below FY25, while fee income grew 17% to A$35.4 million, achieving the FY26 target and lifting cost coverage to 53% (FY25: 36%).
Omni Bridgeway Managing Director and Chief Executive Officer, Raymond van Hulst, said:
“Where FY25 was a year of transformation, FY26 was a year of execution. We set clear targets for the year - on operating expenditure, fee income, cost coverage and capital formation - and achieved or exceeded each of them, alongside record cash investment proceeds and record new commitments.
Investment performance continued to be strong, with completions again closely aligned to reported fair values and realised outcomes - evidence of continued discipline in underwriting and valuation.
FY26 also marks 40 years since the founding of our business and 25 years since our listing on the ASX. In an industry consolidating around a small number of institutional-grade platforms, a four-decade track record, built through multiple economic cycles is the single most difficult asset to replicate.
Omni Bridgeway is debt free, covering its operating costs from realised income, managing a record book with a materially lower cost base, and holding a fully raised flagship fund programme in a growing but consolidating market. With an elevated pipeline and improving terms on new commitments, that is a good position from which to start FY27.”
Investor and Media Contacts
Media
Naomi Barber
, Director, Business Development & Marketing
+61 421 371 844, [email protected]
**
Investor Relations**
Nathan Kandapper
, Global Head of Investor Relations
+61 403 941 502, [email protected]
ABOUT OMNI BRIDGEWAY
Omni Bridgeway is the leading global alternative asset manager dedicated to legal assets, with over A$5.9bn in assets under management across multiple funds. Founded in 1986 and listed on the ASX since 2001, Omni Bridgeway has pioneered the industry and has a unique track record of consistent outperformance across multiple decades and economic cycles. With a team of ~160 professionals operating in over 20 locations and 15 countries, Omni Bridgeway is the largest and most diversified platform for originating, underwriting and managing legal assets and risk across all relevant jurisdictions and areas of law.
All Press Releases
-
© OmniBridgeway , 2026
-
All Rights Reserved
-
Follow Us
ASX Announcement 1 SEPTEMBER 2026
Date of Annual General Meeting and Closing Date of Director Nominations Summary •
Annual General Meeting to be held on Tuesday, 27 October 2026
•
Closing date for receipt of Director nominations is Tuesday, 8 September 2026
Omni Bridgeway Limited (Omni Bridgeway) (ASX:OBL) advises that the Annual General Meeting (AGM) will be held on Tuesday, 27 October 2026. An item of business at the AGM will be the re-election of a Director. In accordance with Article 6.2(f) of Omni Bridgeway’s Constitution, the closing date for receipt of nominations from persons wishing to be considered for election as a Director is Tuesday, 8 September 2026. Accordingly, any nominations must be received at Omni Bridgeway’s registered office no later than 5.00pm (AEST) on Tuesday, 8 September 2026. Omni Bridgeway will provide further details regarding the AGM in a separate notice of meeting which will be provided to Shareholders in due course.
This announcement is authorised for release to the market by the Board.
INVESTOR ENQUIRIES: Nathan Kandapper Global Head of Corporate Development and Investor Relations [email protected]
Omni Bridgeway Limited | ABN 45 067 298 088 | GPO Box 5457 | Sydney NSW 2000 | Freecall 1800 016 464
Appendix 4E – Final Report Omni Bridgeway Limited ABN 45 067 298 088 Financial year ended 30 June 2026 Results for announcement to the market Current reporting period: 30 June 2026 Previous reporting period: 30 June 2025
Revenue and net profit Up/Down
Percentage Change
$'000
Revenue¹
Up
57%
106,468
Total income for the year
Down
(72%)
182,235
Profit for the year
Down
(89%)
45,929
Profit from ordinary activities after tax attributable to members
Down
(85%)
53,697
Net profit for the period attributable to members
Down
(85%)
53,697
Other comprehensive loss after tax for the period
Down
(238%)
(48,745)
Total comprehensive loss after tax for the period
Down
(101%)
(2,816)
- Revenue from ordinary activities includes IFRS revenue and excludes investment activities.
The decrease in income and profit for the year ended 30 June 2026 reflects the impact of the Fund 9 secondary market transaction completed in the prior year, which generated a significant gain and strengthened the Company’s balance sheet through debt repayment. As the Fund 9 secondary market transaction was a one-off extraordinary item, no meaningful comparison can be made between current and prior financial year.
Dividends The Directors have determined not to pay a final dividend for the year ended 30 June 2026. No dividends were paid in both current and prior financial year.
Net tangible asset backing Consolidated 2026 $
2025 $
Net assets per ordinary share
$2.96
$2.99
Book value of investments per ordinary share
$2.25
$2.18
Net tangible assets per ordinary share¹
$2.08
$1.94
- Net tangible assets excludes litigation investments - intangible assets, goodwill, litigation investments - claims portfolio, and contract costs.
Additional Appendix 4E disclosure requirements can be found in the Directors' Report, Financial Statements and the Notes to the Financial Statements contained in the Omni Bridgeway Limited Annual Report for the year ended 30 June 2026.
Audit Report This Appendix 4E (Final Report) is based on the audited financial statements for the year ended 30 June 2026, which are contained within the Omni Bridgeway Limited Annual Report, attached.
Omni Bridgeway
Annual Report 2026
1
2
Omni Bridgeway
Annual Report 2026
3
4
Omni Bridgeway
Annual Report 2026
5
6
Omni Bridgeway
Annual Report 2026
7
8
Omni Bridgeway
Annual Report 2026
9
h
10
Omni Bridgeway
Annual Report 2026
11
12
Omni Bridgeway
Annual Report 2026
13
14
Omni Bridgeway
Annual Report 2026
15
16
Omni Bridgeway
Annual Report 2026
17
Directors’ report Board of Directors
Michael Green
Raymond van Hulst
Karen Phin
Christine Feldmanis
Non-Executive Director and Chairman
Managing Director and Chief Executive Officer
Non-Executive Director
Non-Executive Director
Appointed
Appointed
Appointed
Appointed
April 2023
Committee membership Bachelor of Arts (Honours) Economics (University of Exeter, UK)
Michael Green has over 20 years’ experience in the global investment industry. Mr Green was International CEO for both Morgan Stanley Investment Management and for American Century Investments where he was a member of their respective Executive Management Committees and was a board member for a number of local entities and global fund structures. From 2020 to 2023, Mr Green became a co-opted non-executive member of the Investment Oversight Committee for the London CIV, the local government pension fund asset pooling company. Directorships of other listed entities within the past three years
• Chairman, Non-Executive Director, Independent Trustee and Head of the Investment Committee of Lloyd’s of London Pension Scheme (LON: LLOY) (appointed May 2007)
April 2020
Masters of Business Administration (INSEAD) Masters in Management (University of Groningen, The Netherlands)
Raymond van Hulst was appointed as Executive Director in 2020 and Managing Director and CEO in October 2023. Mr van Hulst is an industry veteran with nearly 25 years’ experience in all aspects of legal finance and legal assets management globally. He has established six institutionally backed funds for legal assets, including in joint venture with the International Finance Corporation/the World Bank for the Distressed Asset Recovery Program, and most recently in partnership with Ares Management the launch of the first continuation fund for legal assets globally. Mr. Van Hulst has been in various leadership roles within Omni Bridgeway since 2002 and has been involved in all aspects of the business. Mr van Hulst also led Omni Bridgeway’s acquisition of its German funding business, Roland ProzessFinanz in 2017, and the merger between IMF Bentham and Omni Bridgeway in 2019. Mr van Hulst was previously with ABN AMRO Bank Structured Finance based out of India and Europe. Directorships of other listed entities within the past three years
Nil
18
Omni Bridgeway
August 2017
November 2018
Committee membership
Committee membership
Bachelor of Arts and Bachelor of Laws (Honours) (University of Sydney, Australia)
Bachelor of Commerce (University of Wollongong, Australia)
Fellow of the Australian Institute of Company Directors
Karen Phin has over 25 years’ experience advising Australian listed companies on capital management, capital raisings and mergers and acquisitions. Ms Phin was a Managing Director and Head of Capital Advisory at Citigroup in Australia and New Zealand. Prior to joining Citigroup, she spent 12 months at ASIC as a Senior Specialist in the Corporations group and Ms Phin was a Managing Director at UBS AG, where she established and led the Capital Management Group for over 13 years. Directorships of other listed entities within the past three years
• Non-Executive Director of ARB Corporation Limited (ASX: ARB) (appointed June 2019) • Non-Executive Director of Supply Network Limited (ASX:SNL) (appointed September 2025) • Member of the Takeovers Panel (since 2015)
Master of Applied Finance (Macquarie University, Australia) Fellow of the Australian Institute of Company Directors Trustee Fellow of the Association of Superannuation Funds of Australia Senior Fellow of the Financial Services Institute of Australasia Certified Practicing Accountant
Christine Feldmanis is a qualified accountant, investment, governance, and risk management specialist with over 30 years’ experience in the finance and investment industry. Ms Feldmanis was previously Managing Director of an ASXlisted boutique funds management incubator business and Chief Finance Officer of the NSW Treasury Corporation. Directorships of other listed entities within the past three years
• Non-Executive Director of United Malt Limited (ASX: UMG) (appointed January 2023 and retired November 2023) • Non-Executive Director of Bell Financial Group Ltd (ASX: BFG) (appointed February 2020)
Officers Industry recognition
David Breeney
Jeremy Sambrook
Global Chief Financial Officer
Global General Counsel and Company Secretary
Appointed
Appointed
March 2025
January 2016
Bachelor of Arts (Honours) Economics (University of the West of England)
Bachelor of Laws (University of Bristol, United Kingdom)
Fellow of the Institute of Chartered Accountants in England and Wales
Jeremy Sambrook is an experienced corporate lawyer with a broad in-house legal and private practice background, having practised in the UK, Hong Kong, the Channel Islands and Australia.
Member of Chartered Accountants Australia and New Zealand
David Breeney brings a depth of experience and capability from over 12 years of experience from Challenger Limited, one of Australia's largest asset managers, where he held senior finance roles, resolving complex financial challenges, developing innovative solutions, and driving initiatives to enhance productivity and transform company culture. Mr Breeney joined Omni Bridgeway in 2023, most recently serving as Deputy CFO before taking on day-today leadership of the finance team as Global Chief Financial Officer.
Mr Sambrook was appointed as General Counsel and Company Secretary in 2016 and has built out the global legal, compliance and risk function, in line with the international growth of the business, to a team of legal and compliance specialists across APAC, North America and EMEA.
Omni Bridgeway’s industry accolades continued to grow in FY26. We received the most recognition of any litigation funder by Chambers and Partners, a thirdparty market research report based solely on client, market, and peer feedback
160+ People
15
Countries
25
Years listed on ASX
40 Years
Annual Report 2026
19
Directors’ report continued Operating and financial review Principal activities The Group’s principal activities were the management of, and co-investment into funds or other investment structures that are focused on legal finance and the investment in legal assets globally. The Group invests in legal assets by entering into financing, purchase, monetisation, or risk sharing agreements with claimants, liquidators, banks, creditors, or law firms in relation to legal claims, awards, judgements and non-performing loans, either standalone or on a portfolio basis. The Group furthermore provides services in relation to the management of the legal assets it has invested in. Overlaying the investment in legal assets is the asset management aspect of the Group that: • provides services to external third party capital; • generates management, service and transaction fees; and • provides the opportunity for further return through carried interests depending on the fund or specific investment or portfolio performance. There were no significant changes to the principal activities of the Group during the year.
Nature of operations The Group is an alternative asset manager specialising in legal assets which are typically uncorrelated to global capital markets. Its operations span the Americas, APAC, and EMEA regions, with investment interests further diversified across relevant areas of law and types of investment. The Group’s core operations involve: • Litigation and Arbitration Funding The Group provides capital to claimants and law firms to pursue legal actions, typically in high-value commercial disputes, class actions, and international arbitrations. Returns are contingent on successful resolution - whether by settlement, judgment or award. The Group retains direct or indirect investment interests in each investment via its equity stake in the respective fund or holds an entitlement to distributions on completed investments as per a fund’s waterfall. • Legal Enforcement and Asset Recovery The Group specialises in funding the legal enforcement and/or monetisation of legal claims, judgments and awards, particularly in complex cross-border scenarios. This includes distressed and non-performing assets, such as non-performing loans, judgments and awards in jurisdictions globally. These operations are supported by proprietary expertise and processes, in-house legal and investment management teams, and insurance structures that mitigate downside risk. • Investment Management The Group acts as the investment advisor to multiple funds and other investment structures with third-party capital. The Group is entitled to various associated fees including:
– – –
Transaction fees (e.g. Funds 4/5 Series II), for investment underwriting and monitoring; Management fees (all funds except Fund 1 and Funds 2&3) for ongoing fund management services during the life of the fund; and Carried interests for its residual profit share in Funds 6 and Funds 4/5 Series I and II.
Depending on the agreement and the Fund structure, a fee may represent the Group’s profit share rather than compensation for the provision of investment management services. The successful completion of an investment and the timing of that completion is, in many respects, beyond the Group’s control and it may take several years between making an initial investment and finalising a completion. The waterfalls and fee structures in the various Funds in part determine the attribution of profits, net assets and distributions between the Group’s equity holders and non-controlling interests. Whether by direct investment or via a Fund structure, the objective is to successfully complete (e.g. by settlement, court judgment, arbitral award or enforcement) litigation investments.
20
Omni Bridgeway
Operating and financial review (continued) The Group is also able to sell a partial or full interest in litigation investments into the secondary market rather than continuing to hold the entirety of the investment through to completion. Secondary sales improve the liquidity, mitigate completion and duration risk of these investments while accelerating realisations. Where the Group has purchased the award, claim or right to action, non-performing loan or distressed debt, the return will be the resolution sum less any legal or professional fees and any residual success fee component to the vendor. Otherwise, the resolution sum is shared with the funded claimant(s) in accordance with the contracted funding terms. The share to the Group will generally be the amount invested plus a return defined as either: • a multiple of the amount invested; or • a percentage of the realised amount; or • a combination of the above. In some instances the presiding court or tribunal of the underlying litigation may be involved to approve a settlement and that involvement can extend to consideration of the litigation funding terms. Generally, the multiple or percentage return to the Group increases as the duration of an investment extends. If the underlying litigation, arbitration, recovery or enforcement is unsuccessful the Group generally does not generate any financial return. In certain jurisdictions, the investment terms may require the Group to pay an amount of adverse costs upon an adverse legal outcome. In certain circumstances, the Group can obtain insurance to protect any deployed capital, commission and adverse costs exposure.
Employees At 30 June 2026, the Group employed 156 permanent staff (2025: 167), as well as 9 consultants (2025: 4).
Operating results for the financial year The Group made a profit after tax (before NCI) for the year of $45.9 million (2025: $416.8 million) and a profit attributed to equity holders of $53.7 million (2025: $349.8 million). The FY26 results reflects a more normalised earnings profile for the Group, following the significant one-off gains recognised in FY25 from the Fund 9 transaction. Total cash investment proceeds of $350.5 million1 from full and partial investment completions reflected a 49% increase over FY25, excluding secondary sales, and a record high for the Group. The Group’s geographic and asset diversification assists in mitigating the risk of any increased competition or regulatory intervention arising in any one region. New commitments are the investment into future income streams and enable the Group to achieve economies of scale to diversify risk and provide superior risk adjusted returns in this asset class. $564.4 million in fair value was added to the portfolio during the year, an increase of $38.5 million on FY25. In the period, $72.5 million of sidecar capital originated and managed by OBL was committed, on which OBL will be entitled to separately agreed management fees and Company carried interests. Cost reduction during the year was ahead of target, reflecting the Group’s continued focus on cost discipline and operational efficiency. Employee expenses decreased by 16% compared to the prior year, reflecting a reduction in headcount to 156 from 167 at 30 June 2025 and one-off cash bonuses paid in the prior year. Corporate overheads also reduced, supported by continued cost management and the non-recurrence of one-off costs associated with the Fund 9 transaction in FY25.
Excerpts from Consolidated Statement of Comprehensive Income for the year ended 30 June 2026 2026
2025
$'000
$'000
Change %
Gross proceeds and investment revenue¹
105,613
423,429
(75%)
Costs of derecognition or disposal of litigation investments
(15,047)
(105,089)
(86%)
Net gain on financial instruments at FVTPL
61,920
279,473
(78%)
Other revenue and income
29,749
53,268
(44%)
Total income
182,235
651,081
(72%)
Other expenses
(134,064)
(155,561)
(14%)
Tax
(2,242)
(78,698)
(97%)
Profit after tax
45,929
416,822
(89%)
- Gross proceeds and investment revenue is calculated as the sum of proceeds on derecognition of litigation investments – intangible assets, proceeds on derecognition of litigation investments – purchased claims, revenue from litigation investments – claims portfolio and gross proceeds from litigation investment in associates for the consolidated group. It is categorised as non-IFRS information prepared in accordance with ASIC Regulatory Guidance 230 – Disclosing non-IFRS financial information, issued in December 2011. If the proceeds attributable to external investors ($244.9 million) were included, the total would be $350.5 million. Refer to Glossary for more detail on non-IFRS disclosures.
Annual Report 2026
21
Directors’ report continued Operating and financial review (continued) Consolidated Statement of Financial Position The Group's Statement of Financial Position reflects its post-Fund 9 structure, following the deconsolidation of Funds 2&3 and Fund 4 Series I&II in the prior year. Accordingly, the underlying assets and liabilities of those funds are no longer consolidated, with the Group’s retained interests recognised at fair value. The Group has maintained a strong capital position following the repayment of its corporate debt in the prior year. Given the nature of the Group’s business and the composition of its asset base, the Statement of Financial Position is presented on an unclassified basis, with assets and liabilities not separately presented as current and non-current. Relevant maturity information is included in the notes to the financial statements.
Litigation investments At year end, the carrying value of litigation investments was $652.0 million (2025: $628.1 million), with the Group’s interests in more than 300 active litigation investments. At 30 June 2026, a majority of the Group’s interests in litigation investments are measured at fair value through profit or loss (FVTPL). The remaining investments are carried at cost. There is typically a lag between investment commitment and capital deployment.
Working capital 2026
2025
$’000
$’000
Change %
Current assets
224,413
269,025
(17%)
Current liabilities
131,879
157,203
(16%)
Net working capital
92,534
111,822
(17%)
Working capital ratio
1.7:1
1.7:1
–%
For the purposes of this working capital analysis, current assets and current liabilities comprise the following balances, representing amounts expected to be realised or settled within twelve months of the reporting date: Current assets: cash and cash equivalents (Note 18); trade and other receivables (Note 22); and other current assets. Current liabilities: trade and other payables (Note 24); provisions (Note 25); lease liabilities (Note 26); financial liabilities - warrants (Note 31) and other current liabilities.
Profile of interest-bearing debt The profile of the Group’s interest-bearing debt is summarised in the table below. 2026
2025
$’000
$’000
%
35,395
19,500
82%
Leases
9,891
13,031
(24%)
Total interest-bearing debt
45,286
32,531
39%
Borrowings
Change
Debt The borrowings included in the Consolidated Statement of Financial Position relate to the Fund 8 facility. This facility is non-recourse to the Group, with recourse limited to insurance and the investment assets of Fund 8, and the Group’s capped standby equity commitment. As at 30 June 2026, $38.2 million drawn down under the Fund 8 facility is classified as borrowings.
Warrants The Group has issued share warrants in the Fund 9 transaction which are convertible into ordinary shares if triggered. The warrants issued are equivalent to $35 million, with a strike/exercise price equal to the 30-day Volume Weighted Average Price (‘VWAP’) as of the date of signing the term sheet. The warrants are able to be exercised at any time after the second anniversary of the transaction date, but before the fifth anniversary. Warrants issued in the Fund 9 transaction are classified as a liability under IFRS. The Group expects the liability will be extinguished via equity settlement.
22
Omni Bridgeway
Operating and financial review (continued) Consolidated Statement of Cash Flows The Consolidated Statement of Cash Flows illustrates that there was a decrease in cash and cash equivalents for the year ended 30 June 2026 of $21.7 million (2025: increase of $44.4 million). In relation to the movement in cash: • Operating activities: ($18.3) million net cash outflows (2025: net cash inflows $17.1 million) • Investing activities: $8.0 million net cash inflows (2025: $284.1 million) Across both operating and investing activities per IFRS classifications, the aggregate cash flows include: • Proceeds from litigation investments: $138.0 million • Management fee proceeds: $28.8 million • Payments for litigation investments: $80.0 million Financing activities $(0.3) million net cash outflows (2025: net cash outflows $273.7 million) include: • Payment of borrowing cost: ($1.1) million • Repayment of debt: $(1.9) million • Borrowing drawdown: $19.0 million • Lease payment: ($5.2) million • Distributions to NCI: ($11.2) million
Investment activity FY26 overview Our business continued to deliver strong investment activity during the year, with record levels of new investment commitments and completions, supported by strong completion metrics and continued growth in the investment pipeline. The Group achieved or exceeded targets for fee income, cost coverage and opex management, while capital formation continued to progress in support of our strategy to scale investment activity through third-party capital while retaining exposure to portfolio upside.
Investment activity highlights: • Strong completions, with 80 full and partial investment completions in FY26 delivering an overall multiple-on-invested-capital (MOIC) of 2.3x and a combined fair value conversion ratio of 105%. • Total cash investment proceeds of $350.5 million in FY26, including $47.5 million in OBL-only investment proceeds, excluding management fees and carried interest. This is a 49% increase over FY25, excluding secondary sales, and a record high for the Group. • Management fees of $35.4 million in FY26, meeting the target of $35 million. • Cash carried interest of $6.6 million in FY26, from funds with American waterfalls. • FY26 consolidated OBL-only cash opex of $67.1 million, materially below the budget of $80 million. • $241.8 million in total deployments in FY26, including $28.3 million OBL-only. • OBL-only cash and receivables of $124.5 million at 30 June 2026; movement in line with expectations. • New conditional and unconditional commitments reached a record $712.2 million across 43 new investments, with $564.4 million in new fair value added ($610.6 million on a like for like basis). • Pipeline remains strong and elevated, with 43 agreed exclusive term sheets, representing an estimated $407.8 million in new commitments if contracted, supporting continued momentum into 1Q27 and beyond. • Continued good momentum on capital formation. Target capital raise of US$1 billion achieved for funds 4/5 Series II post the conclusion of FY26. This includes subscriptions for over US$300m on substantially agreed terms pending finalisation and completion of legal documentation. $72.5 million in fee-paying sidecar capital raised during FY26, with ~$175 million further sidecar capital in diligence.
Annual Report 2026
23
Directors’ report continued Investment activity (continued) Non-IFRS reconciliation to Consolidated Statement of Comprehensive Income
2026
2025
A$ million
A$ million
350.5
235.5
–
294.7
35.4
30.3
Consolidated Group Litigation investments proceeds Proceeds from secondary market transactions Management fees Interest revenue and other
24
2.4
33.2
Total gross revenue
388.3
593.7
Less third party interest
(244.9)
(106.8)
Total revenue
143.4
486.9
Investments derecognised
(15.0)
(119.2)
Fair value adjustments of financials assets and liabilities
61.9
293.6
Management fee - non statutory cash income
(8.1)
(9.9)
Total income (reflecting Consolidated Group)
182.2
651.4
Litigation cost
(47.8)
(58.5)
Platform expenses
(72.6)
(85.9)
Other
(13.6)
(11.5)
Profit before tax (reflecting Consolidated Group)
48.2
495.5
Income tax expense
(2.3)
(78.7)
Profit after tax (reflecting Consolidated Group)
45.9
416.8
Omni Bridgeway
Shareholders Dividends The Company considers its capital management options in light of the cash position and performance of the Group at the time as well as the likely demand for cash over the ensuing 12-month period. In determining the appropriate mechanism to deliver returns to shareholders, the Board will consider both dividends and share buy-backs. Relevant considerations include the source and nature of income or surplus capital, the prevailing share price relative to the intrinsic value and the franking credit balance. Based on the FY26 profit result and expected capital requirements, the Directors have not declared an interim or final dividend for the year (2025: nil). This decision is consistent with the Company’s stated capital allocation policy, and reflects a prudent approach to capital management and supports the Company’s strategic priorities.
Shareholder returns The following summary of operating results reflects the Group’s performance for the year ended 30 June 2026: 2026
2025
Basic profit per share (cents per share)
18.58
123.15
Diluted profit per share (cents per share)
18.46
122.57
Return on assets (NPAT/average assets)
4.0%
34.4%
Return on equity (NPAT/average equity)
5.3%
50.3%
Net debt/equity ratio %1
N/a
N/a
- As cash and short term deposits are greater than total debt, net debt (cash and short term deposits less total debt) is positive as at 30 June 2026.
Shares issued during the year On 4 November 2025, the Company issued 799,259 shares relating to the FY23 LTIP vesting. On 7 April 2026, the Company issued 410,221 shares relating to the employee equity incentive plan.
Share options – unissued shares As at 30 June 2026 there were 8,604,441 share performance rights on issue (2025: 11,846,644).
Risk management Risk management framework Omni Bridgeway’s risk management framework is overseen by the Board and includes our Risk Policy, Risk Strategy and Risk Appetite Statement setting out the arrangements for identification, assessment, monitoring, management and reporting of risks. Our Risk Policy describes our approach to risk management and, as a key corporate governance policy, is available on the OBL website. The Policy is supported by our Risk Appetite Statement, set by the Board and aligned with our Business Strategy and Risk Strategy, which details the process and procedures OBL undertakes within the risk management framework. Our Audit and Risk Committee receives regular and frequent reporting on risks measured against our risk appetite to ensure that we maintain our robust processes and systems for management of our identified current and anticipated risks. The Board receives additional reporting on risk topics across the Group. In FY26, our risk management focus continued to evolve in response to new and emerging risks whilst remaining focused on the quality of our investment management processes. The below ‘Key risks and responses’ table sets out some of our material risks and risk treatment responses.
Annual Report 2026
25
Directors’ report continued Key risks and responses
26
Risk
Description
Risk response
Litigation
Investing in early stage legal proceedings is inherently uncertain with the potential for adverse developments not anticipated at the time of investment which can lead to a complete loss of invested capital.
Extensive investment underwriting and management policies and procedures built on 40 years experience, including utilisation of an investment committee with deep experience. Plus investment structuring enabling reassessment at key capital deployment junctures.
Investment duration
Investment duration in legal assets is uncertain and not within the control of the funder. Duration expansion can adversely impact returns and create earnings volatility.
Pricing structures that protect against extended duration, portfolio diversification and use of the secondary market all coupled with active investment management.
Quantum
The amount ultimately awarded in a successful legal proceeding, or agreed as part of a settlement, may be lower than anticipated.
Our investment professionals draw on specialist quantum expertise and ongoing case monitoring to refine our assessment of likely recoveries throughout the life of an investment.
Budget
The actual costs required to bring an investment to completion are uncertain and may exceed the budget estimated at the time of investment, in part due to the same factors that drive duration risk.
Pricing structures, risk sharing arrangements with law firms, budget monitoring discipline.
Credit and collection
The financial capacity of counterparties, including defendants and other parties from whom amounts are recoverable, may deteriorate over the life of an investment. Counterparties may also fail to honour a judgment or settlement voluntarily.
Payment capacity is a key area of diligence in the underwriting phase and on-going assessment throughout the life of the investment, together with review of financial capacity of the funded counterparty.
Adverse cost
Loss of certain investments may result in a loss of the Use of adverse cost insurance, underwriting discipline and capital deployed to the claimant counterparty’s legal investment staging. costs and also payment of the successful defendant’s legal costs.
Valuation
The fair value of our investment portfolio may be adversely impacted by biases in the assumptions applied.
Concentration
Adverse outcomes in a small number of large Portfolio diversification and disciplined portfolio construction investment exposures could disproportionately affect through internal exposure limits by matter, case type, counterparty and jurisdiction. our overall investment returns. This risk is heightened where investments share common characteristics.
Country
Political, judicial and regulatory developments in the jurisdictions in which we invest may adversely affect the independence of the judiciary, the enforceability of judgments, or the broader legal protections available to claimants.
Geographic diversification across multiple jurisdictions and disciplined underwriting, including assessment of the legal and political environment of a given jurisdiction. Utilisation of local market expertise to monitor developments.
Currency
Differences may arise between the currency in which capital is deployed, the currency of entitlement, the fund's reporting currency, and the currency in which returns are ultimately realised. Movements in exchange rates between these currencies over the life of an investment may lead to adverse investment outcomes.
Geographic diversification, underwriting discipline, portfolio structuring and the use of natural hedging.
Regulatory, compliance and conduct
As a regulated business a material failure in compliance may be highly damaging to the business. In addition, adverse regulatory developments for investing in legal assets may reduce the pool of investment opportunities available to us.
The Group maintains an effective compliance risk management framework and actively builds a diversified portfolio to limit the impact of adverse regulatory developments in any single jurisdiction.
Cybersecurity
A major systems and/or data breach may have material adverse consequences for the business and its reputation. As the business holds a high level of sensitive case material underlying its investments, a data breach could result in the loss of privilege in such material and a breach of confidentiality obligations.
Our cybersecurity risk management framework is supported by our cybersecurity, electronic communications, privacy, data breach management, and other cyber related policies which set out requirements for ensuring the security of confidential and personal information maintained in our systems. Refer to the Corporate Governance Statement for further details.
People risk
Our business depends on our ability to attract, retain and develop experienced investment professionals in a specialised and competitive global market. The loss of key personnel, could adversely affect broader company development.
Long term incentive structures, succession planning and a strong focus on culture and career development. We continue to invest in the recruitment, training and retention of our investment professionals to ensure the depth and continuity of our talent base.
Other
In addition to the specific risks identified above, the Group may be affected by risks that are not currently known, are not reasonably foreseeable, or whose potential impact cannot be fully assessed at this time.
The Board and management maintain a broader enterprise risk management framework, including regular horizon scanning and scenario analysis, to help identify and respond to emerging risks as they arise.
Omni Bridgeway
Utilising our deep historical data set, together with valuation committee oversight and consistent application of our valuation policy and procedures.
Significant events after reporting date No circumstances have arisen since 30 June 2026 that have significantly affected, or may significantly affect the Consolidated Entity’s operations, the results of those operations, or the consolidated entities state of affairs in the future financial years.
Likely developments in the Company’s operations The Group does not provide forecasts considering the difficulty in estimating the timing of the finalisation of its investments but provides an indication of its views of the future value of completions and estimated new commitments in the quarterly portfolio reports. The Group expects demand for its funding to continue in each of its markets. Litigation funding is considered non-cyclical or uncorrelated to underlying economic conditions.
Environmental regulation and performance The Consolidated Entity’s operations are not presently subject to significant environmental regulation under the laws of the Commonwealth and the States of Australia.
Indemnification and insurance of directors and officers During the financial year, the Company has paid premiums in respect of an insurance contract insuring all the directors and officers of the Group against any legal costs incurred in defending proceedings for conduct other than, amongst others: (a) willful breach of duty; or (b) contravention of sections 182 or 183 of the Corporations Act 2001, as may be permitted by section 199B of the Corporations Act 2001. The total amount of premiums paid under the insurance contract referred to above was $1.6 million during the current financial year (2025: $2.0 million).
Indemnification of auditors To the extent permitted by law, the Company has agreed to indemnify its auditors, as part of the terms of its audit engagement against claims by third parties arising from the audit (for an unspecified amount). No payment has been made to indemnify BDO during or since the financial year.
Directors’ meetings The number of meetings of directors held during the period under review, and the number of meetings attended by each director, were as follows:
Board Meetings
Nomination and Audit and Risk Remuneration Committee Committee
Corporate Governance Committee
Total number of meetings held:
10
4
6
4
Meetings attended: M Green R van Hulst K Phin C Feldmanis
10 10 10 10
4 4* 4 4
6 6* 6 6
4 4* 4 4
- Attended by invitation
Raymond van Hulst Managing Director and Chief Executive Officer Sydney, 26 August 2026
Annual Report 2026
27
Directors’ report continued
Letter from the Chair of the Nomination and Remuneration Committee Dear Shareholder, On behalf of the Board of Directors, I am pleased to present Omni Bridgeway’s Remuneration Report for the financial year ended 30 June 2026. FY26 was a pivotal year both for the Company and for the way we reward our people. Following the strategic repositioning undertaken in FY25, Omni Bridgeway continued to transition into a global, capital-light investment management platform for legal assets, executing against our key strategic priorities of improving cost coverage, further expanding and diversifying the legal assets portfolio, maintaining strong investment performance, and broadening third-party capital sources. In parallel, we replaced the Company’s historical short and long-term incentive plans with a carried interest plan modelled on the alternative asset management industry in which Omni Bridgeway now competes for both capital and talent. Rationale for the change in remuneration framework The Board’s conviction is that remuneration and incentive programs must support disciplined long-term value creation and realisation rather than short-term effort or unsustainable growth. Our business is characterised by multi-year investment cycles, uncertain timing of realisations, and the need for highly specialised teams capable of originating, underwriting, managing and realising complex legal assets across multiple jurisdictions. The Board believes that reward should follow realised cash: participants should benefit alongside fund investors and shareholders when investments complete successfully, generating investment returns for fund investors and co-investment returns and fund carried interest for the Company. We also recognise that Omni Bridgeway competes for capital and investment talent with the asset management sector and carried interest is the standard and expected form of long-term alignment in that market. The FY26 remuneration framework During FY26, Omni Bridgeway introduced its Team Carried Interest Plan and finalised proposals to introduce its Executive Plan from FY27, subject to shareholder approval at the forthcoming AGM. Together these plans replace the prior short and longterm incentive plans for participating staff. Remuneration for KMP, senior executives, investment professionals and other senior staff comprises a fixed component and an “at risk” component. Fixed remuneration is market based, benchmarked primarily against the asset management industry in each of our various operating regions. The at-risk component now comprises three elements, set out below. 1.
Team Carried Interest Plan. This is the principal at-risk element for investment professionals and senior staff. Participants hold Carried Interest Points (“CIP”) entitling them to a share (capped at 25%) of the carried interest the Company actually receives from its funds, with the remaining 75% retained for the Company and its shareholders. Carried interest arises only on cumulative proceeds above the fund’s return hurdle. Unvested CIP attach to specific investments and are granted at initial commitment proportionate to the fair value of the investment, and convert to vested CIP only on realisation of the investment, and then in proportion to the realised fair value achieved measured against the initial fair value. Distributions are made on vested points only, with any carried interest on unvested points retained until and subject to vesting. The Team Carried Interest Plan (“Plan”) rewards genuine long-term value creation and realisation. Because participant entitlements track the carried interest the Company itself receives, they follow the Company’s coinvestment performance and its own carry entitlement. This creates a clear connection between employee reward, investment performance, fund investor outcomes and shareholder value, and aligns Omni Bridgeway’s remuneration structure with the alternative asset management industry. The Plan is also structured so that participants are rewarded for the performance of the portfolio and of the firm, and not merely for their own matters. CIP are allocated as a mix across personal, specific portfolio and companywide portfolio investments, and any participant’s entitlement depends on outcomes wider than the investments they manage themselves. This is aimed at aligning the pursuit of individual, team and Company goals and promoting global collaboration. Unlike many examples in the asset management industry, the Plan is deliberately broad based. All investment roles and senior non-investment roles participate. The Plan is also relatively flat, with limited divergence in eligibility for the most senior participants and the most junior participants. The Committee will assess annual allocations of the newly generated unvested points with reference to a combination of eligibility and personal KPI scores. Seniority only sets the starting point for an allocation, and performance determines the outcome, with high performing junior participants able to exceed senior participants in annual allocation. The Plan’s eligibility framework and every individual allocation are recommended by management and approved by the Committee annually. Up to a quarter of the points created each year are withheld in an unallocated reserve, from which the Committee may make allocations to, for example, new employees. As participants and CIP share in a fixed proportion of carried interest actually received, the cost of the Plan cannot exceed that proportion and cannot dilute the share of carried interest retained for shareholders. Consistent with good governance practices, the Plan rules give the Board express powers to prevent inappropriate reward. Three mechanisms operate, and they are distinct. The first is automatic and requires no exercise of discretion: unvested points convert on realisation only in proportion to the value actually realised against the underwritten fair value, so that a matter realised below carrying value converts fewer points than were allocated to it and the shortfall expires. The second addresses the risk that carried interest paid early in a fund’s life must later be returned to that fund because of subsequent underperformance. The Committee sets a retention percentage annually for each fund, close to full retention where a fund’s outcome remains uncertain and reducing as performance is established, and the retained amounts are held in escrow rather than distributed. The Company is therefore able to meet a fund-level clawback obligation without having to pursue recovery from individuals.
28
Omni Bridgeway
Letter from the Chair of the Nomination and Remuneration Committee (continued) The third is the Board’s power to determine that a participant has engaged in a malus event which, among other things, includes deliberately engaging in fraudulent or dishonest conduct, or in conduct resulting in material reputational damage to the Group. In malus circumstances, the Board may cancel both vested and unvested points and may demand repayment of amounts already received in respect of vested points, net of tax. A participant treated as a bad leaver forfeits all points, vested and unvested; a good leaver retains only the amounts already held in escrow for their vested points at departure, and only for so long as they continue to observe the post-departure conditions of the Plan. 2.
Executive Plan. This is a performance rights plan with a narrow and senior scope being the global leadership team, together with a small number of individuals identified for long-term succession. It is intended to deliver the enterprise-wide accountability and direct equity alignment appropriate to those responsible for the Company as a whole. At the start of the first plan year, the performance rights allocated to each executive are conditional and the proportion of them that will be granted as unvested rights is determined at the end of the first year, based on the executive’s achievement of their personal KPIs. The vesting of these rights is then subject to three Company performance metrics measured over the 3 year period from the start of the first plan year as follows: a) 50% of the total award is determined by OBL’s total shareholder return relative to the constituents of the S&P/ASX 300 Diversified Financials index, with no vesting below the index median, 50% vesting at the median, full vesting at or above the 75th percentile and straight-line vesting in between; b) 25% of the total award is determined by OBL’s return on equity measured as a three-year average, with no vesting below 12.5%, 50% vesting at 12.5%, full vesting at or above 17.5% and straight-line vesting in between; and c) 25% of the total award is determined by OBL’s growth in assets under management also measured as a threeyear average, with no vesting below 5%, full vesting at or above 12.5% and straight-line vesting in between. Each measure is tested once, at the end of the three-year period and rights that do not vest lapse. Unvested rights lapse on cessation of employment, subject to good leaver treatment, and are subject to malus and clawback on the same basis as the Team Carried Interest Plan. As vesting conditions (b) and (c) above are additional to the performance conditions approved by shareholders to date, the Company will seek shareholder approval for the Executive Plan at the AGM in October 2026. Any participation by the Managing Director will be the subject of a separate resolution, as required by ASX Listing Rule 10.14.
Discretionary cash bonus. A discretionary bonus of up to 20% of gross salary remains available to staff in noninvestment roles who do not participate in the Team Carried Interest Plan or the Executive Plan. Awards depend on annual personal performance and on the Company’s performance for the year.
FY26 remuneration outcomes The Committee remains mindful of the importance of restraint and alignment in setting fixed remuneration. In FY26 the Board left the fixed remuneration of the Managing Director & Chief Executive Officer, and the Chief Financial Officer unchanged. The fixed remuneration of the Global General Counsel & Company Secretary was increased by 3.16%, in line with inflation. Non-executive director fees remain separate from executive remuneration and contain no variable or at-risk component. Nonexecutive directors do not participate in the Team Carried Interest Plan or the Executive Plan. There was no change to nonexecutive director base fees for FY26, and aggregate fees remain within the shareholder-approved fee pool of A$950k. The Board continues to consider non-executive director fees in light of the responsibilities of directors, the governance requirements of a listed global alternative asset manager, and market relativities, while remaining conscious of shareholder expectations. In FY26 the Company allocated CIP to 84 participants. No cash distributions were made to participants in FY26. The carried interest allocations and any distributions or retentions in relation to FY26 will be assessed in early FY27. No performance rights were granted under the Executive Plan in FY26. Looking ahead The Board believes that the framework now in place is well aligned with Omni Bridgeway’s strategic direction. It supports the Company as a global investment management platform, reinforces accountability for shareholder and investor outcomes, and provides an appropriate mechanism to reward the creation and realisation of long-term value for both shareholders and fund investors. In FY27 the Committee’s priorities will be to complete the approval and implementation of the Executive Plan, report transparently on Plan outcomes as realisations occur, and keep the framework under review as the Company’s third-party capital base grows and its funds mature. On behalf of the Board, I thank shareholders for their continued engagement and feedback. The Committee remains focused on ensuring that Omni Bridgeway’s remuneration framework is transparent, performance-linked, competitive and aligned with long-term shareholder and other stakeholder interests. Yours faithfully,
Karen Phin Chair of the Nomination and Remuneration Committee
Annual Report 2026
29
Directors’ report continued Remuneration report (audited) This Remuneration Report outlines the director and Key Management Personnel (KMP) remuneration arrangements of the Group in accordance with the requirements of the Corporations Act 2001 (Cth) and its Regulations. For the purposes of this report, KMP of the Group are defined as those persons having authority and responsibility for planning, directing and controlling the major activities of the Group, directly or indirectly, including any director (whether executive or otherwise) of Omni Bridgeway Limited (OBL).
Key management personnel Details of OBL’s KMP for the 2026 financial year are:
(i) Directors Michael Green
Non-Executive Director and Chairman
Raymond van Hulst
Chief Executive Officer and Managing Director
Karen Phin
Non-Executive Director
Christine Feldmanis
Non-Executive Director
(ii) Executives Jeremy Sambrook
Global General Counsel and Company Secretary
David Breeney
Global Chief Financial Officer
There were no changes to OBL’s KMP after the reporting date and before the financial report was authorised for issue.
Nomination and Remuneration Committee The Nomination and Remuneration Committee determines and reviews the remuneration arrangements for the Board and KMP. This involves an assessment of the appropriateness of the nature and amount of the emoluments on a periodic basis by reference to relevant employment market conditions. The Company remains on track with the rollout of its team carried interest program for investment management and other senior staff, as previously communicated to the shareholders. The program is designed to strengthen alignment of the team with the Group’s fund management model and overall investor base. Based on shareholder feedback, KMP executives’ variable remuneration remains entirely aligned with shareholder returns.
Remuneration philosophy The performance of the Group is heavily dependent upon the quality of its directors, KMP and staff generally. Accordingly, the Company must attract, incentivise, and retain high-calibre directors and personnel. The Group embodies the following principles in its remuneration framework: • determination of appropriate market rates for the fixed remuneration component, taking into account the specific context of the markets the Group operates in; and • establishment of appropriate performance hurdles for the variable at-risk remuneration component.
Remuneration structure Non-executive director and executive & KMP remuneration structures are separate and distinct.
Non-executive director remuneration structure All non-executive directors enter into service agreements with the Company in the form of a letter of appointment. The letter summarises the Board policies and terms, including remuneration, relevant to the office of Director. Fees and payments to non-executive directors reflect the demands which are made on, and the responsibilities of, the non-executive directors. Non-executive directors’ fees and payments totalled $414,432 (including superannuation), as disclosed in the following tables in this report. At the 2022 Annual General Meeting, shareholders approved payments up to $950,000 per annum to non-executive directors. There are no retirement allowances for non-executive directors, nor do they have a variable at-risk remuneration component. Non-executive directors may elect to have a portion of their remuneration paid into their personal superannuation plans.
30
Omni Bridgeway
Remuneration report (audited) (continued) Executive & KMP remuneration structures Objective The Group aims to reward executives, KMP and other staff with a level and mix of compensation elements commensurate with their position and responsibilities, within the following framework: • reward for Group and individual performance against targets set to appropriate benchmarks; • align the interests with shareholders and fund investors; • link rewards with the internal strategic goals of the Group; and • ensure total compensation is competitive for our industry.
Structure All executives and KMP have employment contracts. Details of these contracts are provided below in the following Executive & KMP Employment Contracts table. Remuneration consists of two key elements: (i) fixed component, consisting of base salary, retirement contributions, and benefits; and (ii) variable at-risk component, which is the long-term incentive plan (LTIP) and, for some executives and KMP, the Carried Interest Plan.
Fixed remuneration component The levels of fixed remuneration are reflective of employment, tax and cost-of living conditions in respective locations and consider skills, experience, and responsibility. Reference is to the market within which the Company competes for talent. Fixed compensation is reviewed annually by the Nomination and Remuneration Committee. The process consists of a review of Group and individual performance, relevant comparative compensation in the market and internally and, where appropriate, external advice on policies and practices.
Variable at-risk remuneration component Objective The objective of the variable compensation component is to reward executives in a manner aligned with the shareholder and fund investor outcomes. The total potential incentive available is set at a level to provide sufficient incentivisation to achieve the operational and strategic targets which are anticipated to drive shareholder returns. The Company’s variable at-risk remuneration framework comprises the following long-term incentivisation plans: (a) a share performance rights plan for key management personnel currently tested against relative total shareholder return outcomes; and (b) a carried interest plan granting participants an opportunity to participate in a portion of the Group’s carried interest proceeds from the funds (Carried Interest Plan). The Carried Interest Plan contains with an option for the Company to settle any final award in shares. This aligns the “at risk” remuneration structure with the broader alternative asset fund management industry, and aims to improve incentivisation and alignment of employee participants with shareholder and fund investor outcomes. The Carried Interest Plan is fully linked to actual cash carried interest proceeds received and retained by the Company, rewarding performance achieved on investments beyond the fund hurdle rates. This aligns with shareholder interests through the Company’s co-investment in the funds and the Company’s entitlement to carried interests.
Long-Term Incentive Plan The LTIP is tied to the Group’s long-term performance. It encourages equity ownership and directly aligns shareholders’ and participants’ interests, whilst also not being a cash drain.
Annual Report 2026
31
Directors’ report continued Remuneration report (audited) (continued) Key Features of LTIP
Participants
Key management personnel
Participation % of TFR
Executive
Payment frequency and type
Annual grant of share performance rights with 3-year vesting Each right over OBL ordinary shares is issued for no consideration or exercise price The number of rights issued at the beginning of each service period is determined by reference to individual’s TFR and the Company’s VWAP at either (i) 30 June of the preceding Financial Year; or 31 December of the preceding Half Financial Year, depending on when a participant became eligible to participate in the LTIP
Performance criteria
Total Shareholder Return (TSR) OBL compared to a peer group comprising entities from the ASX diversified financials industry group with a market capitalisation of < $1bn Vesting depends on the Company’s Percentile ranking over the vesting period compared to the peer group:
max 125%
Percentile rank
Other
32
Omni Bridgeway
– – –
% TSR vesting
less than 50th
nil
equal to 50th
50%
between 50-75%
50-100% determined on a straight line basis
75th or above
100%
Good leaver/bad leaver provisions in respect to unvested rights Malus event provisions in respect to fraud, dishonest behaviour, or gross misconduct 12-month clawback provisions
Remuneration report (audited) (continued) Executive & KMP Employment Contracts Raymond van Hulst Managing Director and Chief Executive Officer Contract commenced
21 April 2020
Gross annual salary package
CHF700,000
Salary review
Annually
Notice period
12 months by either the Group or employee
Termination payment arrangements
Statutory entitlements, notice period, and subject to good or bad leaver status unvested LTIP
Variable compensation
LTIP
Jeremy Sambrook Global General Counsel and Company Secretary Contract commenced
18 January 2016
Gross annual salary package
$515,800 (including super) from 1 July 2025
Salary review
Annually
Notice period
6 months by either the Group or employee
Termination payment arrangements
Statutory entitlements, notice period, and subject to good or bad leaver status unvested LTIP
Variable compensation
LTIP, Carried Interest Plan
David Breeney Global Chief Financial Officer Contract commenced
1 March 2025
Gross annual salary package
$480,000 (including super)
Salary review
Annually
Notice period
12 months by the Group or 6 months by the employee
Termination payment arrangements
Statutory entitlements, notice period, and subject to good or bad leaver status unvested LTIP
Variable compensation
LTIP, Carried Interest Plan
Appointment performance rights
Appointment bonus:
– – –
28,450 rights; for period 31 March 2025 - 31 March 2026 28,450 rights; for period 31 March 2025 - 31 March 2027 28,450 rights; for period 31 March 2025 - 31 March 2028
Annual Report 2026
33
Directors’ report continued Remuneration report (audited) (continued) Remuneration of Key Management Personnel Variable Remuneration
Fixed Remuneration Short-term benefits 2026
Currency
Salary & fees
Post- employment
Long-term benefits
Share-based payments
Cash bonus accrued
Super- annuation / pension
Employee entitlements
Performance Share Termination Total related performance payments remuneration rights %
14,464
–
APAC Directors and Executives K. Phin
AUD
120,536
–
–
–
135,000
C. Feldmanis AUD
135,000
–
–
J. Sambrook
AUD
485,800
–
30,000
D. Breeney
AUD
450,000
–
30,000
R. van Hulst
CHF
701,876
–
M. Green
GBP
75,000
–
–%
–
–
–
135,000
–%
(560)
337,587
–
852,827
40 %
13,534
135,923
–
629,457
22 %
48,106
16,246
293,085
–
1,059,313
28 %
–
–
–
–
75,000
–%
Performance related %
EMEA Directors
Variable Remuneration
Fixed Remuneration Short-term benefits 2025
Currency
Salary & fees
Post- employment
Long-term benefits
Share-based payments
Cash bonus accrued
Super- annuation / pension
Employee entitlements
Share Termination Total performance payments remuneration rights
APAC Directors and Executives M. Kay¹
AUD
77,319
–
13,531
–
–
–
90,850
–%
K. Phin
AUD
121,076
–
13,924
–
–
–
135,000
–%
C. Feldmanis AUD
135,000
–
–
–
–
–
135,000
–%
J. Sambrook
AUD
476,691 50,000
29,932
40,062
236,085
–
832,770
34 %
D Breeney2
AUD
151,303
–
9,977
33,581
21,909
–
216,770
10%
R. van Hulst
CHF
701,841
–
34,813
60,667
77,497
–
874,818
9%
M. Green
GBP
75,000
–
–
–
–
–
75,000
–%
342,272
–
6,925
–
–
58,261
407,458
–%
EMEA Directors
Americas Executive G. Leger2
USD
- Michael Kay left the Group on 19 November 2024.
- Represents the proportionate amount attributable to the period during which David Breeney and Guillaume Leger were classified as KMP. David Breeney joined, and Guillaume Leger departed the Executive Group on 1 March 2025.
34
Omni Bridgeway
Remuneration report (audited) (continued) Share performance rights – Granted and vested during the year – Key Management Personnel
Grant
Vesting
Expiry
date
date
date
2026
Approved Fair value per during the rights at year grant date
Value approved during the year
Vested and exercised during the years
Value remaining to be expensed to profit & loss
Number
AUD
AUD
Number
AUD
–
246,575
84,684
Executive Directors R. van Hulst - FY25 offer
01-July-24
30-June-27
30-June-27
1,395,705
0.53
739,724
J. Sambrook - FY25 offer
01-July-24
30-June-27
30-June-27
479,342
0.53
254,051
–
J. Sambrook
31-Mar-25
31-Mar-26
31-Mar-40
–
–
–
24,657
–
J. Sambrook
31-Mar-25
31-Mar-27
31-Mar-40
–
–
–
–
12,384
J. Sambrook
31-Mar-25
31-Mar-28
31-Mar-40
–
–
–
–
19,276
D. Breeney - FY25 offer
01-July-24
30-June-27
30-June-27
166,812
0.53
88,410
–
29,470
D. Breeney Bonus T1
31-Mar-25
31-Mar-26
31-Mar-40
–
–
–
28,450
–
D. Breeney Bonus T2
31-Mar-25
31-Mar-27
31-Mar-40
–
–
–
–
15,143
D. Breeney Bonus T3
31-Mar-25
31-Mar-28
31-Mar-40
–
–
Executives
Total
2,041,859
–
–
23,569
1,082,185
53,107
431,101
Granted during the year
Grant
Vesting
Expiry
date
date
date
2025
Total
Value remaining Vested to be during expensed the to profit & years loss
Tranche 1 Fair value per Awarded rights at during grant the year date 1
Tranche 2 Fair value per Awarded rights at during grant the year date 1
Tranche 3 Fair value per Awarded rights at during grant the year date 1
Awarded during the year
Value granted during the year
Number
AUD
Number
AUD
Number
AUD
Number
AUD
Number
AUD
343,096
0.05
85,774
1.01
–
–
428,870
102,071
22,520
34,024
Executive Directors R. van Hulst FY24 offer
01-July-23 30-June-26
01-July-38
Executives J. Sambrook
01-July-23 30-June-26
01-July-38
–
–
–
–
–
–
–
–
29,370
115,993
J. Sambrook 1
31-Mar-25
31-Mar-26
31-Mar-40
24,657
1.34
–
–
–
–
24,657
33,041
–
24,781
J. Sambrook 1
31-Mar-25
31-Mar-27
31-Mar-40
–
–
24,657
1.34
–
–
24,657
33,041
–
28,911
J. Sambrook 1
31-Mar-25
31-Mar-28
31-Mar-40
–
–
–
–
24,657
1.34
24,657
33,041
–
30,287
D. Breeney
01-July-23 30-June-26
01-July-38
–
–
–
–
–
–
–
–
–
13,125
D. Breeney Bonus T1 1
31-Mar-25
31-Mar-26
31-Mar-40
28,450
1.42
–
–
–
–
28,450
40,399
–
30,299
D. Breeney Bonus T2 1
31-Mar-25
31-Mar-27
31-Mar-40
–
–
28,450
1.42
–
–
28,450
40,399
–
35,349
D. Breeney Bonus T3 1
31-Mar-25
31-Mar-28
31-Mar-40
–
–
–
–
28,450
1.42
Total
396,203
138,881
53,107
28,450
40,399
–
37,032
588,191
322,391
51,890
349,801
- J. Sambrook’s and D. Breeney’’s T1, T2 and T3 awards are included in addition to performance rights.
Non-executives (K. Phin, C. Feldmanis, M. Green) did not participate in LTIP. They have not been included in the table. The fair value of performance rights is determined at the time of grant as prescribed in IFRS 2. For details on the valuation of performance rights, including models and assumptions used, refer to Note 29.
Annual Report 2026
35
Directors’ report continued Remuneration report (audited) (continued) Share performance right holdings of Key Management Personnel Balance 1 July 2025 Number
2026
Balance 30 June 2026 Number
Movement for the year
Total
Granted as remuneration
Exercised
Lapsed
Total
Vested
Unvested
Number
Number
Number
Number
Number
Number
Number
496,549
1,395,705
–
–
1,892,254
67,679
1,824,575
490,030
479,342
–
–
969,372
246,096
723,276
107,371
166,812
–
–
274,183
28,450
245,733
1,093,950
2,041,859
–
–
3,135,809
342,225
2,793,584
Executive Directors R. van Hulst Executives J. Sambrook D. Breeney Total
Balance 1 July 2024
Balance 30 June 2025
Movement for the year
Total
Granted as remuneration
Exercised
Lapsed¹
Total
Vested¹
Unvested
Number
Number
Number
Number
Number
Number
Number
127,406
428,870
30,353
(90,080)
496,549
67,679
428,870
J. Sambrook
533,538
73,971
–
(117,479)
490,030
221,439
268,591
D. Breeney
22,021
85,350
–
–
107,371
–
107,371
Total
682,965
588,191
30,353
(207,559)
1,093,950
289,118
804,832
2025
Directors R. van Hulst Executives
- As of 30 June 2025, the aggregated balance of performance rights held by KMP reflects the 20% vesting under the FY23 Long Term Incentive Plan, with the remaining performance rights set to lapse.
Non-executives (K. Phin, C. Feldmanis, M. Green) did not participate in LTIP. They have not been included in the table.
36
Omni Bridgeway
Remuneration report (audited) (continued) Interests of Key Management Personnel Shares
2026
Balance 1 July 2025
Received as remuneration
Share performance rights exercised
Net change other1
Balance 30 June 2026
Number
Number
Number
Number
Number
Directors R. van Hulst
6,319,529
–
–
35,600
6,355,129
K. Phin
102,266
–
–
–
102,266
C. Feldmanis
85,000
–
–
50,000
135,000
M. Green
207,115
–
–
–
207,115
J. Sambrook
8,446
–
–
–
8,446
D. Breeney
–
–
–
–
–
6,722,356
–
–
85,600
6,807,956
Executives
Total
Shares
2025
Balance 1 July 2024
Received as remuneration
Share performance rights exercised
Net change other1
Balance 30 June 2025
Number
Number
Number
Number
Number
Directors R. van Hulst
5,048,765
–
(30,353)
1,301,117
6,319,529
K. Phin
102,266
–
–
–
102,266
C. Feldmanis
85,000
–
–
–
85,000
M. Green
72,212
–
–
134,903
207,115
J. Sambrook
8,446
–
–
–
8,446
D. Breeney
–
–
–
–
–
5,316,689
–
(30,353)
1,436,020
6,722,356
Executives
Total
- Net change other relates to shares bought or sold on market.
Shares above are held nominally by the Directors or the other KMP.
Loans to Key Management Personnel There have been no loans provided to KMP in 2026 (2025: nil).
Transactions with Key Management Personnel There have been no transactions with KMP in 2026 (2025: nil).
Annual Report 2026
37
Directors’ report continued
Auditor’s Independence Declaration
38
Omni Bridgeway
Consolidated Statement of Comprehensive Income for the year ended 30 June 2026 Consolidated Note
2026
2025
$'000
$'000
54,986
Continuing operations Revenue from contracts with customers
2
96,312
Interest revenue
3
10,156
12,996
Net gain on litigation investments - financial assets
4
61,920
279,698
Net gain on derecognition of litigation investments - intangible assets
5
7,037
26,499
Net gain on litigation investments - purchased claims
13
5,566
4,323
Net gain on disposal of subsidiaries and other assets
31
–
242,241
Share of profit in associates
32
222
15,461
Other income
6
Total income
1,022
15,243
182,235
651,447
Finance costs
7(a)
1,322
11,119
Amortisation of litigation investments - claims portfolio
7(b)
35,073
22,718
Depreciation expense
7(c)
4,012
4,379
Employee benefits expenses
7(d)
51,160
61,110
Corporate and office expenses
7(e)
13,541
20,950
Other expenses
7(f)
7,917
3,804
Impairment expense and adverse costs - litigation investments
7(g)
12,733
35,818
Expected credit loss expense/(reversal)
7(h)
1,646
(4,196)
Fair value adjustment of financial liabilities
31
Profit before tax Income tax expense
8
Profit for the year
6,660
225
48,171
495,520
2,242
78,698
45,929
416,822
Attributable to: Equity holders of the Parent
9
53,697
349,797
Non-controlling interests
31
(7,768)
67,025
(42,819)
3,201
(5,926)
32,208
Other comprehensive income/(loss) Items that may be subsequently reclassified to profit or loss: Movement in foreign currency translation reserve Items that will not be subsequently reclassified to profit or loss: Movement in foreign currency translation reserve attributed to non-controlling interests
31
Other comprehensive (loss)/income net of tax
(48,745)
35,409
Total comprehensive (loss)/income for the year
(2,816)
452,231
Equity holders of the Parent
10,878
352,998
Non-controlling interests
(13,694)
99,233
Attributable to:
Profit per share attributable to the equity holders of the Company (cents per share) Basic profit per share (cents per share)
9
18.58
123.15
Diluted profit per share (cents per share)
9
18.46
122.57
The above Consolidated Statement of Comprehensive Income should be read in conjunction with the accompanying notes.
Annual Report 2026
39
Consolidated Statement of Financial Position as at 30 June 2026 Consolidated 2026
2025
Note
$'000
$'000
18 22
158,607 78,284 – 16,185 90,385 26,641 61,977 472,980 1,073
180,289 101,123 705 16,938 125,307 19,242 65,483 418,059 8,250
16 23 32 8
104,407 8,754 9,423 93,786 1,122,502
112,910 12,227 10,174 115,204 1,185,911
Trade and other payables Income tax payable Provisions Lease liabilities Other financial liabilities Borrowings Deferred tax liabilities Other liabilities
24
92,238 1,765 5,435 9,891 1,760 35,395 86,530 1,441
114,756 5,482 33,059 13,031 2,704 19,500 108,799 2,931
Financial liabilities - warrants¹ Total liabilities Net assets
31
29,462 263,917 858,585
22,869 323,131 862,780
20 21(a) 21
484,864 (5,058) 196,831
475,717 49,734 143,134
31
676,637 181,948 858,585
668,585 194,195 862,780
Assets Cash and cash equivalents Trade and other receivables Contract costs Other assets Litigation investments - claims portfolio Litigation investments - purchased claims Litigation investments - intangible assets Litigation investments - financial assets Litigation investments - investment in associates Goodwill Right-of-use assets and other plant and equipment Investment in associates Deferred tax assets Total assets
12 13 14 15 32
Liabilities
Equity Contributed equity Reserves Retained earnings Equity attributable to equity holders of the parent Non-controlling interests Total equity
25 26 19 8
- Warrants issued in the Fund 9 transaction are classified as a liability under IFRS. The Group expects the liability will be extinguished via equity settlement.
The above Consolidated Statement of Financial Position should be read in conjunction with the accompanying notes.
40
Omni Bridgeway
Consolidated Statement of Cash Flows for the year ended 30 June 2026 Consolidated 2026
2025
$'000
$'000
Proceeds from litigation investments - claims portfolio
75,086
107,897
Payments for litigation investments - claims portfolio
(45,041)
(23,748)
Proceeds from management fees and carried interests
28,820
27,089
Payments to suppliers and employees
Note
Cash flows from operating activities
(68,056)
(74,022)
Interest received
1,396
2,217
Interest paid
(5,615)
(19,036)
Income tax paid
(4,933)
(3,308)
(18,343)
17,089
4,503
34,948
Net cash flows (used in)/from operating activities
11
Cash flows from investing activities Proceeds from litigation investments - purchased claims Payments for litigation investments - purchased claims
(972)
(2,203)
Proceeds from litigation investments - intangible assets
58,457
70,314
Payments for litigation investments - intangible assets
(33,954)
(93,536)
Proceeds from litigation investments - financial assets
6,625
–
Payments for litigation investments - financial assets
(18,390)
(8,940)
Payments for litigation investments - capitalised overheads and employee costs
(1,223)
(8,864)
(132)
(44)
(7,330)
(17,607)
–
(21,818)
Payments for plant and equipment Prepayments for litigation investments Deconsolidation of subsidiaries Investment in associates
(824)
(7,331)
Proceeds from investment in associates
1,231
25,048
Proceeds from disposal of subsidiaries Net cash flows from investing activities
–
314,136
7,991
284,103
(1,100)
(180) (250,000)
Cash flows from financing activities Payments of borrowing costs Repayment of debt
19
(1,919)
Proceeds from issue of borrowings
19
19,003
5,925
(5,180)
(4,854)
Payments of lease liabilities Contributions from non-controlling interests
31
–
66,103
Distributions to non-controlling interests
31
(11,200)
(91,313)
Receipts from debt insurance
–
639
Payments of share buy-back scheme
–
(10)
Share capital
108
–
Net cash flows used in financing activities
(288)
(273,690)
(10,640)
27,502
Net (decrease)/increase in cash and cash equivalents held Net foreign exchange difference
(11,042)
16,907
Cash and cash equivalents at beginning of year
180,289
135,880
158,607
180,289
Cash and cash equivalents at end of year
18
The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.
Annual Report 2026
41
Consolidated Statement of Changes in Equity for the year ended 30 June 2026
Issued capital Notes
Sharebased payment reserve
Foreign currency translation reserve
Other equity reserve
Fund equity reserve
Retained earnings
Total
Total equity
$'000
$'000
$'000
$'000
$'000
$'000
$'000
$'000
$'000
475,717
16,437
26,061
7,236
–
143,134
668,585
194,195
862,780
Profit for the year
–
–
–
–
–
53,697
53,697
(7,768)
45,929
Other comprehensive loss
–
–
(42,819)
–
–
–
(42,819)
(5,926)
(48,745)
Total comprehensive income/ (loss) for the year
–
–
(42,819)
–
–
53,697
10,878
(13,694)
(2,816)
Shares issued
At 1 July 2025
–
(9,144)
–
–
–
–
(9,144)
–
(9,144)
Share-based payments, net of tax
9,147
3,097
–
–
–
–
12,244
–
12,244
Distributions to non-controlling interests
–
–
–
–
–
–
–
(4,385)
(4,385)
Changes in the proportion of equity held by non-controlling interests At 30 June 2026
20, 21, 29, 31
–
–
(5,926)
–
–
–
(5,926)
5,832
(94)
484,864
10,390
(22,684)
7,236
–
196,831
676,637
181,948
858,585
The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.
42
Noncontrolling interests
Omni Bridgeway
Consolidated Statement of Changes in Equity (continued) for the year ended 30 June 2026
Issued capital Notes
Sharebased payment reserve
Foreign currency translation reserve
Other equity reserve
Fund equity reserve
Retained earnings/ (Accumulated losses)
Total
Noncontrolling interests
Total equity
$'000
$'000
$'000
$'000
$'000
$'000
$'000
$'000
$'000
460,716
18,121
(14,516)
7,236
(14,172)
(206,663)
250,722
544,207
794,929
Profit for the year
–
–
–
–
–
349,797
349,797
67,025
416,822
Other comprehensive income
–
–
3,201
–
–
–
3,201
32,208
35,409
Total comprehensive income/ (loss) for the year
–
–
3,201
–
–
349,797
352,998
99,233
452,231
At 1 July 2024
Equity Transactions: Shares issued
–
(7,207)
–
–
–
–
(7,207)
–
(7,207)
Share-based payments, net of tax
7,103
5,594
–
–
–
–
12,697
–
12,697
Shares issued to settle deferred and variable deferred consideration
7,898
–
–
–
–
–
7,898
–
7,898
Contributions from noncontrolling interests
–
–
–
–
–
–
–
59,202
59,202
Distributions to non-controlling interests
–
–
–
–
–
–
–
(94,995)
(94,995)
Deconsolidation of Subsidiary
–
(71)
5,168
–
23,795
–
28,892
Changes in the proportion of equity held by non-controlling interests At 30 June 2025
20, 21, 29, 31
(400,925) (372,033)
–
–
32,208
–
(9,623)
–
22,585
(12,527)
10,058
475,717
16,437
26,061
7,236
–
143,134
668,585
194,195
862,780
The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.
Annual Report 2026
43
Notes to the Financial Statements for the year ended 30 June 2026
About this Report The financial report of Omni Bridgeway Limited (OBL, Company, Parent) and its subsidiaries (Group, Consolidated Entity) for the year ended 30 June 2026 was authorised for issue in accordance with a resolution of the directors on 26 August 2026. The principal activities of the entities within the consolidated group are: i.
the investment into, capital raising and management of Funds (or Fund-like structures) that are focused on investing into litigation and dispute resolution matters globally; and
ii.
the continued holding of direct investments into similar litigation and dispute resolution matters.
Omni Bridgeway Limited (ABN 45 067 298 088) is a for profit Company incorporated and domiciled in Australia and limited by shares that are publicly traded on the Australian Securities Exchange (ASX code: OBL). This section sets out the basis upon which the Group’s Financial Statements are prepared. Specific accounting policies are described in the respective notes to the Financial Statements. This section also shows information on new or amended accounting standards and interpretations and their impact on the financial position and performance of the Group.
a. Basis of preparation The financial report is a general purpose financial report, which has been prepared in accordance with the requirements of the Corporations Act 2001, Australian Accounting Standards and other authoritative pronouncements of the Australian Accounting Standards Board. The financial report has been prepared on a historical cost basis, except for the financial assets and liabilities that have been measured at fair value. The amounts contained within this report have been rounded to the nearest $1,000 or $100,000 (where rounding is applicable) under the option available to the Company under ASIC Corporations (Rounding in Financial/Directors’ Reports) Instrument 2026/183, unless stated otherwise.
b. Compliance with IFRS The financial report also complies with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board.
c. Basis of consolidation The consolidated financial statements comprise the financial statements of Omni Bridgeway Limited and its subsidiaries at 30 June 2026. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. The Group includes Fund collective investment vehicles over which Omni Bridgeway Limited has the right to direct the relevant activities of the Fund under contractual arrangements and has exposure to variable returns from the Fund collective investment vehicles. See Note 31. The financial results of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. A change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction. In preparing the consolidated financial statements, all intercompany balances and transactions, income and expenses and profits and losses resulting from intra-group transactions have been eliminated in full.
Foreign currency The Group’s consolidated financial statements are presented in Australian dollars, which is also the Parent’s functional currency. The Group determines the functional currency of each entity in the Group. The Group uses the direct method of consolidation and on disposal of a foreign operation, the gain or loss that is reclassified to profit or loss reflects the amount that arises from using this method.
Transactions and balances Transactions in foreign currencies are initially recorded by each entity in the Group at their respective functional currency spot rates at the date the transaction first qualifies for recognition. Monetary assets and liabilities denominated in foreign currencies are converted at the functional currency spot rates of exchange at the reporting date. Exchange differences arising on settlement or conversion of monetary items are recognised in profit or loss. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value is determined. The gain or loss arising on translation of non-monetary items measured at fair value is treated in line with the recognition of gain or loss on change in fair value of the item (i.e. translation differences on items whose fair value gain or loss is recognised in other comprehensive income or profit or loss are also recognised in other comprehensive income or profit or loss, respectively).
Group companies On consolidation, the assets and liabilities of foreign operations are translated into Australian dollars at the rate of exchange prevailing at the reporting date and their statements of profit or loss are translated at exchange rates prevailing at the dates of the transactions. The exchange differences arising on translation for consolidation purposes are recognised in other comprehensive income. On disposal of a foreign operation, the component of other comprehensive income relating to that particular foreign operation is recognised in profit or loss.
44
Omni Bridgeway
About this Report (continued) d. New and amended accounting standards and interpretations adopted during the year The accounting policies adopted are consistent with those followed in the preparation of the Group’s annual consolidated financial statements for the year ended 30 June 2025. The Group has applied the following standards and amendments for the first time for its annual reporting period commencing 1 July 2025: • AASB 2023-5 Amendments to Australian Accounting Standards – Lack of Exchangeability. • AASB 2026-1 Amendments to Australian Accounting Standards – Disclosures about Uncertainties in the Financial Statements. The amendments listed above did not have any impact on the amounts recognised in prior periods and had no significant effect on current period.
e. New and amended accounting standards and interpretations issued but not yet effective The new and amended standards and interpretations that are issued, but not yet effective, up to the date of issuance of the Group’s financial statements that the Group reasonably expects will have an impact on its disclosures, financial position or performance when applied at a future date, are disclosed below. • AASB 2024-2 Classification and Measurement of Financial Instruments. • AASB 2024-3 Amendments to Australian Accounting Standards – Annual Improvements Volume 11. • AASB 18 Presentation and Disclosure in Financial Statements. The Group intends to adopt these new and amended standards and interpretations, if applicable, when they become effective. Of the other standards and interpretations that are issued, but not yet effective, as these are not expected to impact the Group, they have not been listed.
f. Significant accounting judgments, estimates and assumptions The preparation of the Group’s consolidated financial statements requires management to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures, and the disclosure of contingent liabilities at the date of the consolidated financial statements.
Key judgments In the process of applying the Group’s accounting policies, management has made the following judgments, which have the most significant effect on the amounts recognised in the consolidated financial statements:
Consolidation of entities in which the Group holds less than a majority voting right (de facto control) The Group has assessed the entities in which it has an interest to determine whether or not control exists and the entity is, therefore, consolidated into the Group. These entities are listed in Notes 30 and 31. For those entities consolidated, the Group uses judgment to determine that it has power to direct the relevant activities of the investee under contractual arrangements and sufficient exposure to variable returns.
Taxation The Group’s accounting policy for taxation requires management’s judgment in assessing whether deferred tax assets and certain deferred tax liabilities are recognised on the Statement of Financial Position. Deferred tax assets, including those arising from tax losses, capital losses and temporary differences, are recognised only where it is considered more likely than not that they will be recovered, which is dependent on the generation of sufficient future taxable profits. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows as contained in the Group’s yearly budget. These depend on estimates of future income, operating costs, capital expenditure, dividends and other capital management transactions. Judgments and assumptions are also required about the application of income tax legislation. These judgments and assumptions are subject to risk and uncertainty, hence there is a possibility that changes in circumstances will alter expectations, which may impact the amount of deferred tax assets and deferred tax liabilities recognised in the Consolidated Statement of Financial Position and the amount of other tax losses and temporary differences not yet recognised. In such circumstances, some or all of the carrying amounts of recognised deferred tax assets and liabilities may require adjustment, resulting in a corresponding credit or charge to the Consolidated Statement of Comprehensive Income.
Litigation investments Classification of litigation investments as either claims portfolio, purchased claims, intangible assets, financial assets or investment in associates requires judgment on the circumstances and contracts attached to the investment. Refer to Notes 12 - 15 and 32 on the accounting policies for litigation investments and investment in associates.
Annual Report 2026
45
Notes to the Financial Statements continued About this Report (continued) Significant estimates and assumptions The key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are described below. The Group based its assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising that are beyond the control of the Group. Such changes are reflected in the assumptions when they occur.
Impairment of financial and non-financial assets The Group assesses impairment of all required financial and non-financial assets at each reporting date by evaluating conditions specific to the Group and to the particular asset that may lead to impairment. Impairment exists when the carrying value of an asset or cash generating unit exceeds its recoverable amount, which is the higher of its fair value less costs of disposal and its value in use. The Group primarily relies on value in use calculations based on Discounted Cash Flows (DCF) models. The cash flows are derived from either the Group’s budget or from estimates made by investment managers. The recoverable amount is sensitive to the discount rate used for the DCF model as well as the expected future cash-inflows and the growth rate used for extrapolation purposes. These estimates are most relevant to goodwill and other intangibles recognised by the Group. Refer to individual notes for further information around impairment of financial and non- financial assets.
Fair value measurement of financial liabilities through profit or loss When warrants issued by the Group as part of the Fund 9 transaction is classified as a financial liability at fair value through profit or loss, it is subsequently remeasured to fair value at each reporting date. The determination of the fair value is based on option pricing methodology. The key inputs are detailed in Note 31. The warrants issued by the Group contain certain non-standard features that could potentially impact their valuation. Management concluded that the impact of the non-standard features could be reasonably approximated within a standard Black-Scholes framework. Accordingly, the warrants have been valued using a modified Black-Scholes call option model. The key adjustment involves the time-toexpiry input, which has been derived from the call feature trigger. This approach reflects management’s judgement that the simplified model provides a reliable and transparent estimate of fair value, while balancing complexity and relevance to the underlying economic characteristics of the instrument.
Provision for adverse costs The Group raises a provision for adverse costs upon an underlying litigation receiving a losing judgment in certain jurisdictions that require adverse costs to be paid to the litigation’s counterparty. If an appeal is lodged, the Group still raises a provision. The provision raised is the Group’s best estimate of the amount of adverse costs it will have to remit. Typically, this estimate is between nil to 80% of the amount spent by the plaintiff, on the basis that there is only one defendant per the litigation. Refer to Notes 25 and 27 for further details on adverse costs.
Share-based payments Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the expected life of the performance rights, volatility, dividend yield and risk-free rate and making assumptions about them. For the measurement of the fair value of performance rights at the grant date, the Group uses a Monte-Carlo simulation model and Black-Scholes model. The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in Note 29.
Measurement of non-controlling interests (NCI) Profits and losses are attributed to non-controlling interests in line with the allocation of profit distributions under the terms of the respective agreements with non-controlling investors. Therefore, at the end of each reporting period, the non-controlling interests represent the non-controlling shareholders’ share of net assets, as would be distributed under the relevant shareholders or investors agreements at the balance date.
Revenue recognition – estimating variable consideration on management fees The Group estimates variable considerations to be included in the transaction price for management fees. Management fees are based on the level of external investors’ net deployed capital or net committed capital per quarter and any uncertainty is resolved at the end of the same quarter. Therefore, management fee revenues are recognised quarterly in arrears, corresponding with the delivery of performance obligations.
Net gain on derecognition of litigation investments – intangible assets The Group recognises proceeds and derecognises carrying costs on disposal in accordance with the investments’ funding terms. In some instances, the calculation requires certain estimates and assumptions to be made. Refer to Note 14 for further information.
Investments in associates (former subsidiaries) For all subsidiaries where there is more than 50% ownership interest and voting rights, the Group’s power to direct the relevant activities of the investee is subject to a without-cause kick-out right exercisable by a third party, the Group is considered to be acting as an agent and thus has no control. The Group’s retained power is able to significantly influence the financial and operating activities of the investee. The retained interest is equity accounted for as an investment in associates and initially recognised at the fair value. The Group uses Investment Managers’ best estimate to calculate the present value of probability-weighted cashflows from litigation investments held in the associate which represents the fair value of the retained non-controlling interest held by the Group. Refer to Note 32 for further information.
Litigation investments – purchased claims The Group initially recognises litigation investments – purchased claims at fair value. These are subsequently measured at amortised cost by applying the credit-adjusted effective interest rate based on estimated cash flows. Refer to Note 13 for further information. 46
Omni Bridgeway
About this Report (continued) Litigation investments – financial assets The Group classifies litigation investments - financial assets as financial assets at fair value through the profit or loss in accordance with IFRS 9 Financial Instruments. These investments are initially recognised at fair value plus any attributable transaction costs and are subsequently measured at fair value at each reporting date. Subsequent changes in fair value are recognised as fair value gains or losses to profit or loss. Refer to Note 15 for further information. At inception the fair value of an investment is determined as the net present value of the future loss-adjusted probability-weighted investment cash flows for the likely outcome scenarios (including loss) for the investment. The model uses informed assumptions for outcome scenarios, probabilities, cash inflows and cash outflows, which rely on inputs around the key risk factors for legal investments, including loss risk, duration risk, budget risk, quantum risk and recoverability risk (credit risk). In subsequent periods the fair value of an investment is adjusted, positively or negatively, based on the combination of: • Deployments made for the investment during the period. • The unwinding of the discount due to the passage of time. • Changes in the discount rate. • Material litigation events, which are objectively verifiable events leading to changes in assumptions or inputs. A discount rate of 12% is used, based on the weighted average cost of capital (WACC) for the legal finance asset class, which closely aligns with the WACC for OBL and with the hurdle rates for our third-party fund capital. All main investment risks associated with legal investments, including loss risk, duration risk, budget risk, quantum risk and credit risk are reflected in the probabilistic scenarios, and therefore fall outside the scope of risks determining the required discount rate. There are many possible material litigation events, with some generally applicable to most litigation investments and others more investment specific. A material litigation event is always objectively verifiable and not based on a subjective reassessment of an investment. Typical material litigation events include: • Judgments, arbitral decisions, new relevant case law, mediations, partial settlements or recoveries, new external legal opinions (e.g. as a result of changes to fact base or legal discovery), new expert opinions (e.g. on damages). • Changes to expected duration (e.g. following case management hearings, court timetables or observed delays), book-building results, budget changes, asset freezes, new recoverability intelligence, etc.
Expected credit losses (ECLs) of receivables The Group uses Investment Managers’ best estimate to calculate ECLs for receivables. The provision is based on assessment of customer segments that have similar loss patterns. Refer to Note 22 for further information.
Annual Report 2026
47
Notes to the Financial Statements continued A. RESULTS FOR THE YEAR Note 1: Segment information The Group operates in one industry, being funding and provision of services in relation to legal dispute resolution. For management purposes, the Group is organised into operating segments comprising the Group’s corporate operations and business across geographic locations: • Americas - the Group’s investment management business operating in America, Canada and Latin America • APAC - the Group’s investment management business operating in Australia, Asia and New Zealand; and • EMEA - the Group’s investment management business operating in Europe, Middle East and Africa Operating segments have been reported in a manner consistent with internal management reporting provided to the chief operating decision-maker (CODM) for assessing performance and determining resource allocation. The CODM consists of the Group Chief Executive Officer and other members of the Investment Committee. Total assets and liabilities are reviewed at a consolidated level, and the CODM does not regularly review segment assets and liabilities. The tables below set forth the components of the profit/(loss) by segment for the periods indicated. Americas
APAC
EMEA
Corporate
Total Group
A$ million
2026
2025
2026
2025
2026
2025
2026
2025
2026
2025
Revenue
11
7
10
117
95
68
2
(165)
118
27
Inter-segment income¹
22
2
22
18
21
21
–
5
65
46
Fair value gain/(loss)4 5
(25)
79
49
106
31
95
–
–
55
280
Other income2
1
115
2
254
–
(4)
–
(58)
3
307
Total Segment Income
9
203
83
495
147
180
2
(218)
241
660
Operating expenses
(19)
(8)
(15)
(18)
(17)
(15)
(20)
(25)
(71)
(66)
Inter-segment expenses¹
(8)
(2)
(1)
(9)
(56)
(29)
–
(5)
(65)
(45)
Other expenses
(7)
(5)
–
(8)
1
(9)
(11)
8
(17)
(14)
EBITDA
(25)
188
67
460
75
127
(29)
(240)
88
535
Amortisation and depreciation
(2)
(2)
(1)
(2)
(36)
(24)
–
–
(39)
(28)
EBIT
(27)
186
66
458
39
103
(29)
(240)
49
507
Interest expenses Profit/(Loss) before tax Tax expenses3 Profit/(Loss) after tax
–
(1)
–
–
(1)
–
–
(10)
(1)
(11)
(27)
185
66
458
38
103
(29)
(250)
48
496
–
–
–
–
–
–
2
79
2
79
(27)
185
66
458
38
103
(31)
(329)
46
417
- Inter-segment revenue/expenses comprise interest revenue/expenses on intercompany loans, transfer pricing, advisory fees and other charges, which are eliminated on consolidation.
- Other income comprises the income generated from secondary market sales, management services, other investments and foreign exchange.
- The tax effect accounting is managed on a Group basis and not allocated to the individual segments.
- The fair value gains and losses arise from the changes in the fair value of the litigation investment, which is classified as a financial asset measured at fair value through profit or loss (FVTPL).
- The regional segment split is based on the fair value movement of investment portfolio, with each investment assigned to a region according to its jurisdiction or legal venue. This geographic allocation reflects the Group’s economic exposure and investment performance, aligned with internal management reporting.
Note 2: Revenue from contracts with customers Revenue from contracts with customers is recognised when control of the service is transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those services.
(i) Litigation investments – claims portfolio The nature of services Revenue is generated from providing enforcement, collection, monetisation and recovery services to customers with judgments, awards or contractual debts and receivables.
Performance obligations At investment inception, the Group assesses the services promised in its contracts with customers and identifies the performance obligation involved in each promise to transfer funds received to the customer. Performance obligations are satisfied at a point in time, upon the recovery of each dollar.
48
Omni Bridgeway
Note 2: Revenue from contracts with customers (continued) Transaction price Almost all revenues from litigation investments – claims portfolio are based on a no success, no fee basis. The transaction price contains various components, with each component being either fixed or variable. The Group includes variable consideration (a portion or all) in the transaction price only when it is highly probable that the recognised revenue will not incur a significant revenue reversal. The revenue is based on a percentage that is recovered so the uncertainty is typically removed when the money is received or settlement agreement has been signed and where applicable, court approval obtained as, at that point, the revenue formula can be applied to the amount collected.
(ii) Management, service and transaction fees The management, service or transaction fee revenue earned during the year was derived from Investment Management Agreements with the investors. The services provided are for the administration of the investor accounts and fund structures. The consideration is considered to be variable consideration if it is determined with reference to the net invested capital attributable to the co-investor’s accounts. Variable consideration is recognised to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur. The revenue is recognised over the period as the Group transfers control of the services over a specific period. Management, service and transaction fees related to fund monitoring are recognised progressively over the period when there is net invested capital in the fund. These fees are calculated and recognised at the end of each quarter when the net invested capital or commitment is determined. Transactions fees associated with underwriting activities are recognised over the underwriting period. These fees are calculated and recognised at the conclusion of the underwriting phase, when the litigation funding agreement is successfully executed. Americas
APAC
EMEA
Corporate
Total
$'000
$'000
$'000
$'000
$'000
2026 Type of service
Timing of revenue recognition
(i) Litigation investments – claims portfolio
Services transferred at a point in time
1,419
–
67,556
–
68,975
(ii) Management, service and transaction fees
Services transferred over time
10,820
8,732
4,057
3,728
27,337
12,239
8,732
71,613
3,728
96,312
–
–
34,533
–
34,533
7,568
2,802
3,620
6,463
20,453
7,568
2,802
38,153
6,463
54,986
2025 Type of service
Timing of revenue recognition
(i) Litigation investments – claims portfolio
Services transferred at a point in time
(ii) Management, service and transaction fees
Services transferred over time
Note 3: Interest revenue Interest revenue is recognised using the effective interest rate method. The effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to the net carrying amount of the financial asset. The Group earned 46% (2025: 43%) of its interest revenue on cash and deposits in Australia. Interest revenue on receivables relates to the EMEA, Americas and APAC regions. The purchased claims revenue relates to the EMEA geographical market. Consolidated 2026
2025
$'000
$'000
1,170
2,206
918
2,803
Interest revenue Interest revenue on cash and deposits Interest revenue on receivables Interest revenue on litigation investments - purchased claims
8,068
7,987
10,156
12,996
Annual Report 2026
49
Notes to the Financial Statements continued Note 4: Net gain on fair value of financial assets at fair value through profit or loss Net gain on financial instruments at fair value through profit or loss (FVTPL) represents the fair value movements of the Group’s financial assets and liabilities recognised at fair value through profit or loss. The determination of the fair value for the Group’s financial assets and liabilities is designated as level 3 in the fair value hierarchy. Unrealised fair value gains/(losses) are determined as the total fair value gains and losses during the period less cash received or called for full or partial completions. Each cash receipt from the funds represents a realised gain or loss. This is not representative of activity within the underlying funds. Consolidated 2026
2025
$'000
$'000
Litigation investments - financial assets Realised fair value gains
6,493
19,282
Unrealised fair value gains
55,427
260,416
61,920
279,698
Note 5: Net gain on derecognition of litigation investments - intangible assets Net gain on derecognition of litigation investments – intangible assets are derived from the disposal through sale or completion (partial or full) of the underlying litigation that the Group invested in. The accounting policy for litigation investments - intangible assets is outlined in Note 14. Consolidated 2026
2025
$'000
$'000
Proceeds
22,084
51,899
Derecognition of carrying cost
(15,047)
(25,400)
7,037
26,499
Net gain on derecognition of litigation investments - intangible assets
Net gain on derecognition of litigation investments – intangible assets can be represented geographically as follows: Consolidated
Americas
50
2026
2025
$'000
$'000
–
6,978
APAC
295
1,844
EMEA
6,742
17,677
7,037
26,499
Omni Bridgeway
Note 6: Other income Consolidated 2026
2025
$'000
$'000
–
15,111
Other income Net foreign exchange gain Other income
1,022
132
1,022
15,243
Note 7: Expenses Finance costs Borrowing costs directly attributable to the acquisition and development of a qualifying asset (i.e. an asset that necessarily takes a substantial period of time to get ready for its intended use or sale) are capitalised as part of the cost of that asset. All other borrowing costs are expensed in the period they occur. Borrowing costs consist of interest and other costs that the Group incurs in connection with the borrowing of funds. Detailed information is provided in Note 19.
Amortisation of litigation investments – claims portfolio Amortisation of litigation investments – claims portfolio represents the amortisation of the capitalised contract costs due to completion of the underlying enforcement or recovery action. Detailed information is provided in Note 12.
Depreciation The depreciation policy is disclosed in Note 23.
Employee benefits Provision is made for employee benefits accumulated as a result of employees rendering services up to the end of the reporting period. These benefits include salaries and wages, annual leave, long service leave and bonuses. Liabilities in respect of employees’ services rendered that are not expected to be wholly settled within one year after the end of the periods in which the employees render the related services are recognised as long-term employee benefits. These liabilities are measured at the present value of the estimated future cash outflow to be made to the employees using the projected unit credit method. Liabilities expected to be wholly settled within one year after the end of the period in which the employees render the related services are classified as short-term benefits and are measured at the amount due to be paid. The corresponding movements are expensed together with those incurred during the year.
Share-based payments The policy for share-based payments is disclosed in Note 29.
Impairment expense – litigation investments The policy for impairment expense – litigation investments is disclosed in Notes 12-15 according to asset classes litigation investments – claims portfolio, litigation investments – purchased claims, litigation investments – intangible assets and litigation investments – financial assets.
Adverse costs – litigation investments The expense raised is the Group’s best estimate of the amount of adverse costs it will have to remit where the underlying litigation has received an unfavourable judgment. Refer to Notes 25 and 27 for further details on adverse costs.
Annual Report 2026
51
Notes to the Financial Statements continued Note 7: Expenses (continued) Consolidated 2026
2025
Note
$'000
$'000
26
762
1,015
(a) Finance costs Interest on lease liabilities Other finance charges
560
10,104
1,322
11,119
12
35,073
22,718
23
4,012
4,379
Wages and salaries
42,535
50,313
Superannuation expense
2,142
2,367
404
484
2,982
3,794
(b) Amortisation of litigation investments - claims portfolio Amortisation of litigation investments - claims portfolio (c) Depreciation expense Depreciation (d) Employee benefits expenses
Directors' fees Payroll tax Share-based payments
29
3,097
4,152
51,160
61,110
Insurance expense
4,025
4,610
Network expense
1,890
2,081
Marketing expense
962
892
(e) Corporate and office expenses
Occupancy expense Professional fees expense Recruitment expense Travel expense
806
835
4,360
11,307
173
4
1,325
1,221
13,541
20,950
4,158
2,782
Amortisation of contract costs
704
939
Staff training, development and conferences
112
83
2,943
–
7,917
3,804
(f) Other expenses General expenses
Net foreign exchange loss (g) Impairment expense and adverse costs - litigation investments Adverse costs - litigation investments Net impairment loss - litigation investments
25 12-15
72
4,523
12,661
31,295
12,733
35,818
1,646
(4,196)
1,646
(4,196)
(h) Expected credit loss allowance Expected credit loss expense/(reversal)
52
Omni Bridgeway
22
Note 8: Income tax Income tax Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities based on the taxable income for the current period. The tax rates and tax laws used to compute the amount are those enacted or substantively enacted by the reporting date. Deferred income tax is provided in full, using the balance sheet method, on taxable temporary differences arising between the carrying amounts of assets and liabilities for financial reporting and tax purposes. Deferred income tax liabilities are recognised for all taxable temporary differences except: • When the deferred income tax liability arises from the initial recognition of goodwill or of an asset or liability in a transaction that is not a business combination and that, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; or • When the taxable temporary difference is associated with investments in subsidiaries, associates or interests in joint ventures, and the timing of the reversal of the temporary difference can be controlled and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred income tax assets are recognised for all deductible temporary differences, carry-forward of unused tax assets and unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary differences and the carry-forward of unused tax credits and unused tax losses can be utilised, except: • When the deferred income tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; or • When the deductible temporary difference is associated with investments in subsidiaries, associates or interests in joint ventures, in which case a deferred tax asset is only recognised to the extent that it is probable that the temporary difference will reverse in the foreseeable future and taxable profit will be available against which the temporary difference can be utilised. The carrying amount of deferred income tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilised. Unrecognised deferred income tax assets are reassessed at each reporting date and are recognised to the extent that it has become probable that future taxable profit will allow the deferred tax assets to be recovered. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realised or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. Income taxes relating to items recognised directly in other comprehensive income are recognised in equity and not in profit or loss. Deferred tax assets and deferred tax liabilities are offset only if a legally enforceable right exists to set off current tax assets against current tax liabilities and the deferred tax assets and liabilities relate to the same taxable entity and the same taxation authority.
Australian tax consolidated group The Parent and its Australian resident wholly owned subsidiaries have formed an income tax consolidated group. The Parent has entered into tax funding arrangements with its Australian resident wholly owned subsidiaries, pursuant to which each subsidiary has agreed to pay or receive a tax equivalent amount based on the net taxable amount or loss of the subsidiary at the current tax rate. The tax consolidated group has applied the separate taxpayer approach in determining the appropriate amount of current taxes to allocate to each entity.
Other taxes
Revenues, expenses and assets are recognised net of the amount of GST, except (i) when the GST incurred on a purchase of goods and services is not recoverable from the taxation authority, in which case the GST is recognised as part of the cost of acquisition of the asset or as part of the expense item, as applicable; and (ii) receivables and payables, which are stated with the amount of GST included. The net amount of GST recoverable from, or payable to, the taxation authority is included as part of receivables or payables in the Consolidated Statement of Financial Position. Cash flows are included in the Consolidated Statement of Cash Flows on a gross basis and the GST component of cash flows arising from investing and financing activities, which is recoverable from, or payable to, the taxation authority is classified as part of cash flows from operating activities.
Annual Report 2026
53
Notes to the Financial Statements continued Note 8: Income tax (continued) Commitments and contingencies are disclosed net of the amount of GST recoverable from, or payable to, the taxation authority. Consolidated 2026
2025
$'000
$'000
(324)
17,768
Consolidated Statement of Comprehensive Income The major components of income tax expense are: Current income tax: Current income tax (credit)/expense Current year losses moved to deferred tax asset
3,902
2,483
Current year utilisation of carried forward tax losses
(1,386)
(17,778)
Adjustment in respect of current income tax expense of previous year
(94)
78
State and local based taxes
310
2,225
Other
749
1,558
Relating to origination and reversal of temporary differences
(1,261)
65,460
Adjustment in respect of deferred income tax of previous year
7,389
(2,054)
Deferred tax on items not in current tax
(1,553)
–
Reduction in deferred tax asset for loss utilisation
1,277
17,778
Current year losses moved to deferred tax asset
(4,519)
(8,820)
Other
(2,248)
–
2,242
78,698
–
–
–
229
–
229
Deferred income tax:
Income tax expense reported in the Consolidated Statement of Comprehensive Income Other comprehensive income Deferred income tax related to items charged or credited directly to equity Deferred tax associated with share-based payments Income tax expense reported in equity
54
Omni Bridgeway
Note 8: Income tax (continued) A reconciliation between income tax expense and the product of accounting loss before income multiplied by the Group’s applicable income tax rate is as follows: Consolidated 2026
2025
$'000
$'000
Accounting profit before tax
48,171
495,520
At the Group's statutory income tax rate of 30%
14,451
148,656
Adjustment in respect of income and deferred tax
6,171
3,793
Expenditure not allowable for income tax purposes
2,931
728
–
31,805
Permanent differences relating to Fund 9 transaction Other assessable income
3,266
–
Non-assessable income
(21,326)
(106,481)
Foreign tax rate adjustment
(495)
(3,181)
State/Provincial income tax
310
2,225
(3,066)
1,153
2,242
78,698
Other Income tax expense reported in the Consolidated Statement of Comprehensive Income
Consolidated Statement of Financial Position
Statement of Comprehensive Income
2026
2025
2026
2025
$'000
$'000
$'000
$'000
15,858
17,542
1,685
14,436
–
444
444
(444)
Deferred income tax at 30 June relates to the following: Deferred income tax liabilities Intangibles Accrued interest & unrealised foreign exchange differences Right-of-use assets
1,942
3,494
1,551
(1,946)
Fund 9 transaction
75,281
93,662
18,381
(93,662)
Other Gross deferred income tax liabilities
(953)
(298)
655
4,951
92,128
114,843
22,716
(76,664)
–
56
(56)
56
1,749
389
1,360
21
222
1,080
(858)
471
3,471
4,303
(832)
1,685
Offsetting deferred tax assets Accruals and Provisions Expenditure deductible for income tax over time Leases Net operating losses Share based payments
156
216
(59)
75
Gross deferred tax assets
5,598
6,044
(445)
2,308
Net deferred tax liabilities
86,530
108,799
Annual Report 2026
55
Notes to the Financial Statements continued Note 8: Income tax (continued) Consolidated Statement of Financial Position
Statement of Comprehensive Income
2026
2025
2026
2025
$'000
$'000
$'000
$'000
1,532
9,706
(8,174)
975
Deferred tax assets Accruals and provisions Intangibles
–
800
(800)
16
Intercompany
–
2,278
(2,278)
47
Other
(1,933)
–
(1,934)
–
Expenditure deductible for income tax over time
41,607
41,329
278
25,452
Share based payments
1,865
1,948
(83)
495
Leases
2,105
2,945
(841)
1,553
Net operating losses
48,610
56,196
(7,586)
(14,873)
93,786
115,204
(21,418)
13,664
853
(60,692)
Deferred movements charged directly to net-asset-write off account in profit & loss
–
(10,694)
Movements in foreign exchange
64
(979)
Deferred tax expense
917
(72,364)
Deferred tax assets Net deferred income tax
Unrecognised temporary differences and tax losses At 30 June 2026, the Group had $19.0 million (2025: $20.8 million) of unused tax losses carried forward in its Canadian subsidiaries for which no deferred tax asset has been recognised. The Group also had $4.8 million of unused tax losses in it’s European subsidiaries for which no deferred tax asset has been recognised.
Deferred tax assets relating to Australian operations The deferred tax assets balance includes $13.2 million (2025: $15.9 million) of assets relating to carried forward tax losses of the Omni Bridgeway Limited (OBL) tax consolidated group at 30 June 2026. The utilisation of these losses is considered probable, supported by the expectation of continued growth in recurring income streams and the deferred consideration associated with the Fund 9 transaction.
Deferred tax assets relating to USA operations The deferred tax assets balance includes $34.6 million (2025: $39.4 million) of assets relating to carried forward tax losses of Omni Bridgeway Holdings (USA) Inc. Under current U.S. tax law, losses incurred prior to 1 July 2018 may be carried forward for up to 20 years and may fully offset taxable income. Losses generated from 1 July 2018 onwards may be carried forward indefinitely, although utilisation is generally limited to 80% of taxable income in any given year. The U.S. business has historically incurred tax losses, largely attributable to the expansion of its operating base to support strategic growth initiatives. These investments in people, systems and infrastructure were made in advance of expected investment activity, consistent with long-term plans. Based on approved budgets, existing fund commitments and business performance, it is probable that sufficient taxable income will be generated to utilise the available losses. The U.S. business has raised significant external capital over the past seven years through its Fund Structures. Fund 4, launched in 2019 with investor commitments of US$500 million (80% external), has an average investment life of 3-4 years. The income from the Fund 4 structure is expected to generate investment returns and management fee. Despite the Fund 9 transaction, the U.S. Group remains the legal holder of its limited partnership interest in Fund 4 and, as such, remains subject to tax on this income. Accordingly, the carried forward tax losses are expected to be recovered as and when the taxable income is realised from Fund 4. In addition to tax losses, deferred tax assets of $29.9 million (2025: $29.1 million) have been recognised in respect of the U.S. Group’s outside basis differences in its U.S. limited partnership and fund entities, principally the Fund 4 Series 1 partnerships and Omni Bridgeway (Fund 1) LLC. Although the Fund 4 Series 1 entities were deconsolidated for accounting purposes as part of the Fund 9 transaction, the U.S. Group retains its legal ownership interest. The deductible temporary difference arises because the tax basis of the interest exceeds its carrying amount in these fund entities and will unwind upon disposal or dissolution of the partnerships. As a result of the Fund 9 transaction in FY25, Omni Bridgeway Holdings (USA) Inc. has recognised deferred tax liabilities of $27.7 million, representing taxable temporary differences arising from the U.S. tax treatment of the transaction and the future revenue the US group will potentially generate from the provision of services to Fund 9.
56
Omni Bridgeway
Note 9: Profit per share Basic profit per share is calculated as net profit attributable to members of the Parent, adjusted to exclude any costs of servicing equity (other than dividends), divided by the weighted average number of ordinary shares outstanding during the financial year, adjusted for any bonus element. Diluted profit per share is calculated as net profit attributable to members of the Parent, adjusted for: • Costs of servicing equity (other than dividends); • The after-tax effect of interest dividends associated with dilutive potential ordinary shares that have been recognised; and • Other non-discretionary changes in revenue or expenses during the period that would result from dilution of potential ordinary shares; • Divided by the weighted average number of shares and dilutive shares, adjusted for any bonus element. At 30 June 2026, 8,604,441 performance rights (2025: 11,846,644) were on issue as detailed in Note 29. Upon meeting certain performance and service conditions, the vesting of each right will result in the issue of 1 ordinary share. The performance shares are contingently issuable and are not considered dilutive. The following reflects the income and share data used in the basic profit per share computation:
a. Profit used in calculating profit per share Consolidated 2026
2025
$'000
$'000
53,697
349,797
2026
2025
'000
'000
289,052
284,051
For basic and diluted profit/(loss) per share Total net profit attributable to equity holders of the Parent
b. Weighted average number of shares
Weighted average number of ordinary shares outstanding Effect of dilution: Performance rights Weighted average number of ordinary shares
1,899
1,344
290,951
285,395
The weighted average number of ordinary shares outstanding includes performance rights granted under the Long-Term Incentive Plan which are only included in dilutive earnings per ordinary share where the performance hurdles are met as at period end and they do not have an anti-dilutive effect. There have been no transactions involving ordinary shares or potential ordinary shares that would significantly change the number of ordinary shares outstanding between the reporting date and the date of completion of these financial statements.
Note 10: Dividends paid and proposed by Omni Bridgeway Limited (the parent entity) (a) Cash dividends on ordinary shares declared and paid There were no dividends declared or paid for the year ended 30 June 2026 (2025: nil cents per share). Omni Bridgeway Limited’s retained earnings and reserves are disclosed in Note 21. The Company considers all its capital management options in light of the cash position and performance of the Group at the time as well as the likely demand for cash over the ensuing 12-month period. In determining the appropriate mechanism to deliver returns to shareholders, the board will consider both semi-annual dividends and share buy-backs. Relevant considerations include the source and nature of income or surplus capital, the prevailing share price relative to the intrinsic value and the franking credit balance. The Company has a dividend reinvestment plan (DRP) that shareholders may elect to participate in. On appropriate occasions, the Company may arrange DRP underwriting to reduce the impact a particular dividend might otherwise have on the Group’s cash resources.
(b) Franking credit balance 2026
2025
$'000
$'000
Franking account balance at the end of previous financial year at 30%
5,903
5,903
Balance at 30 June
5,903
5,903
The amount of franking credits for the subsequent financial year are:
(c) Tax rates The tax rate at which paid dividends have been franked is 30% (2025: 30%).
Annual Report 2026
57
Notes to the Financial Statements continued Note 11: Statement of cash flows reconciliation Reconciliation of net profit for the year to net cash flows used in operations: Consolidated 2026
2025
$'000
$'000
45,929
416,822
from investing activities
11,697
(199,688)
Fair value adjustments to financial instruments at fair value through profit and loss
(61,920)
(279,629)
Amortisation of litigation investments - claims portfolio
35,073
22,718
705
705
Depreciation
4,012
4,379
Share-based payments
3,097
5,460
Unrealised foreign exchange loss/(gain)
2,943
(15,111)
Decrease in receivables
22,839
66,526
Decrease in other assets and contract cost
1,458
6,207
Decrease in litigation investments - intangible assets
3,506
268,793
Decrease in litigation investments - claims portfolio
34,922
2,000
(Increase)/decrease in litigation investments – purchased claims
(7,399)
33,859
Increase in litigation investments - financial assets
(54,921)
(404,421)
(851)
60,920
Decrease in other liabilities
(2,434)
(10,286)
Decrease in lease liabilities
(3,140)
(3,951)
(Decrease)/increase in trade and other payables
(22,518)
50,311
Decrease in provisions
(27,624)
(14,007)
Net profit for the year Adjustments for: Net impact of the reclassification of litigation investments - intangible assets related to cash flows
Amortisation of contract costs
Changes in assets and liabilities
(Increase)/decrease in net deferred tax assets
(Decrease)/increase in current income tax receivable/payable
(3,717)
5,482
Net cash (used in)/from operating activities
(18,343)
17,089
Disclosure of financing facilities Refer to Notes 18, 19 and 26.
Changes in liabilities arising from financing activities Refer to Notes 19 and 26. Non-cash financing and investing financial liabilities include warrants, refer to Note 31.
58
Omni Bridgeway
B. LITIGATION INVESTMENTS AND GOODWILL Note 12: Litigation investments - claims portfolio (a) Recognition and measurement Litigation investments - claims portfolio assets consist of the capitalised costs incurred to purchase, obtain or fulfil a contract with a customer. These contracts with customers involve a vendor-customer relationship established in the contract. They comprise the litigation enforcement and recovery investment contracts and certain merits-based funding contracts. Costs incurred to obtain a contract are only capitalised to the investment when it is expected that a contract will be executed, and where those costs will be recoverable. The Group recognises an asset for costs incurred to fulfil a contract if those costs relate directly to the contract, the costs generate or enhance resources of the Group to satisfy performance obligations in the future and the costs are expected to be recovered. All capitalised contract costs are amortised to the profit or loss on a systematic basis that follows delivery of performance obligations to the customer. The delivery of performance obligations to the customer on the contracts are aligned with each individual dollar of recovery to the customer. The carrying value of the litigation investments - claims portfolio is measured at cost less amortisation and any impairment. At each reporting date an assessment is made on an individual investment by investment basis to determine if the carrying amount of a contract exceeds its recoverable amount. In order to determine the recoverable amount a probabilistic cashflow model is used which includes forecast revenues and expenses, together with an estimate of directly attributable overheads to complete the contract. If the carrying value exceeds the recoverable amount the difference is recognised as an impairment expense in the profit or loss.
Reconciliation of carrying amounts Consolidated 2026
2025
$’000
$’000
Balance at 1 July
125,307
127,307
Additions
11,899
21,782
Reclassification
(1,701)
(3,303)
Amortisation of carrying costs
(35,073)
(32,068)
Impairment expense
(3,221)
(702)
Foreign currency adjustment
(6,826)
16,559
–
(4,268)
90,385
125,307
Deconsolidation - carrying amount in former subsidiaries Balance at 30 June
Note 13: Litigation investments - purchased claims (a) Recognition and measurement Litigation investments – purchased claims are litigation actions which have been acquired by the Group (except by business combination). They are classified as purchased credit-impaired financial assets which are initially recognised at fair value. The credit-adjusted effective interest rate on these financial assets is calculated taking into account the initial lifetime expected credit loss in the estimated cash flows. In determining the lifetime expected credit losses for these financial assets, the Group has taken into account the financial position of the counterparties, the legal environment in which the enforcement occurs, historical default experience and considering various external sources of actual and forecast information, as appropriate. Purchased claims are subsequently measured at amortised cost by applying the credit-adjusted effective interest rate. The Group recognises: i.
Interest income through the application of the credit-adjusted effective interest rate to the amortised cost of the purchased claims; and
ii.
Impairment losses and gains, when material, due to the changes in estimated lifetime expected credit losses. At each reporting period, the Group reviews the estimated cash flows from purchased claims on an investment by investment basis, estimating the expected recovery, its timing and any other cashflows that may be attributable to the counterparties. The net present value of the cashflows are then determined using the credit-adjusted effective interest rate and the value compared to the carrying value. Where there is a material gain, this gain is recognised by adjusting the gross carrying amount of the receivable. Where there is a material loss, it is recognised as an impairment provision.
Annual Report 2026
59
Notes to the Financial Statements continued Note 13: Litigation investments - purchased claims (continued) Reconciliation of carrying amounts Consolidated 2026
2025
$’000
$’000
Balance at 1 July
19,242
53,101
Interest revenue
8,068
8,408
Increase/(decrease) in carrying value reflected in deferred consideration
7,506
(8,783)
Carrying value disposed
(4,165)
(22,404)
Impairment loss
(2,617)
(1)
Foreign currency adjustment
(1,393)
4,150
–
(15,229)
26,641
19,242
Deconsolidation - carrying amount in former subsidiaries¹ Balance at 30 June
- No deconsolidation transactions occurred in FY26. Comparative amounts relate to the Fund 9 deconsolidation disclosed in Note 35 of the FY25 Financial Report.
At 30 June 2026, the fair value of the litigation investments - purchased claims amounted to $26.6 million (2025: $19.2 million) and the gross contractual amount was $50.2 million (2025: $61.9 million). Consolidated 2026
2025
$’000
$’000
Proceeds
5,206
31,510
Impairment gain/(loss)
4,525
(3,940)
Carrying value disposed
(4,165)
(23,247)
5,566
4,323
Net gain on litigation investments - purchased claims
Note 14: Litigation investments - intangible assets (a) Recognition and measurement Litigation investments involve funding provided to pursue an underlying litigation dispute that are not classified as purchased claims, claims portfolio or financial assets. They are recognised as intangible assets in the financial statements of the Group when they represent future economic benefits controlled by the Group. The Group is able to control the expected future economic benefit as the investment may be exchanged or sold. The litigation funding contract does not give rise to an unconditional right to receive cash. Rather, it provides the Group with a right to a share of litigation proceeds which may be in the form of cash or other non-financial assets. These litigation contracts are not considered contracts with customers as they are collaborative arrangements and there is no vendorcustomer relationship established in the contract. Litigation investments – intangible assets are measured at cost on initial recognition. They are not amortised as the assets are not available for use until the determination of a judgment or settlement, withdrawal or sale, at which point the assets are realised through disposal. Gains or losses arising from derecognition are measured as the difference between the net disposal proceeds and the carrying amount of the asset at the time and are recognised in the profit or loss when the asset is derecognised. The following specific asset recognition and derecognition rules have been applied to litigation investments – intangible assets:
(i) Ongoing litigation When the underlying litigation action is ongoing and pending a determination, the investments are carried at cost (subject to any provision for impairment). Initial and subsequent ongoing expenditure is capitalised when it meets all the following criteria: (a) the Group is able to demonstrate its ability to complete the litigation so that the asset will be available for use and the benefits embodied in the asset will be realised; (b) the Group retains control of the asset;
60
Omni Bridgeway
Note 14: Litigation investments - intangible assets (continued) (c) the Group can demonstrate that it intends to complete the litigation; (d) the Group is able demonstrate the availability of adequate technical, financial and other resources to complete the litigation; and (e) the Group can measure reliably the expenditure attributable to the intangible asset during the life of the litigation investments – intangible assets. Impairment is considered in line with the policy described in (b) below:
(ii) Completion Where the underlying litigation has been finally determined or a settlement has been agreed, such that there is not considered to be a significant risk of reversal, this constitutes a disposal transaction, the carrying cost is derecognised and a gain or loss on disposal of the intangible asset is recognised in the Consolidated Statement of Comprehensive Income. Control of the intangible asset is considered to be transferred as follows: • For judgments, typically after a judgment has been determined and the relevant appeal periods have expired; • For settlements, typically when settlement agreement is reached and if relevant, court approval is obtained; and • For sales, typically when a binding agreement is executed.
(iii) Partial completion Where litigation investments have been subject to a partial sale transaction, consideration has been agreed, such that there is not considered to be a significant risk of reversal and it is evident the litigation investment can be assessed at the respective percentage of interest level, this constitutes a disposal transaction and a gain or loss on disposal is recognised in the statement of comprehensive income. Control of the partial intangible asset is considered to be transferred as follows: • When the partial sale agreement is executed. Upon this date, the purchaser is considered to be able to direct the use of the interest and assume substantially all the remaining benefits of the interest.
(iv) Appeal/enforcement If a funded client obtains an unsuccessful decision from the court, arbitration or tribunal and appeals against the judgment, where the investment and funding was undertaken by the Group with that as a central thesis, the investment may be considered to be ongoing with deployment capitalised to the investment. Where there was no such thesis, the investment is derecognised and future costs incurred in relation to the appeal are expensed as incurred. If a funded client obtains a successful decision from the court, arbitration or tribunal and has to subsequently undertake enforcement activities, where the investment and funding was undertaken with that as a central thesis, the investment may be considered to be ongoing with a delivery of a partial service obligation requiring partial derecognition of the investment and income recognition. Where there was not such a thesis, the investment is derecognised, with a receivable recognised and any future costs incurred in relation to the enforcement appeal are expensed as incurred.
(v) Portfolio investments Upon completion of an underlying litigation within a portfolio, a corresponding portion of the intangibles carrying value is derecognised. The difference between the disposal proceeds received and the derecognised carrying value is recognised as a net gain or loss in the profit or loss. The remainder of the portfolio continues to be carried at cost (subject to usual impairment considerations) until the earlier of either the full return to the Group is obtained or each case within the portfolio has completed.
Reconciliation of carrying amounts Consolidated 2026
2025
$’000
$’000
Balance at 1 July
65,483
334,276
Additions - external funding costs
17,649
90,528
Additions - capitalised overheads
3,969
25,645
Reclassification
(2,260)
(4,676)
Derecognition - external expenditure
(14,740)
(35,084)
Derecognition - capitalised overheads
(100)
(4,329)
Net derecognition of purchase price adjustment arising from business combination
(1,222)
(8,794)
Impairment expense
(2,193)
(1,156)
–
(351,001)
Effect of movement in foreign currency
(4,609)
20,074
Balance at 30 June
61,977
65,483
Deconsolidation - carrying amount in former subsidiaries
Annual Report 2026
61
Notes to the Financial Statements continued Note 14: Litigation investments - intangible assets (continued) The carrying value includes external costs such as solicitors’ fees, counsels’ fees and experts’ fees funded by the Group, the capitalisation of certain directly attributable internal costs of managing the litigation funding investment, such as certain direct salaries and wages, occupancy costs, other out of pocket expenses and the capitalisation of borrowing costs as described below. The capitalised salaries and wages in 2026 equated to approximately 2.6% of the Group’s total salary and wages expense (2025: 14.8%). No other internal costs were capitalised in the current year (2025: 18.7%). The Group has determined that litigation investments – intangible assets meet the definition of qualifying assets and that all borrowing costs are eligible for capitalisation. The weighted average cost of borrowing was 7.9% (2025: 7.2%). The carrying value of litigation investments – intangible assets can be summarised as follows: Consolidated 2026
2025
$’000
$’000
External funding costs
60,343
63,405
Capitalised overheads
5,410
3,821
Gross carrying amount at cost
65,753
67,226
Accumulated impairment - Investments in progress
(3,776)
(1,743)
Balance at 30 June
61,977
65,483
(b) Impairment testing of litigation investments – intangible assets Except for specific litigation investments – intangible assets that are subject to an unfavourable judgment or award, the recoverable amount of each of the litigation investments – intangible assets are assessed for impairment using a value-in-use methodology based on discounted cash flow (DCF) models. The DCF inputs are derived from management-approved budgets and/or investment manager forecasts and reflect probability-weighted outcomes. Key assumptions include expected cash inflows and outflows, scenario probabilities, and discounting, with sensitivity to the principal risks inherent in legal investments such as loss risk, duration risk, budget risk, quantum risk and recoverability (credit) risk. A discount rate of 12% is used, based on the weighted average cost of capital (WACC) for the legal finance asset class, which closely aligns with the WACC for OBL and with the hurdle rates for our third-party fund capital. All main investment risks associated with legal investments, including loss risk, duration risk, budget risk, quantum risk and credit risk are reflected in the probabilistic scenarios, and therefore fall outside the scope of risks determining the required discount rate. At 30 June 2026, 8 investments (2025: 10) across the portfolio recognised impairments, 5 of which totalled $3.7 million.
62
Omni Bridgeway
Note 15: Litigation investments - financial assets a) Recognition and measurement The litigation investments - financial assets are classified as financial assets at fair value through the profit or loss in accordance with IFRS 9 Financial Instruments. These investments are initially recognised at fair value plus any attributable transaction costs and are subsequently measured at fair value at each reporting date. Subsequent changes in fair value are recognised as fair value gains or losses to profit or loss, refer to Note 4. The determination of the fair value is designated as level 3 in the fair value hierarchy. Management judgment is required when calculating the fair value of the investments. Level 3 inputs are used in the fair value calculation and estimation of fair value is inherently uncertain. The Group’s litigation investments - financial assets were recognised for its equity or participation interests in the co-investments, including those residual or carried interests in former subsidiaries. The classification of assets was re-assessed when there was a change in the investment arrangements or changed fund structures that could affect the asset classifications under relevant accounting standards.
i) Managed Investment Schemes (MISs) The Group previously held investments in MISs under Fund 5 Series I, representing a 20% participation interest. These investments were fully re-classified as litigation investments - intangible assets in prior periods and subsequently derecognised from the Group’s financial statements upon the completion of Fund 9 transaction. The Group’s residual interests in these investments are now accounted for as financial assets at fair value through profit and loss via Fund 9 and are not consolidated into the Group’s financial statements due to the absence of control.
ii) Participation interests The Group has participation interests in various co-funded fund structures which are neither consolidated nor equity accounted for in the Group Consolidated Financial Statements, due to the absence of control or significant influence. These represent an unconditional right to receive cash and do not meet the solely payments of principal and interest (SPPI) criteria, and are therefore classified as financial assets at fair value through profit or loss (FVTPL). The Group holds 20% participation interests in the co-invested Funds 4/5 and Series II, and retained participation interests in Fund 9, which represent its residual interests in Funds 2&3, Funds 4/5 Series I as well as the entitlements on the one Balance Sheet Investment (Fund 9 Assets). These interests are recognised as the Group’s proportionate share of the fair value of underlying investments.
iii) Residual interests These are the Group’s residual interests in deconsolidated funds under the Investment Management Agreements (IMAs). Following the Fund 9 transaction, the change of general partner, deconsolidation of the relevant funds, and assignment of its participation rights to a third party, required a re-assessment of the accounting treatment. The residual interests represent the Group’s contractual right to receive cash without future performance obligations. Accordingly, they are classified as litigation investments- financial assets at fair value through profit or loss.
(b) Reconciliation of carrying amounts The following table reconciles the movements in recurring fair value measurements categorised within level 3 of the fair value hierarchy: Consolidated 2026
2025
$’000
$’000
Balance at 1 July
418,059
13,638
Additions
18,016
–
Carried Interest/completions
(6,493)
–
–
(18,061)
Fair value gain recognised in profit or loss¹
61,920
422,482
Foreign currency adjustment
(18,522)
–
Balance at 30 June
472,980
418,059
Disposals
¹ The FY26 amount is recognised within net gain on litigation investments – financial assets (refer to Note 4). The FY25 amount was recognised within net gain on litigation investments – financial assets and within net gain on disposal of subsidiaries and other assets, the latter arising on the initial recognition, at fair value, of the residual interests retained on completion of the Fund 9 transaction on 25 February 2025 (refer to Note 31).
Annual Report 2026
63
Notes to the Financial Statements continued Note 16: Goodwill (a) Recognition and measurement Goodwill is initially measured at cost (being the excess of the aggregate of the consideration transferred and the amount recognised for non-controlling interests and any previous interest held over the fair value of the net identifiable assets acquired and liabilities assumed). Goodwill is subsequently measured at cost less any impairment. Goodwill arose on the acquisition of Omni Bridgeway Holding BV and its subsidiaries (collectively known as the OBE Group) accounted for as a business combination. For impairment purposes, goodwill has been solely allocated to the OBE Group, its related enforcement business and income generated by the OBE Group. The Group performs its annual impairment test on the goodwill associated with the OBE Group at 30 June each year. The impairment test performed on the OBE Group goodwill is done via a value-in-use calculation using the following inputs: i.
Cashflows generated over a 5-year period from the OBE Group’s annual budget. The annual budget includes an estimation for all cashflows from operations of the OBE Group, including returns from investments and payments of overheads. The budget cashflows are sensitive to the timing and amount of investment completions. The investment completions refer to income earned from claims portfolio, purchased claims and intangible assets – litigation contracts in progress. The timing of completion and amount of investment income are based on the relevant investment manager’s best estimates during the Group’s annual budget process and are reviewed internally by management. The cashflows from investment completions have a compound annual growth rate of 8.4% (2025: 50.9%) over the cash flow period. This is reflective of the management’s estimate of the OBE Group’s expected future growth in business activity. The current year growth rate excludes new commitments in the underlying value-in-use calculation, reflecting a conservative approach. On a basis consistent with the prior year (including new commitments), the compound annual growth rate would be 41.3%.
ii.
Discount rate of 12.0% (2025: 12.0%). The discount rate represents the current assessment of the risks specific to OBE Group cashgenerating unit (CGU), taking into consideration the time value of money and individual risks of the underlying OBE Group investment that have not been incorporated in the cash flow estimates. The discount rate was arrived at using the OBL’s weighted average cost of capital (WACC) as a starting base.
iii. Terminal value growth rate applied is 3% (2025: 3%). No reasonably possible change in key assumption would result in the carrying amount of the CGU exceeding its recoverable amount.
(b) Reconciliation of carrying amounts Consolidated
Balance at 1 July Effect of movement in foreign currency Balance at 30 June
64
Omni Bridgeway
2026
2025
$’000
$’000
112,910
100,885
(8,503)
12,025
104,407
112,910
C. CAPITAL STRUCTURE Note 17: Financial risk management The Group’s principal financial instruments comprise cash and short-term deposits, purchased claims, financial assets, receivables, payables, debt securities, lease liabilities and deferred consideration. The Group manages its exposure to key financial risks, including interest rate risk and currency risk in accordance with the Group’s financial risk management policy. The objective of the policy is to support the delivery of the Group’s financial targets whilst protecting its future financial security. The main risks arising from the Group’s financial instruments are interest rate risk, foreign currency risk, credit risk and liquidity risk. The Group uses different methods to measure and manage different types of risks to which it is exposed. These include monitoring levels of exposure to interest rates and currencies and assessments of market forecasts for interest rates and foreign currencies. Ageing analyses and monitoring of specific credit allowances are undertaken to manage credit risk. Liquidity risk is monitored through the development of future rolling cash flow forecasts.
Risk exposures and responses Interest rate risk The Group’s exposure to the risk of changes in market interest rates relates primarily to the Group’s cash holdings with a floating interest rate. The Group has no borrowings subject to a variable interest rate as at 30 June 2026. The borrowings relate to the Fund 8 debt facility at a fixed rate, and as such, not subject to risk exposure. Refer to Note 19 for further details. At reporting date, the Group had the following financial instruments exposed mainly to Australian variable interest rate risk: Consolidated 2026
2025
$’000
$’000
Cash and cash equivalents
158,607
180,289
Net exposure
158,607
180,289
Financial instruments
The Group regularly analyses its interest rate exposure. Within this analysis, consideration is given to expected interest rate movements and the Group’s future cash requirements, potential renewals of existing positions, alternative financing available, and the mix of fixed and variable interest rates.
Credit risk Credit risk arises from the financial assets of the Group, which comprises cash and cash equivalents, purchased claims and receivables from litigation contracts and other. The Group’s exposure to credit risk arises from potential default of the counterparty, with a maximum exposure equal to the carrying amount of these instruments. Exposure at reporting date is addressed in each applicable note. Apart from ratings on cash held and litigation contract receivables, as detailed below, the remainder of the Group’s receivables typically do not carry a credit risk rating from a ratings agency. To mitigate credit risk on litigation contract receivables the Group assesses the defendants in the investments funded by the Group prior to entering into any agreement to provide funding and continues this assessment during the course of funding. Wherever possible, the Group ensures that security for settlement sums is provided, usually with the settlement funds placed into solicitors’ trust accounts. The Group’s continual monitoring of the defendants’ financial capacity mitigates this risk. To mitigate credit risk on purchased claims, the Group assesses the defendants in the investments funded by the Group prior to purchasing the claim. The Group’s continual monitoring of the defendants’ financial capacity mitigates this risk. To mitigate credit risk on cash and cash equivalents, the Group holds over 99.0% (2025: 99.2%) of its cash with Australian, American, Canadian, European and Singaporean AA rated banks. Refer to each financial asset’s respective note for information on how impairment and credit loss is determined.
Equity price risk The variable deferred consideration was finalised in FY25, and therefore does not represent any further risk.
Liquidity risk The liquidity position of the Group is managed to ensure sufficient liquid funds are available to meet the Group’s expected financial commitments in a timely and cost-effective manner. Management continually reviews the Group’s liquidity position, including the preparation of cash flow forecasts, to determine the forecast liquidity position and to maintain appropriate liquidity levels. All financial liabilities of the Group, except the consideration liabilities and non-current lease liabilities, are current and payable within 30 days.
Annual Report 2026
65
Notes to the Financial Statements continued Note 17: Financial risk management (continued) The maturity profile of the Group’s financial liabilities based on contractual maturity on an undiscounted basis are set out below. < 6 months
6-12 months
1-5 years
5 years
Total
$'000
$'000
$'000
$'000
$'000
Trade and other payables
92,238
–
–
–
92,238
Lease liabilities
1,540
1,541
6,437
373
9,891
949
–
811
–
1,760
–
29,462
–
–
29,462
94,727
31,003
7,248
373
133,351
2026 Financial Liabilities
Deferred consideration - Insurance Financial liabilities - warrants 2025 Financial Liabilities Trade and other payables
114,756
–
–
–
114,756
Lease liabilities
1,930
1,930
7,614
1,557
13,031
Deferred consideration - Insurance
1,030
–
1,674
–
2,704
–
–
22,869
–
22,869
117,716
1,930
32,157
1,557
153,360
Financial liabilities - warrants
The Group has borrowings relating to the Fund 8 facility, which has recourse to insurance, the investment assets of Fund 8 and the capped standby equity commitment from the Group.
Fair value (a) Fair values hierarchy The methods for estimating fair value are outlined in the relevant notes to the financial statements. The carrying amounts of financial assets and liabilities of the Group carried at amortised cost approximate their fair values. For the purposes of disclosure, the fair value measurements used for all assets and liabilities below are level 3. Carrying Value
Fair Value
2026
2025
2026
2025
$’000
$’000
$’000
$’000
Trade and other receivables (Refer to Note 22)
78,284
101,123
78,284
101,123
Litigation investments - purchased claims (Refer to Note 13)
26,641
19,242
26,641
19,242
Litigation investments - financial assets (Refer to Note 15)
472,980
418,059
472,980
418,059
1,057
1,052
1,057
1,052
578,962
539,476
578,962
539,476
Trade and other payables (Refer to Note 24)
92,238
114,756
92,238
114,756
Borrowings (Refer to Note 19)
35,395
19,500
35,395
19,500
Deferred consideration - insurance
1,760
2,704
1,760
2,704
129,393
136,960
129,393
136,960
Financial assets
Other assets/security deposits Financial liabilities
The fair value movements in relation to litigation investments - financial assets were recognised in the Group’s Consolidated Statement of Comprehensive Income, refer to Note 4 for further details.
(b) Fair value measurement using significant unobservable inputs (level 3) Refer to Note 15(b) and 31 for movements in the Group’s financial assets and financial liabilities measured at Level 3 fair value.
(c) Valuation process The finance department of the Group includes a team that performs the valuations of financial instruments required for financial reporting purposes, using level 3 fair values. This team reports directly to the chief executive officer (CEO). Valuation methodologies, significant inputs and results are approved by the valuation committee (VC) and are periodically reviewed by the Audit and Risk Committee (ARC). Meetings between the VC, the CEO, and the valuation team occur at least once every six months, in line with the Group’s half-yearly reporting periods.
(d) Valuation inputs to fair value The significant inputs and assumptions used in the fair value measurements of litigation investments - financial assets, categorised within Level 3 of the fair value hierarchy, together with a quantitative sensitivity analysis at 30 June 2026 are shown below:
66
Omni Bridgeway
Note 17: Financial risk management (continued)
Item
Litigation investments financial assets
Valuation technique
Weighted average based on Monte Carlo Model
Significant unobservable inputs
Input
Sensitivity of the input to fair value
Discount rate
7% to 17%¹
Increasing the discount rate by 500 basis points would result in a change in fair value of ($76.5) million. Decreasing the discount rate by 500 points would result in a change in fair value of $79.9 million.
Income
10% +/-
If expected cash inflows were 10% higher, the fair value would increase by $83.4 million. If expected cash inflows were 10% lower, the fair value would decrease by $98.3 million.
¹ A discount rate of 12% is applied in the valuation of all litigation investments - financial assets. The range disclosed reflects the discount rate applied in the sensitivity assessment.
Foreign currency risk The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily with respect to the Euro, United States Dollar and Great British Pound. Foreign exchange risk arises from commercial transactions and recognised assets and liabilities denominated in a currency that is not the functional currency in which they are measured. The risk is monitored using sensitivity analysis and cash flow forecasting. The Group is also exposed to foreign exchange translation risk arising from its foreign operations. The Group’s investments in its subsidiaries are not hedged as those currency positions are considered to be longterm in nature. In addition, the parent entity has intercompany receivables from its subsidiaries denominated in Australian Dollars which are eliminated on consolidation. The gains or losses on re-measurement of these intercompany receivables from foreign currencies to Australian Dollars are not eliminated on consolidation as the loans are not considered to be part of the net investment in the subsidiary. The Group’s exposure to foreign currency risk at 30 June was as follows: AUD
USD
GBP
EUR
SGD
CAD
HKD
CHF
AED
JPY
NZD
SAR
CNY
MAD
SEK
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
Cash and cash equivalents
4,074
44,319
703 51,262
571
1,355
29
409
342
–
51
204
–
5,244
–
Trade receivables¹
115
–
–
–
1
–
–
–
204
–
–
–
2026
Financial Assets
Intercompany loan receivable
6,126 26,324
–
6,348 14,332
–
–
–
–
1,548
–
–
–
–
4,189
21,030 27,784 58,379
6,919 15,687
29
410
342
–
1,599
408
–
5,244
–
Trade payables
30,281
6,767
218
7,422
36
3,808
–
7,456
–
–
(7)
–
–
–
–
Total liabilities
30,281
6,767
218
7,422
36
3,808
–
7,456
–
–
(7)
–
–
–
–
Total assets
(29,415)
757
7,117
Financial Liabilities
AUD
USD
GBP
EUR
SGD
CAD
HKD
CHF
AED
JPY
NZD
SAR
CNY
MAD
SEK
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
$’000
Cash and cash equivalents
25
19,667
5
9,424
8
47
279
–
31
12
–
203
1
20,795
–
Trade receivables¹
446
39,745
26,246
25,963
5
16,463
–
–
–
–
3
–
–
–
–
2025
Financial Assets
Intercompany loan receivable
194
–
3,188
–
–
–
–
–
978
–
–
–
–
471
3,092
26,445
35,387
3,201
16,510
279
–
31
12
981
203
1
20,795
–
Trade payables
(9,188)
8,229
3,403
13,798
70
135
12,906
136
42
–
1
–
–
161
32
Total liabilities
(9,188)
8,229
3,403
13,798
70
135
12,906
136
42
–
1
–
–
161
32
Total assets
– (56,320)
Financial Liabilities
- Receivables includes intercompany loan, trade receivable and payable.
The Group’s exposure to foreign currency risk on cash and cash equivalents primarily relates to foreign cash holdings within the parent entity. The USD foreign currency risk for receivables is predominantly due to the Group’s AUD and Euro denominated subsidiaries which have USD receivables.
Annual Report 2026
67
Notes to the Financial Statements continued Note 17: Financial risk management (continued) Sensitivity The following table summarises the sensitivity of financial instruments held at balance date to movement in the exchange rate of the subsidiary’s functional currency to the listed currencies, with all other variables held constant. The sensitivity is based on management’s estimate of reasonable possible changes over the financial year. Impact on profit or loss before tax ($’000) AUD
30 June 2026
30 June 2025
USD
GBP
EUR
SGD
CAD
HKD
CHF
AED
JPY
NZD
SAR
CNY
MAD
SEK
+10%
–
(2,072) (5,309) (8,455)
(774) (1,215)
(1)
1,267
(14)
–
(132)
(16)
–
(81)
–
(10%)
–
2,072
5,309
8,455
774
1,215
1
(1,267)
14
–
132
16
–
81
–
+10%
–
786
(4,840)
(3,874)
(376)
(1,829)
246
26
–
–
(91)
(8)
–
(349)
–
(10%)
–
(786)
4,840
3,874
376
1,829
(246)
(26)
–
–
91
8
–
349
–
Note 18: Cash and cash equivalents Cash and cash equivalents in the Consolidated Statement of Financial Position and Consolidated Statement of Cash Flows comprise cash at bank and on hand, and short-term deposits with an original maturity of three months or less that are readily convertible to known amounts of cash on hand and which are subject to an insignificant risk of changes in value. Consolidated
Cash at bank
2026
2025
$’000
$’000
157,453
171,009
Short-term deposits
1,154
9,280
Balance at 30 June
158,607
180,289
Cash at bank earns interest at floating rates based on daily bank deposit rates. The carrying amounts of cash and cash equivalents represent fair value. Of the cash at bank, $59.8 million (2025: $90.9 million) is restricted, given it is held with Stichting. The Stichting vehicles were founded as a separate, independent foundation to ensure the cash flows related to the claims were secured. Short-term deposits are made for varying periods depending on the immediate cash requirements of the Group. At 30 June 2026, all short-term deposits are due to mature in less than 90 days from inception and earn interest at the respective short-term deposit rates.
Bank Guarantees Bank guarantees have been issued by the Group’s bankers as security for leases over premises. At 30 June 2026, guarantees of $1.3 million were outstanding (2025: $1.8 million). The Group has a total guarantee facility limit of $1.3 million (2025: $1.8 million) that is secured by an offset arrangement with deposits of $1.3 million (2025: $1.6 million).
Note 19: Borrowings All loans and borrowings are initially recognised at fair value, net of directly attributable transaction costs. Subsequent to initial recognition, interest-bearing loans and borrowings are measured at amortised cost using the effective interest rate method. Borrowings relate to Fund 8 debt capital, of which the capital loss is insured pursuant to a principal protection insurance indemnity. As of 30 June 2026, $38.2 million had been drawn down under the Fund 8 facility (2025: $21.0 million). Consolidated 2026
2025
$’000
$’000
Borrowings
35,395
19,500
Balance at 30 June
35,395
19,500
Non-current
68
Omni Bridgeway
Note 19: Borrowings (continued) Cash and non-cash movements in borrowings are shown below: Consolidated 2026
2025
$’000
$’000
Balance at 1 July
19,500
254,813
Proceeds from issue of borrowings
19,003
5,925
Repayment of debt facility
(1,919)
(250,000)
(237)
10,511
Recognition of capitalised borrowing costs Amortisation/(derecognition) of capitalised borrowing costs
517
(3,547)
Foreign exchange
(1,469)
1,798
Balance at 30 June
35,395
19,500
The application of IAS 23 Borrowing Costs (revised 2007) has resulted in the capitalisation of interest and borrowing cost amounting to $4.9 million (2025: $19.2 million) during the current financial year as part of the litigation investments which are deemed to be qualifying assets post the application date of IAS 23 (revised) 1 July 2009 (refer to Note 14).
Note 20: Contributed equity (a) Ordinary shares Ordinary shares are classified as equity. Issued and paid up capital is recognised at the fair value of the consideration received by the Company. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds. There is no par value of ordinary shares. Fully paid ordinary shares carry one vote per share and the right to dividends. Consolidated 2026
2025
$’000
$’000
484,864
475,717
Number ’000
$’000
282,545
460,716
5,214
7,898
674
7,103
288,433
475,717
1,209
9,147
289,642
484,864
Contributed equity Issued and fully paid ordinary shares
Movement in ordinary shares At 1 July 2024 Shares issued during the year (deferred and variable deferred consideration - business combination) Shares issued upon exercise of performance rights (Note 29) At 30 June 2025 Shares issued upon exercise of performance rights At 30 June 2026
(b) Performance rights At 30 June 2026, there were 8,604,441 unissued ordinary shares in respect of which share performance rights have been issued but not vested (2025: 11,846,644). Refer to Note 29.
(c) Capital management Capital includes debt, lease liabilities and equity attributable to the equity holders of the Parent. When managing capital, management’s objective is to ensure the Group continues as a going concern while maintaining optimal returns to shareholders and benefits for other stakeholders. Management also aims to maintain a capital structure that ensures the lowest cost of capital available to the Group. The Group’s earnings often vary dramatically, and this is expected to continue in the future. Management’s policy is to pay dividends to shareholders from earnings where there is capital surplus to the needs of the business. The Group is not subject to any externally imposed capital requirements. The Parent’s retained earnings/(accumulated losses) are disclosed in Note 30.
Annual Report 2026
69
Notes to the Financial Statements continued Note 21: Retained earnings/(accumulated losses) and reserves Movements in retained earnings/(accumulated losses) were as follows: Consolidated 2026
2025
$’000
$’000
Balance at 1 July
143,134
(206,663)
Net profit for the year
53,697
349,797
Balance at 30 June
196,831
143,134
(a) Movements in reserves were as follows: Share-based payment reserve
Foreign currency translation reserve
Other equity reserve
Fund equity reserve
Total reserves
$’000
$’000
$’000
$’000
$’000
Balance at 1 July 2024
18,121
(14,516)
7,236
(14,172)
(3,331)
Movements in reserves during the year
(1,684)
40,577
–
14,172
53,065
Balance at 30 June 2025
16,437
26,061
7,236
–
49,734
Movements in reserves during the year
(6,047)
(48,745)
–
–
(54,792)
Balance at 30 June 2026
10,390
(22,684)
7,236
–
(5,058)
(b) Nature and purpose of reserves i.
Share-based payment reserve
The share-based payment reserve is used to recognise the value of equity-settled share-based payments provided to employees, including key management personnel as part of their remuneration. Refer to Note 29 for further details of this plan.
ii. Foreign currency translation reserve This reserve is used to record differences on the translation of the assets and liabilities of foreign operations.
iii. Other equity reserve Other equity reserve includes: • Option premium reserve - This reserve was used to record the value of equity benefits provided to employees and directors, including Key Management Personnel, as part of their remuneration. This reserve relates to the previous plan for options already vested. • Convertible note reserve - This reserve was used to record the equity portion on the convertible notes (issued on 13 December 2010), which were fully redeemed by the Company during December 2013.
iv. Fund equity reserve This reserve is used to record changes in the proportion of equity held by non-controlling interests within the Group.
70
Omni Bridgeway
D. WORKING CAPITAL, OTHER ASSETS AND OTHER LIABILITIES Note 22: Trade and other receivables Receivables are recognised initially at fair value and subsequently remeasured at amortised cost using the effective interest rate method, less an allowance for any uncollectible amounts. Receivables due from the completion of litigation investments are recognised upon various stages of completion of the underlying litigation in conjunction with the income recognition criteria of each investment. Collectability is reviewed on an ongoing basis and at each reporting period. The Group recognises an allowance for expected credit losses (ECLs) for all receivables based on the difference between the contractual cash flows due and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. ECLs are recognised in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided for credit losses that result from default events that are possible within the next 12-months (a 12-month ECL). For those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL). At 30 June 2026, the value of the ECL allowance is $1.7 million (2025: $0.04 million). Other receivables comprise interest receivable upon the maturity of the Group’s short-term deposits (between 30 and 90 days), receivables from co-funders of litigation contracts in progress, short term loans and deposits receivable. Consolidated 2026
2025
$’000
$’000
Receivables due from the completion of litigation investments
53,088
61,918
Other receivables
8,272
21,185
61,360
83,103
16,924
18,012
Current
Non-current Receivables due from the completion of litigation investments Other receivables
Total
–
8
16,924
18,020
78,284
101,123
(a) Fair value and credit risk Due to the nature of these receivables, the carrying value of the current receivables approximates its fair value. The maximum exposure to credit risk is the carrying value of receivables. It is not the Group’s policy to transfer (on-sell) receivables.
Note 23: Right-of-use assets and other plant and equipment Plant and Equipment Plant and equipment is stated at historical cost less accumulated depreciation and impairment. Such cost includes the cost of replacing parts that are eligible for capitalisation when the cost of replacing parts is incurred. All other repairs and maintenance are recognised in the profit or loss as incurred. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The major categories of plant and equipment are depreciated as follows: • Equipment
2 to 5 years;
• Furniture
2 to 6 years;
• Leasehold
2 to 11 years; and
• Right-of-use
3 to 10 years.
The assets’ residual values, useful lives and amortisation methods are reviewed, and adjusted if appropriate, at each financial year end. An item of plant and equipment is derecognised upon disposal or when no further future economic benefits are expected from its use or disposal.
Right-of-use assets The Group recognises right-of-use assets at the commencement date of the lease (i.e. the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognised (Refer to Note 26), initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Unless the Group is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the recognised right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated useful life and the lease term. Right-of-use assets are subject to impairment indicator assessments.
Annual Report 2026
71
Notes to the Financial Statements continued Note 23: Right-of-use assets and other plant and equipment (continued) Consolidated 2026
2025
$’000
$’000
Gross carrying amount - at cost
26,741
30,358
Accumulated depreciation
(17,987)
(18,131)
8,754
12,227
Net carrying amount
Reconciliation of carrying amounts at the beginning and end of the year
Equipment
Furniture, fixtures and fittings
Leasehold improvements
Right-of-use assets
Total
$'000
$'000
$'000
$'000
$'000
Balance at 1 July 2024
1,502
1,165
1,295
27,256
31,218
Additions
(453)
(44)
(980)
(1,477)
Disposals
283
(17)
(717)
(691)
Gross carrying amount
Effect of movement in foreign currency Balance at 30 June 2025
(240)
69
77
20
1,142
1,308
1,401
1,181
1,075
26,701
30,358
Additions
86
26
195
935
1,242
Disposals
(321)
(36)
24
(4,689)
(5,022)
Effect of movement in foreign currency
(57)
(76)
2
294
163
1,109
1,096
1,295
23,241
26,741
Balance at 1 July 2024
1,026
849
760
11,937
14,572
Depreciation charge for the year
(270)
84
(31)
2,874
2,657
Disposals
286
(16)
–
–
270
Balance at 30 June 2026 Accumulated depreciation
Effect of movement in foreign currency
41
49
18
523
631
1,083
966
747
15,334
18,131
Depreciation charge for the year
169
73
210
3,560
4,012
Disposals
(283)
(21)
218
(3,172)
(3,258)
Effect of movement in foreign currency
(43)
(60)
5
(797)
(896)
Balance at 30 June 2026
926
957
1,179
14,925
17,987
Balance at 30 June 2025
Refer to Note 26 for further information on right-of-use assets and their associated leases.
Note 24: Trade and other payables Trade payables, other payables and accruals are carried at amortised cost. Due to their short-term nature they are not discounted. They represent liabilities for goods and services provided to the Group or liabilities to provide funding in relation to a litigation investment to the end of the financial year that are unpaid and arise when the Group becomes obliged to make future payments in respect of the purchase of these goods and services or deployment against investment commitments. The amounts are unsecured, non-interest bearing and are usually paid within 30 days of recognition. Consolidated 2026
2025
$'000
$'000
Trade payables
26,765
20,504
Distributable funds to other parties from completed matters
62,116
88,661
565
611
Unearned revenue (Refer to Note 2) Wage accruals
537
595
Interest accruals
2,255
4,385
Balance at 30 June
92,238
114,756
Fair Value
Due to the nature of trade and other payables, their carrying value approximates their fair value.
72
Omni Bridgeway
Note 25: Provisions General provisions Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. Provisions are measured at the present value of management’s best estimate of the expenditure required to settle the present obligation at the balance date. If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects the time value of money and the risks specific to the liability. The increase in the provision resulting from the passage of time is recognised in finance costs. Refer to Notes 12 - 15 in respect to litigation investment impairment provisions.
Employee benefits Provision is made for employee benefits accumulated as a result of employees rendering services up to the end of the reporting period. These benefits include wages, salaries, annual leave, long service leave and bonuses. Liabilities in respect of employees’ services rendered that are not expected to be wholly settled within one year after the end of the periods in which the employees render the related services are recognised as long-term employee benefits. These liabilities are measured at the present value of the estimated future cash outflow to be made to the employees using the projected unit credit method. Liabilities expected to be wholly settled within one year after the end of the period in which the employees render the related services are classified as short-term benefits and are measured at the amount due to be paid. Consolidated 2026
2025
$’000
$’000
3,850
3,652
533
28,423
4,383
32,075
Premises lease make good
617
629
Long service leave
435
355
1,052
984
5,435
33,059
Current Annual leave and vested long service leave Litigation investments - adverse costs Non-current
Total
Annual Report 2026
73
Notes to the Financial Statements continued Note 25: Provisions (continued) (a) Movement in provisions Litigation investments adverse costs
Annual leave
Long service leave
Premises lease make good
Total
$'000
$'000
$'000
$'000
$'000
Balance at 1 July 2024
41,581
3,657
1,206
622
47,066
Arising during the year
2,968
4,085
74
–
7,127
Utilised
(320)
(4,646)
(446)
–
(5,412)
(15,851)
–
–
–
(15,851)
44
78
–
7
129
28,422
3,174
834
629
33,059
Deconsolidation of subsidiaries Effect of movement in foreign currency Balance at 30 June 2025 Arising during the year
8
3,533
185
–
3,726
(28,102)
(3,289)
(28)
–
(31,419)
Effect of movement in foreign currency
205
(124)
–
(12)
69
Balance at 30 June 2026
533
3,294
991
617
5,435
Utilised
(b) Nature and timing of provisions Litigation investments – adverse costs The Group raises a provision for adverse costs upon receipt of a losing judgment in jurisdictions that require adverse costs to be paid to the litigation’s counterparty. Refer to Notes 7 and 27 for further details on adverse costs. At 30 June 2026, the Group had an adverse costs provision of $0.5 million (2025: $28.4 million). $0.1 million of adverse costs have been expensed in FY26.
Premises lease make good The make good provision relates to amounts recognised for make good requirements on leases of office space.
Note 26: Lease liabilities The Group has lease contracts for rental property. These leases generally have lease terms between 3 and 10 years. The Group’s obligations under its leases are secured by the lessor’s title to the leased assets. Generally, the Group is restricted from assigning and subleasing the leased assets. There are several lease contracts that include extension and termination options and variable lease payments, which are further discussed below. The Group assesses at contract inception whether a contract is, or contains, a lease. That is, if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
Group as lessee Lease liabilities At the commencement date of the lease, the Group recognises lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating a lease, if the lease term reflects the Group exercising the option to terminate. In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset.
Short-term leases and leases of low-value assets The Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e. those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption to leases of office equipment that are considered of low value. Lease payments on short-term leases and leases of low-value assets are recognised as expense on a straight-line basis over the lease term.
74
Omni Bridgeway
Note 26: Lease liabilities (continued) Set out below are the carrying amounts of lease liabilities and the movements during the year: Consolidated 2026
2025
$’000
$’000
Balance at 1 July
13,031
16,982
Additions
1,280
–
Terminations
(231)
–
Accretion of interest
762
1,015
Payments
(4,349)
(5,376)
Effects of movement in foreign currency
(602)
410
Balance at 30 June
9,891
13,031
Current
3,081
3,860
Non-current
6,810
9,171
9,891
13,031
The following are the amounts recognised in profit or loss: Consolidated
Depreciation expense on right-of-use assets Interest expense on lease liabilities (included in finance costs) (Note 7(a)) Expense relating to short-term leases Expenses relating to leases of low-value assets (included in corporate and office expense) Total amount recognised in profit or loss
2026
2025
$’000
$’000
3,560
2,874
762
1,015
–
1
107
195
4,429
4,086
The Group had total cash outflows for leases of $4.46 million in 2026 (2025: $5.6 million). The Group has several lease contracts that include extension and termination options. These options are negotiated by management to provide flexibility in managing the leased-asset portfolio and align with the Group’s business needs. Management exercises significant judgment in determining whether these extension and termination options are reasonably certain to be exercised.
Note 27: Commitments and contingencies Capital commitments The Company has $290.8 million (2025: $218.2 million) in aggregate Investor Capital commitments to its Funds under management, of which $186.2 million is undrawn at 30 June 2026 (2025: $128.9 million). The Company's commitment to Funds 2&3, 4.1 and F5.1 is via its residual interest in Fund 9.
Remuneration commitments Consolidated 2026
2025
$'000
$'000
2,759
3,220
–
–
2,759
3,220
Commitments for the payment of salaries and other remuneration under long-term employment contracts in existence at the reporting date but not recognised as liabilities payable: Within one year After one year but no more than five years
Amounts disclosed as remuneration commitments also include commitments arising from the service contracts of, and bonuses payable to, directors and executives referred to in the Remuneration Report of the Directors’ Report that are not recognised as liabilities and are not included in the compensation of Key Management Personnel.
Annual Report 2026
75
Notes to the Financial Statements continued E. THE GROUP, MANAGEMENT AND RELATED PARTIES Note 28: Key management personnel Details of key management personnel There were no changes to Key Management Personnel after the reporting date and before the date the financial report was authorised for issue.
Compensation of key management personnel Consolidated 2026
2025
$’000
$’000
2,598
3,038
Post-employment benefits
161
145
Long-term employee benefits
42
190
Termination payments
–
89
Share-based payments
1,001
407
3,802
3,869
Short-term employee benefits
Note 29: Share-based payment plan Share-based payment transactions (i) Equity-settled transactions The Company’s LTIP awards share performance rights to key senior employees. The cost of equity-settled transactions with employees is measured by reference to the fair value of the equity instruments at the date at which they are granted. The fair value is determined using a Monte Carlo or Black-Scholes Model depending on the type of LTIP. In valuing equity-settled transactions, no account is taken of any vesting conditions, other than conditions linked to the price of the shares of OBL (i.e. market conditions) if applicable. The cost of equity-settled transactions is recognised, together with a corresponding increase in the share-based payment reserve, over the period in which the performance and/or service conditions are fulfilled (the vesting period), ending on the date on which the relevant employees become fully entitled to the award (the vesting date). The charge to the profit or loss for the period is the cumulative amount as calculated above less the amounts already charged in previous periods. There is a corresponding credit to equity. Equity-settled awards granted by OBL to employees of subsidiaries are recognised in the Parent’s separate financial statements as an additional investment in the subsidiary with a corresponding credit to equity. These amounts are eliminated through consolidation. As a result, the expenses recognised by the Company in relation to equity-settled awards only represents the expense associated with grants to employees of the Parent. The expense recognised by the Group is the total expense associated with all such awards. Until an award has vested, any amounts recorded are contingent and will be adjusted if more or fewer awards vest than were originally anticipated to do so. Any award subject to a market condition is considered to vest irrespective of whether or not that market condition is fulfilled, provided that all other conditions are satisfied. If the terms of an equity-settled award are modified, as a minimum an expense is recognised as if the terms had not been modified. An additional expense is recognised for any modification that increases the total fair value of the share-based payment arrangement, or is otherwise beneficial to the employee, as measured at the date of modification. If an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and an expense not yet recognised for the award is recognised immediately. However, if a new award is substituted for the cancelled award and designated as a replacement award on the date that it is granted, the cancelled and new award are treated as if they were a modification of the original award, as described in the previous paragraph. Where outstanding rights do not have an anti-dilutive effect and are currently meeting the performance criteria, the dilutive effect, if any, is added to share dilution in the computation of diluted earnings per share.
(ii) Cash-settled transactions The Group does not provide cash-settled share-based benefits to employees or senior executives.
Long Term Incentive Plan LTIP awards are delivered in the form of performance rights over shares which vest after a period of three years subject to meeting performance measures. The Group uses relative TSR of Funds Deployed as the performance measures. LTIP is subject to the relative TSR performance measure, the fair value of share performance rights granted is estimated at the date of grant using a Monte-Carlo simulation model, taking into account the terms and conditions upon which the share performance rights were granted.
76
Omni Bridgeway
Note 29: Share-based payment plan (continued) Performance Rights On 26 June 2026, 2,041,859 share performance rights were approved by the Board under the long term incentive plan, reflecting the retrospective FY25 LTIP offer. The grant date fair value of the performance rights is set out below: Valuation date
19 November 2024
Number of rights granted
2,041,859
Share price at valuation date
$1.043
Exercise price Expected Volatility (%) Dividend yield (%) Risk-free rate (%)
Nil 50% 0% 4.11%
Performance period
3 years ending
Models used
Monte Carlo & Black-Scholes
30 June 2027
Relative TSR (value per right $)
$0.530
The expense recognised for share-based payments during the year is shown below: Consolidated
Share-based payments expense (Note 7(d))
2026
2025
$’000
$’000
3,097
4,152
The following table illustrates the number and weighted average exercise prices (WAEP) of, and movements in, share performance rights during the year: 2026
2026
2025
2025
Number
WAEP
Number
WAEP
11,846,644
–
15,786,422
–
Granted
49,038
–
428,870
–
Exercised
(2,336,790)
–
(588,430)
–
Movements during the year Outstanding at 1 July
(954,451)
–
(3,780,218)
–
Outstanding at 30 June
Forfeited
8,604,441
–
11,846,644
–
Exercisable at 30 June
2,528,366
–
1,001,617
–
Annual Report 2026
77
Notes to the Financial Statements continued Note 30: Parent entity information 2026
2025
$’000
$’000
Current assets
127,565
96,499
Total assets
432,792
458,569
Current liabilities
(80,276)
(56,161)
Total liabilities
(89,210)
(109,069)
Net assets
343,582
349,500
Information relating to Omni Bridgeway Limited:
Issued capital
485,206
476,058
Accumulated losses
(158,746)
(149,426)
Reserves
17,122
22,868
Total shareholders' equity
343,582
349,500
(Loss)/profit of the Parent
(9,319)
408
Total comprehensive (loss)/income of the Parent
(9,319)
408
Details of the contractual commitments and contingent liabilities of the Parent are contained in Note 27. The consolidated financial statements include the financial statements of OBL and the subsidiaries listed in the following table: Percentage owned Country of Incorporation
2026
2025
%
%
Omni Bridgeway Capital (Canada) Limited
Canada
100
100
Lien Finance Canada Limited
Name
Group Subsidiaries Canada
100
100
Omni Bridgeway Holdings (USA) Inc
USA
100
100
Security Finance (Fund 4) LLC
USA
100
100
Omni Bridgeway Management (USA) LLC
USA
100
100
Omni Bridgeway (USA) LLC
USA
100
100
Security Finance LLC (USA)
USA
100
100
Omni Bridgeway Holdings (Fund 1) LLC
USA
100
100
Crestwood I LLC
USA
100
100
Omni Bridgeway (UK) Limited
United Kingdom
100
100
Omni Bridgeway (Cayman) Limited
Cayman Islands
100
100
Australia
100
100
Omni Bridgeway (Fund 5) GPA Pty Ltd Omni Bridgeway (Storm) Holdings Pty Ltd
Australia
100
100
Omni Bridgeway (Storm) Holdings BV⁴
Netherlands
N/A
100
Omni Bridgeway Holding BV
Netherlands
100
100
Omni Bridgeway Investment BV
Netherlands
100
100
Singapore
100
100
Omni Bridgeway (Singapore) Pte Limited Omni Bridgeway Investment Management Pty Limited
Australia
100
100
New Zealand
100
100
Omni Bridgeway BV
Netherlands
81
81
Omni Bridgeway LegalTech BV
Netherlands
41
41
Omni Bridgeway Emerging Markets BV
Netherlands
81
81
Omni Bridgeway Collective Redress BV
Netherlands
81
81
Omni Bridgeway Asia Pte Ltd⁵
Singapore
N/A
81
Omni Bridgeway Holding (Switzerland) SA
Switzerland
81
81
Omni Bridgeway SA
Switzerland
81
81
Omni Bridgeway (NZ) Limited Fund 6
78
Omni Bridgeway
Note 30: Parent entity information (continued) Percentage owned Country of Incorporation
2026
2025
%
%
Germany
81
81
Omni Bridgeway Finance BV
Netherlands
81
81
Omni Bridgeway France SAS
France
81
81
Omni Bridgeway Italy S.r.L
Italy
81
81
United Arab Emirates
81
81
Netherlands
81
81
Stichting Client Accounts Omni Bridgeway
Netherlands
N/A
N/A
Stichting Cartel Compensation1
Netherlands
N/A
N/A
Stichting Trucks Cartel Compensation1
Netherlands
N/A
N/A
Morocco
N/A
N/A
Omni Bridgeway (Fund 8) Guernsey Investments Limited
Guernsey
81
81
Omni Bridgeway (Fund 8) Guernsey SPV Limited
Guernsey
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 1
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 2
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 3
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 4
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 5
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 6
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 7
USA
81
81
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 8³
USA
81
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 9³
USA
81
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 10³
USA
81
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 11³
USA
81
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 12³
USA
81
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 13³
USA
81
N/A
Name
Fund 6 (continued) Omni Bridgeway GmbH
Omni Bridgeway Advisory Ltd Omni Bridgeway DARP Cooperatief U.A. 1
FT Atlas I2 Fund 8
The Stitching vehicles were founded as separate, independent foundations to ensure the cash flows related to the claims were secured.
The Moroccan securitisation special purpose vehicle was founded on 3 November 2023 to set up a portfolio purchased by Omni Bridgeway S.A.
Incorporated on 18 July 2025.
Omni Bridgeway (Storm) Holding BV was merged into Omni Bridgeway Holding BV on 30 June 2026 and ceased to exist as a separate legal entity.
Omni Bridgeway Asia Pte. Ltd. was struck off the Singapore Companies Register on 18 June 2026 and ceased to exist as a legal entity.
The list of subsidiaries disclosed includes only those entities that are consolidated into the Group’s financial statements. Subsidiaries that are wholly owned but not consolidated due to the absence of control, or which are considered immaterial to the Group for the purpose of the financial statement disclosures, are excluded from this list.
Annual Report 2026
79
Notes to the Financial Statements continued Note 31: Material partly-owned subsidiaries For all subsidiaries where there is less than 51% ownership interest, the Group has power to direct the relevant activities of the investee under contractual arrangements and exposure to variable returns. Therefore the Group is considered to be acting as principal and thus has control. The Group’s subsidiaries that have material non-controlling interests (NCI) are set out below. Percentage owned Country of Incorporation
2026
2025
%
%
Omni Bridgeway BV
Netherlands
19
19
Omni Bridgeway LegalTech BV
Netherlands
59
59
Omni Bridgeway Emerging Markets BV
Netherlands
19
19
Omni Bridgeway Collective Redress BV
Netherlands
19
19
Omni Bridgeway Asia Pte Ltd
Singapore
N/A
19
Omni Bridgeway Holding (Switzerland) SA
Switzerland
19
19
Omni Bridgeway SA
Switzerland
19
19
Germany
19
19
Omni Bridgeway Finance BV
Netherlands
19
19
Omni Bridgeway France SAS
France
19
19
Omni Bridgeway Italy S.r.L
Italy
19
19
United Arab Emirates
19
19
Netherlands
19
19
Omni Bridgeway (Fund 8) Guernsey Investments Limited
Guernsey
19
19
Omni Bridgeway (Fund 8) Guernsey SPV Limited
Guernsey
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 1
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 2
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 3
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 4
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 5
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 6
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 7
USA
19
19
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 8
USA
19
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 9
USA
19
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 10
USA
19
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 11
USA
19
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 12
USA
19
N/A
Omni Bridgeway (Fund 8) Delaware SPV LLC - Series 13
USA
19
N/A
Proportion of equity interest held by non-controlling interests: Fund 6
Omni Bridgeway GmbH
Omni Bridgeway Advisory Ltd Omni Bridgeway DARP Cooperatief UA Fund 8
80
Omni Bridgeway
Note 31: Material partly-owned subsidiaries (continued) Financial information of subsidiaries that have material non-controlling interests is provided below:
(i) Accumulated balances 2026
2025
$'000
$'000
181,948
194,195
181,948
194,195
Fund 4
–
34,064
Fund 6
(7,768)
32,961
(7,768)
67,025
Accumulated balances of material non-controlling interest: Fund 6 Profit/(loss) allocated to material non-controlling interest:
(ii) Movements in NCI’s during the year Consolidated
Balance at 1 July 2024
Funds 2&3
Fund 4
Fund 6
Total
$'000
$'000
$'000
$'000
114,830
227,512
201,865
544,207
Contributions
2,880
40,296
16,026
59,202
Distributions
(11,150)
(34,124)
(49,721)
(94,995)
Deconsolidation of subsidiaries
(116,182)
(284,743)
–
(400,925)
9,373
(10,994)
(10,906)
(12,527)
Change in share of net assets attributable to NCI Profit
–
34,064
32,961
67,025
249
27,989
3,970
32,208
Balance at 30 June 2025
–
–
194,195
194,195
Distributions
–
–
(4,385)
(4,385)
Change in share of net assets attributable to NCI
–
–
5,832
5,832
Loss
–
–
(7,768)
(7,768)
Other comprehensive loss
–
–
(5,926)
(5,926)
Balance at 30 June 2026
–
–
181,948
181,948
Other comprehensive income
Funds 2&3 On 13 September 2017, the Group established Omni Bridgeway (Fund 2) Pty Ltd and Omni Bridgeway (Fund 3) Pty Ltd. On 26 July 2019, the Group established IMF Bentham ROW SPV 1 Limited. On 15 March 2021, the Group established IMF Bentham ROW SPV 2 Pty Ltd. These entities are collectively “Funds 2&3”. Given the European waterfall structure of Funds 2&3, NCI has the priority to cash proceeds in the early stage, and provide a substantial back-end return attribution to the Group in later periods. Funds 2&3 were deconsolidated on 25 February 2025 due to the loss of control upon the completion of the Fund 9 transaction. The Group no longer retains decision-making rights over the relevant activities of these funds and it does not have power over, nor significant influence on, the funds’ operations. The Group’s residual interests in Funds 2&3, held via Fund 9, are recognised as litigation investments - financial assets. Refer to Note 15 for further details.
Fund 4 On 26 October 2018, the Group established Omni Bridgeway Capital GP (Fund 4) LLC. On 29 November 2018, the Group established Security Finance (Fund 4) LLC. On 4 December 2018, the Group established Omni Bridgeway (Fund 4) Invt 1 – 9 LP. On 7 July 2020, the Group established JPV I LP. These entities are collectively “Fund 4”. Fund 4 was deconsolidated on 25 February 2025 following the loss of control, as the Group no longer retains decision-making rights over the relevant activities of these funds and it does not have power over, nor significant influence on, the fund’s operations. The Group’s residual interests in Fund 4, held via Fund 9, are recognised as litigation investments - financial assets. Refer to Note 15 for further details.
Annual Report 2026
81
Notes to the Financial Statements continued Note 31: Material partly-owned subsidiaries (continued) Fund 6 Fund 6 was created in 2016 and was acquired by the Group as part of the November 2019 acquisition of OBE. The Group established Omni Bridgeway France SAS and Omni Bridgeway Italy S.r.L. on 8 March 2023 and 31 May 2023 respectively. This is a Europe, Middle East and Africa focused investment structure.
Fund 9 On 18 December 2024, the Group established Fund 9, a continuation fund for over 150 investments across Funds 2&3, Funds 4&5 Series I, and one remaining balance sheet investment (Fund 9 Assets). An external investment group acquired a 70% interest in Fund 9 for an upfront cash consideration of $314 million paid to the Group. The transaction resulted in the deconsolidation of these Fund entities because of the loss of control of Funds 2-4 and the novation of the participation agreement with Fund 5 (referred to as “other assets” below) on the transaction completion date on 25 February 2025. The residual interests in the Fund 9 Assets were recognised as litigation investments - financial assets within the Group Consolidated Financial Statements. The prior period transaction resulted in a net gain on deconsolidation of subsidiaries and other assets. Further details of the Fund 9 transactions are disclosed in Note 35 to the FY25 Financial Report.
Options The Group has issued share warrants in the Fund 9 transaction which are convertible into ordinary shares if triggered. The warrants issued are equivalent to $35 million, with a strike/exercise price equal to the 30-day Volume Weighted Average Price (‘VWAP’) as of the date of signing the Term Sheet. The warrants are able to be exercised at any time after the second anniversary of the transaction date, but before the fifth anniversary. The warrants include settlement features that allow for either cash or equity settlement, at the sole discretion of the Group (issuer). In accordance with IAS 32 Financial Instruments: Presentation, this is classified as a financial liability due to the presence of a cash settlement option that results in a variable amount of cash being exchanged for a fixed number of shares. This assessment requires significant judgement, particularly in evaluating the enforceability of settlement terms and the implications of discretion under IAS 32. The key inputs used in the valuation of the option are as follows: Valuation input
30-Jun-26
30-Jun-25
Share price
$1.65
$1.34
Exercise price of option
$0.938
$0.938
1
2.67
Number of periods to exercise in years Compounded risk-free interest rate
4%
4%
Volatility
52 %
52 %
Fifth anniversary of Issue Date
Fifth anniversary of Issue Date
37,333,333
37,333,333
Expiry date Number of option
Warrants issued in the Fund 9 transaction are classified as a liability under IFRS, the Group expects the liability will be extinguished via equity settlement.
(iii) Summarised cash flows The summarised financial information of controlled entities with material non-controlling interests provided below is based on amounts prior to intercompany eliminations: Consolidated Fund 2 & 3
Fund 4
Fund 6
2026
2025
2026
2025
2026
2025
$'000
$'000
$'000
$'000
$'000
$'000
Operating
–
(235)
–
(1,101)
3,754
70,486
Investing
–
3,482
–
(10,784)
14,724
19,942
Financing
–
(5,983)
–
13,879
(44,416)
(28,678)
Net (decrease)/increase in cash and cash equivalents
–
(2,736)
–
1,995
(25,938)
61,750
Cash and cash equivalents at the beginning of the period
–
9,677
–
13,742
101,934
20,285
Deconsolidation of subsidiaries
–
(2,218)
–
(19,600)
–
–
Foreign exchange (loss)/gain
–
(4,723)
–
3,863
5,052
19,900
Cash and cash equivalents at the end of the period
–
–
–
–
81,048
101,934
Summarised statement of cash flows
82
Omni Bridgeway
Note 32: Interest in associates Set out below are the associates of the Group as at 30 June 2026 which, in the opinion of the directors, are material to the Group. The entities listed below have share capital consisting solely of ordinary shares, which are held directly by the Group. The country of incorporation or registration is also their principal place of business.
Name of entity
Place of business/country of incorporation
OB Capital Coop U.A¹ Omni Bridgeway (Fund 1) LLC2
Netherlands USA
% of ownership interest
Litigation investments
- Investment in associates
% of voting rights
Investment in associates
2026
2025
2026
2025
2026
2025
2026
2025
%
%
%
%
$’000
$’000
$’000
$’000
5 100
5 100
5 100
5 100
– 1,073
– 8,250
9,423 –
10,174 –
1,073
8,250
9,423
10,174
Total equity-accounted investments
- OB Capital Coop U.A is an associate of the Group and it was acquired through the acquisition of Omni Bridgeway Holding BV in November 2019. The entity invests in litigation investments in the Netherlands. The Coop agreement outlines the various powers, rights and responsibilities of the members, includes provisions that provide the Group with significant influence over the entity.
- Omni Bridgeway (Fund 1) LLC is a litigation investment in associate of the Group and it is an entity within Fund 1 which invests in litigation investments in the United States. The Group has 100% voting rights subject to a removal right exercisable by an external investor.
(a) Recognition and measurement An associate is an entity over which the Group has significant influence. Significant influence is the power to participate in the financial and operating policy decisions of the investee, but is not control or joint control over those policies. Litigation investment - investment in associates are the investments in the entities which holding substantially all of its assets in litigation investments. The considerations made in determining significant influence are similar to those necessary to determine control over subsidiaries. The Group’s investment in its associates are accounted for using the equity method. Under the equity method, the investment in an associate is initially recognised at cost. The carrying amount of the investment is adjusted to recognise changes in the Group’s share of net assets of the associate since the acquisition date. Goodwill relating to the associate is included in the carrying amount of the investment and is not tested for impairment separately. If the existence of an associate results from the loss of control over a former subsidiary of the Group’s consolidated financial statements, the associate is initially recognised at the fair value of the retained residual interest held by the Group. The fair value is determined using the methodology of the initial recognition of a financial asset, which represents the present value of the risk-adjusted future potential cashflows to be received by the Group. Since the probability-weighted cashflows are a significant unobservable input, the fair value of the retained interest is classified as a level 3 fair value. The statement of profit or loss reflects the Group’s share of the results of operations of the associate. Any change in Other Comprehensive Income (OCI) of those investees is presented as part of the Group’s OCI. In addition, when there has been a change recognised directly in the equity of the associate, the Group recognises its share of any changes, when applicable, in the statement of changes in equity. Unrealised gains and losses resulting from transactions between the Group and the associate are eliminated to the extent of the interest in the associate. The aggregate of the Group’s share of profit or loss of an associate is shown on the face of the statement of profit or loss outside operating profit and represents profit or loss after tax and non-controlling interests in the subsidiaries of the associate. The financial statements of the associate are prepared for the same reporting period as the Group. When necessary, adjustments are made to bring the accounting policies in line with those of the Group. After application of the equity method, the Group determines whether it is necessary to recognise an impairment loss on its investment in its associate. At each reporting date, the Group determines whether there is objective evidence that the investment in the associate is impaired. If there is such evidence, the Group calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value, and then recognises the loss within ‘Share of profit/(loss) of associates’ in the statement of profit or loss. Upon loss of significant influence over the associate, the Group measures and recognises any retained investment at its fair value. Any difference between the carrying amount of the associate upon loss of significant influence and the fair value of the retained investment and proceeds from disposal is recognised in profit or loss.
(b) Commitments and contingent liabilities in respect of associates As part of the gain on disposal calculation for Fund 1 and Fund 4 Eagle SPV, an allowance has been made for future costs of managing the fund and requirement for capital commitments. The Group remains as an investment advisor to the Fund 4 Eagle SPV through Fund 9. Accordingly, the related allowance remains recognised on the Group’s balance sheet and is not impacted by the Fund 9 transaction. Apart from those described in Note 27, there are no other material commitments or contingent liabilities from share of associates.
(c) Summarised financial information for associates Interest in those associates that are material to the Group for the relevant financial year is provided below:
Annual Report 2026
83
Notes to the Financial Statements continued Note 32: Interest in associates (continued) Omni Bridgeway (Fund 1) LLC1
OB Capital Coop U.A
2026
2025
2026
2025
$’000
$’000
$'000
$'000
(177) 86 (263) – – (263)
1,872 2,043 (171) – – (171)
20 32 (12) – 4,451 4,439
53 55 (2) – 37,754 37,752
– – –
(2,239) (108) (2,347)
222 – 222
1,888 (221) 1,667
Current assets Non-current assets Current liabilities Non-current liabilities Equity
813 14,783 54 1,125 14,417
185 14,185 24 777 13,569
26 188,490 53 – 188,463
175 210,722 7,412 – 203,485
Group's share in equity Group's carrying amount of the investment
1,073 1,073
8,250 8,250
9,423 9,423
10,174 10,174
Income Total expenses Operating loss Tax Equity accounted investment result Net (loss)/profit Share of (loss)/profit in associates Effect of movement in foreign currency Net share of (loss)/profit in associates
- The profit or loss and balance sheet of this entity represents IFRS standalone financial statements of Fund 1, whereas the Group’s share in equity is its residual interest that was recognised at fair value at deconsolidation. Refer to Note 31.
Note 33: Related party disclosure There were no related party transactions for the Group for the relevant financial year.
Note 34: Auditor’s remuneration The auditor of Omni Bridgeway Limited is BDO Audit Pty Ltd. Consolidated
Audit and review of financial reports covering the group and controlled entities Taxation fees
2026
2025
$'000
$'000
1,228
1,628
420
536
1,648
2,164
Note 35: Events after the reporting date There are no circumstances that have arisen since 30 June 2026 that have significantly affected, or may significantly affect the Consolidated Entity’s operations, the results of those operations, or the Consolidated Entity’s state of affairs in the future financial years.
84
Omni Bridgeway
Consolidated Entity Disclosure Statement As at 30 June 2026 Trustee, partner or participant in joint venture
% of share capital held
Country of incorporation
Australian resident
Foreign jurisdiction(s) in which the entity is a resident for tax purposes (according to the law of the foreign jurisdiction)
Name of entity
Type of entity
Omni Bridgeway Limited
Body corporate N/A
N/A
Australia
Yes
N/A
Omni Bridgeway Capital (Canada) Limited
Body corporate N/A
100
Canada
No
Canada
Lien Finance Canada Limited
Body corporate N/A
100
Canada
No
Canada
Omni Bridgeway Holdings (USA) Inc
Body corporate N/A
100
USA
No
USA
Security Finance (Fund 4) LLC
Body corporate N/A
100
USA
No
USA
Omni Bridgeway Management (USA) LLC
Body corporate N/A
100
USA
No
USA
Omni Bridgeway (USA) LLC
Body corporate N/A
100
USA
No
USA
Security Finance LLC (USA)
Body corporate N/A
100
USA
No
USA
Omni Bridgeway Holdings (Fund 1) LLC
Body corporate N/A
100
USA
No
USA
Crestwood I LLC
Body corporate N/A
100
USA
No
USA
Omni Bridgeway (UK) Limited
Body corporate N/A
100
United Kingdom No
United Kingdom
Omni Bridgeway (Cayman) Limited
Body corporate N/A
100
Cayman Islands
No
Cayman Islands
Omni Bridgeway (Fund 5) GPA Pty Ltd
Body corporate N/A
100
Australia
Yes
N/A
Omni Bridgeway (Storm) Holdings Pty Ltd
Body corporate N/A
100
Australia
Yes
N/A
Omni Bridgeway Holding BV
Body corporate N/A
100
Netherlands
No
Netherlands
Omni Bridgeway Investment BV
Body corporate N/A
100
Netherlands
No
Netherlands
Omni Bridgeway (Singapore) Pte Limited
Body corporate N/A
100
Singapore
No
Singapore
Omni Bridgeway Investment Management Pty Limited
Body corporate N/A
100
Australia
Yes
N/A
Omni Bridgeway (NZ) Limited
Body corporate N/A
100
New Zealand
No
New Zealand
Omni Bridgeway BV
Body corporate N/A
81
Netherlands
No
Netherlands
Omni Bridgeway LegalTech BV
Body corporate N/A
41
Netherlands
No
Netherlands
Omni Bridgeway Emerging Markets BV
Body corporate N/A
81
Netherlands
No
Netherlands
Omni Bridgeway Collective Redress BV
Body corporate N/A
81
Netherlands
No
Netherlands
Omni Bridgeway Holding (Switzerland) SA
Body corporate N/A
81
Switzerland
No
Switzerland
Omni Bridgeway SA
Body corporate N/A
81
Switzerland
No
Switzerland
Omni Bridgeway GmbH
Body corporate N/A
81
Germany
No
Germany
Omni Bridgeway Finance BV
Body corporate N/A
81
Netherlands
No
Netherlands
Omni Bridgeway France SAS
Body corporate N/A
81
France
No
France
Omni Bridgeway Italy S.r.L
Body corporate N/A
81
Italy
No
Italy
Omni Bridgeway Advisory Ltd
Body corporate N/A
81
United Arab Emirates
No
United Arab Emirates
Omni Bridgeway DARP Cooperatief UA
Body corporate N/A
81
Netherlands
No
Netherlands
Omni Bridgeway (Fund 8) Guernsey Investments Limited
Body corporate N/A
81
Guernsey
No
Guernsey
Omni Bridgeway (Fund 8) Guernsey SPV LLC
Body corporate N/A
81
Guernsey
No
Guernsey
Omni Bridgeway (Fund 8) Delaware SPV LLC
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Omni Bridgeway (Fund 8) Delaware SPV LLC Series 1 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 2 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 3
Annual Report 2026
85
Consolidated Entity Disclosure Statement continued As at 30 June 2026
Name of entity
Omni Bridgeway (Fund 8) Delaware SPV LLC Series 4 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 5 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 6 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 7 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 8 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 9 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 10 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 11 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 12 Omni Bridgeway (Fund 8) Delaware SPV LLC Series 13
86
Omni Bridgeway
% of share capital held
Country of incorporation
Australian resident
Foreign jurisdiction(s) in which the entity is a resident for tax purposes (according to the law of the foreign jurisdiction)
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Body corporate N/A
81
USA
No
USA
Type of entity
Trustee, partner or participant in joint venture
Directors’ Declaration We state that, in the Directors’ opinion: a.
the financial statements and notes of Omni Bridgeway Limited for the financial year ended 30 June 2026 are in accordance with the Corporations Act 2001, including: i. giving a true and fair view of its financial position as at 30 June 2026 and performance for the year ended on that date; and ii. complying with Accounting Standards (including the Australian Accounting Interpretations) and the Corporations Regulations 2001;
b. the financial statements and notes also comply with International Financial Reporting Standards as disclosed in the notes to the financial statements; c.
there are reasonable grounds to believe that the Company will be able to pay its debts as and when they become due and payable; and
d. the Consolidated Entity Disclosure Statement is true and correct. Signed in accordance with a resolution of directors of Omni Bridgeway Limited pursuant to section 295A of the Corporations Act 2001 for the financial year ended 30 June 2026, on behalf of the directors.
Michael Green
Raymond van Hulst
Non-Executive Chairman
Managing Director and Chief Executive Officer
Sydney, 26 August 2026
Sydney, 26 August 2026
Annual Report 2026
87
Independent Auditor’s Report
88
Omni Bridgeway
Annual Report 2026
89
90
Omni Bridgeway
Annual Report 2026
91
92
Omni Bridgeway
Shareholder information The information set out below is current as at 31 July 2026.
(a) Distribution of shareholders Ordinary share capital 289,642,218 fully paid ordinary shares are held by 2,615 individual shareholders. All issued ordinary shares carry one vote per share and carry the right to dividends.
Options There are 37,333,333 options issued over ordinary shares. The options were issued on 21 March 2025 at an exercise price of $0.9375 and an expiry of 25 February 2030.
Share performance rights 8,789,726 share performance rights were issued to 98 rights holders under the Company’s Long Term Incentive Plan.
Distribution of securities The number of shareholders by size of holding, in each class are as at 31 July 2026: Number
Fully paid ordinary shares
% of issued capital
1 – 1,000
961
368,435
0.13
1,001 – 5,000
811
2,126,641
0.73
5,001 – 10,000
324
2,374,089
0.82
10,001 – 100,000
447
12,827,994
4.43
100,001 and over
72
271,945,059
93.89
2,615
289,642,218
100.00
Number of ordinary Shares
% of issued capital
Perpetual Limited
41,291,970
14.26 %
Retail Employees Superannuation Pty Ltd
38,413,435
13.26 %
Samuel Terry Asset Management Pty Ltd
20,153,230
7.10 %
Non-marketable parcels There were 491 holders of less than a marketable parcel of ordinary shares.
(b) Substantial shareholders The names of the substantial shareholders listed in the Company’s register as at 31 July 2026 are: Shareholder
Annual Report 2026
93
Shareholder information continued (c) 20 largest holders of quoted equity securities as at 31 July 2026 Number of ordinary shares
Issued capital
‘000
%
- HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED
87,662
30.27
- J P MORGAN NOMINEES AUSTRALIA PTY LIMITED
52,893
18.26
- CITICORP NOMINEES PTY LIMITED
35,140
12.13
- HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED - A/C 2
23,151
7.99
- BNP PARIBAS NOMS PTY LTD
14,083
4.86
- UBS NOMINEES PTY LTD
12,328
4.26
- BNP PARIBAS NOMINEES PTY LTD <IB AU NOMS RETAILCLIENT>
10,962
3.78
- HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED <GSCO CUSTOMERS A/C>
6,522
2.25
- HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED-GSCO ECA
5,224
1.80
- CPU SHARE PLANS PTY LTD <OBL LTI UNALLOCATED A/C>
2,523
0.87
- MRS SAU HAN ALICE PHILLIPS
1,474
0.51
- GA PEASE NOMINEES PTY LTD <GA PEASE INVESTMENT A/C>
1,450
0.50
- GRAHAM NEWMAN PTY LTD
1,283
0.44
- MS CATHERINE OLWENY
1,184
0.41
- BNP PARIBAS NOMINEES PTY LTD <CLEARSTREAM>
976
0.34
- MR ALEXANDER PAUL CHANG
760
0.26
- B F A PTY LTD
747
0.26
- HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED
670
0.23
- SWANBROOK CAPITAL PTY LTD <GREEN FAMILY A/C>
610
0.21
- DEMETA PTY LTD
580
0.20
260,222
89.83
Ordinary Shares
(d) Options as at 31 July 2026 – unquoted There are 37,333,333 options issued over ordinary shares. The options were issued on 21 March 2025 at an exercise price of $0.9375 and an expiry of 25 February 2030.
94
Omni Bridgeway
Shareholder information (continued) US ownership restriction The ordinary shares of Omni Bridgeway are subject to ownership restrictions applying to residents of the United States. The Shares have not been registered under the US Securities Act of 1933 or the securities laws of any state or other jurisdiction of the United States. In addition, OBL has not been registered under the US Investment Company Act of 1940 in reliance on an exemption from registration. Accordingly, the Shares may not be offered or sold in the United States or to, or for the account or benefit of US Persons except in accordance with an available exemption from, or a transaction not subject to, the registration requirements of the US Securities Act, the US Investment Company Act and applicable US state securities laws. In order to qualify for an exemption under the US Investment Company Act, the constitution of OBL provides that where a holder is an Excluded US Person: OBL may refuse to register a transfer of Shares to that Excluded US Person; and The Excluded US Person may be requested to sell such person’s Shares and, if the Excluded US Person fails to do so within 30 business days, to be divested of such Shares and to receive the proceeds of sale (net of transaction costs, including any applicable brokerage) as soon as practicable after the sale. In addition, OBL’s constitution provides that a holder may be required to complete a statutory declaration in relation to whether they (or any person on whose account or benefit it holds Shares) are an Excluded US Person. Any holder who does not comply with such a request will be deemed to be an Excluded US Person. The Shares are issued on terms under which each holder who is or becomes an Excluded US Person agrees to the above terms and irrevocably appoints OBL as that holder’s agent and attorney to do all acts and things and execute all documents which OBL considers necessary, desirable or reasonably incidental to effect the above actions.
Shares issued during the year On 4 November 2025, the Company issued 799,259 shares relating to the FY23 LTIP vesting. On 7 April 2026, the Company issued 410,221 shares relating to the employee equity incentive plan.
Share options – unissued shares As at 30 June 2026 there were 8,604,441 share performance rights on issue (2025: 11,846,644).
Annual Report 2026
95
Corporate information Bridgeway Limited
shares are listed on the Australian Securities Exchange This annual report covers both Omni Bridgeway Limited as an individual entity and the Consolidated Entity comprising Omni Bridgeway Limited and its subsidiaries. The Group’s functional and presentation currency is AUD ($). A description of the Group’s operations and of its principal activities is included in the review of operations and activities in the Directors’ Report. The Directors’ Report is not part of the Financial report.
Directors Michael Green
Non-Executive Director & Chairman
Raymond van Hulst
Managing Director and Chief Executive Officer
Karen Phin
Non-Executive Director
Christine Feldmanis
Non-Executive Director
Company Secretary Jeremy Sambrook
Registered office and principal place of business in Australia Level 7, 35 Clarence Street Sydney NSW 2000 Phone: +61 (0)2 8223 3567 Fax: +61 (0)2 8223 3555
Solicitors DLA PIPER Level 9, 480 Queen Street Brisbane QLD 4000 THOMSONS Level 29, Central Park Tower 152-158 St Georges Terrace Perth, WA 6000
Share registry COMPUTERSHARE Level 11, 172 St Georges Terrace Perth WA 6000
Auditors BDO AUDIT PTY LTD 25/252 Pitt Street, Sydney NSW 2000
Bankers NATIONAL AUSTRALIA BANK LIMITED 3/2 Carrington Street Sydney NSW 2000 WESTPAC BANKING CORPORATION 275 Kent Street Sydney NSW 2000
Internet address www.omnibridgeway.com
The Company is listed on the Australian Securities Exchange with Sydney, Australia as its home exchange. Its ASX ticker symbol is “OBL” and its shares were trading as at the date of this report.
96
Omni Bridgeway
Glossary
Throughout Omni Bridgeway Limited’s (OBL, Company, Parent) publicly available information, the following terms have the meanings detailed in this glossary which shall be updated from time to time: AASB
Australian Accounting Standards Board.
Addressable Market
OBL’s estimate of the annual amount spent by claimants on external costs of dispute resolution (excluding enforcement) that could be addressed by OBL’s dispute finance service offering.
Adverse cost
The cost that a losing party to litigation (in certain jurisdictions only) is required to pay to the winning party as compensation for the legal costs they have incurred in the litigation process.
After the event (ATE) Insurance
Insurance cover to protect against adverse cost exposure.
AFSL
Australian Financial Services Licence.
ALFA American Waterfall
Association of Litigation Funders of Australia. The waterfall refers to the order in which investment proceeds in a fund are distributed between Fund participants. Under an American-style distribution Carried Interest hurdles are calculated by reference to completed investments only and in subject to annual clawback assessment.
Americas
The geographic region of North, Central and South America.
APAC
The geographic region incorporating Asia and the Pacific Region including Australia and New Zealand.
ASX
Australian Securities Exchange.
AUM/Assets Under Management
AUM is the fair value of the Investments of the funds and any Sidecar investments together with any undrawn Committed Capital and Fund cash balances.
CAGR
Compound annual growth rate.
Carried Interest
OBL is entitled to be paid a fee in connection with the management of each investment subject to the IRR generated. These are paid out of proceeds arising from the realisation of an investment.
Committed Capital/Commitments
The amount of funding that has been contractually committed by the funding vehicle to a litigation investment under a funding arrangement which is either (i) a capped amount; or (ii) the estimated budgeted amount to run the investment to completion, as amended and duly approved from time to time. It does not include; Sidecar contributions, or possible overheads to be capitalised or, unless expressly part of the budget, possible adverse costs that may become payable if the litigation is lost or other associated expenses of the funding vehicle.
Capital deployed
Is the portion of the Committed Capital which has been expended from time to time. For completed investments it includes any net adverse costs. It does not include Sidecar contributions.
Capitalised overheads
Internal costs (including borrowing costs and direct staff costs) that are incurred in relation to Investments that are not expensed in the period they were incurred but added to the investment carrying value and recognised through the profit and loss in line with the completion of each respective investment. Capitalisation occurs at the OBL and consolidation level, not within each Fund and does not affect portfolio or Fund performance, waterfall or fees.
Completed investments / Completion
For merits investments, this refers to the situation where the underlying litigation has progressed to a state where there are no further risk to the legal result notwithstanding that such finalisation may be conditional upon certain matters such as court approval. For enforcement investments, completion occurs at the point where there is no further recovery action planned.
Discount rate
OBL uses a discount rate of 12% for calculation of fair value, based on the weighted average cost of capital (WACC) for the legal finance asset class, which closely aligns with the WACC for OBL and with the hurdle rates for our third-party fund capital. All main investment risks associated with legal investments, including loss risk, duration risk, budget risk, quantum risk and credit risk are reflected in the probabilistic scenarios, and therefore fall outside the scope of risks determining the required discount rate.
Direct balance sheet
Relates to investments of the Group that are not held via a Fund.
CGU
Cash-generating unit which is defined as the smallest group of assets that generates largely independent cash inflows.
Distressed Asset Recovery Program (DARP) A strategic program of the World Bank’s International Finance Corporation to reduce the effects of poverty in emerging markets by preventing the loss of assets and allowing access to formal credit, while helping to preserve jobs. Refer to Fund 7. DRP
Dividend Reinvestment Plan.
ELFA
European Litigation Funders Association.
EMEA
The geographic region incorporating Europe, Middle East and Africa.
Annual Report 2026
97
Glossary continued
98
Enforcement investment
Refers to investments where the underlying dispute has a debt and/or judicial finding that is not being honoured and requires action to be collected.
ESG
Environmental, social and governance.
EPS
Earnings per share.
European Waterfall
The waterfall refers to the order in which investment proceeds in a fund are distributed between Fund participants. Under an European-style distribution, Carried Interest hurdles are calculated by reference to all fund investments and not just completed investments. The manager receives any Carried Interest until the full amount of investors capital and preferred return have been fully satisfied.
Excluded US Person
Means a holder of Shares (or a person who seeks to be registered as a holder of Shares) whom the directors of OBL have determined (i) is a US Person who is not a Qualified Purchaser or a Knowledgeable Employee or (ii) holds or will hold Shares for the account or benefit of any US Person who is not a Qualified Purchaser or a Knowledgeable Employee.
Fair Value (FV)
As defined in the investor day presentation available here.
12-month Fair Value
The proportionate part of our total book fair value, which has expected cash inflows over the applicable 12-month period based on the underlying probability weighted net cash flows fair value models. All, part or none of these investment inflows may eventuate during the next 12-month period.
Fair value conversion rate
In respect of a stated period, the net value of deployments and proceeds received from fully completed investments, since the date of the last reported portfolio fair value, divided by the aggregate of the last reported fair value for the applicable investments.
First Generation Fund(s)
OBL’s Fund 1, & Fund 2&3; which were established by the Group in 2017 with generally consistent terms.
Fourth Generation Fund
OBL’s Fund 8 as raised in 2022.
Fund Commitments
The amount of capital agreed to be provided to an OBL Fund from OBL and external investors.
Funds
Means funds, or fund like structures, that OBL manages, advises and invests into. It includes Fund 1, Fund 2&3, Fund 4 Series I, Fund 5 Series I, Fund 6, Fund 8, Fund 9, Fund 4 Series II and Fund 5 Series II.
Funded investments
Refers to investments where the Group has entered an unconditional binding contract.
FUM/Funds under Management Commitments
The aggregate amount of Fund commitments (whether called or uncalled) for all of the Funds that are in operation at any point in time.
Funds deployed
Refer to Capital deployed.
Fund 1
Funding structure for Litigation Investments in the US established in 2017. A participation in the fund was sold in May 2023 and is Fund 1 is now deconsolidated from the group. OBL continues to manage the Fund.
Funds 2&3
Funding structure for Litigation investments in the RoW established in 2017 with Fund commitments of AUD 189 million. Funds 2&3 are now deconsolidated from the group.
Fund 4 (Series I)
Funding structure for Litigation Investments in the US established in 2019 with Fund commitments of USD 500 million.
Fund 4 (Series II)
Funding structure follow-on from Fund 4 (Series I), with the same mandate.
Fund 5 (Series I)
Funding structure for Litigation investments in the RoW established in 2019 with Fund commitments of USD 500 million.
Fund 5 (Series II)
Follow-on Fund to Fund 5 Series I, substantially based on same terms.
Fund 6
Funding structure established in 2017 for investments focused on EMEA, purchased as part of OBE Group in 2019, with Fund commitments of EUR 188 million. This Fund is in the harvest phase post the end of the applicable investment period.
Fund 7
A joint venture with the IFC/World Bank to facilitate investments in distressed assets recoveries. This has subsequently been merged into Funds 6 and 8.
Fund 8
Funding structure closed in 1Q24 focused on investing up to EUR 150 million in global enforcement investments.
Fund 9
A continuation fund established in 2025 by OBL. The fund was formed to acquire OBL’s co-investment interests in over 150 legal finance assets across Funds 2/3, Funds 4/5 Series 1, and one balance sheet investment (collectively, the Fund 9 Assets).
IC/Investment Committee(s)
Investment Committee(s) of Omni Bridgeway which make investment advisory recommendations with regard to investments and comprise both internal and external appointees.
IC approved/conditionally funded
Refers to investments that are approved by the Group’s internal investment process but have not reached an unconditional status. This may relate to the state of the funding contract, or book build, loss quantification, discovery or other evidence requirements.
Omni Bridgeway
Glossary continued ICC
International Chamber of Commerce.
IFRS
International Financial Reporting Standards.
ILFA
International Legal Finance Association.
IMF
IMF Bentham Limited and its Group, now known as OBL following a name change in 2020.
Investment commitment
Refer to committed capital/commitments.
Income v revenue terminology
Income, revenue and proceeds are generally used interchangeably for realised sums on litigation investments regardless of how IFRS may classify the assets and its consequential P&L disclosure.
Income yet to be recognised
Is the estimated value of income that may be generated from investments that are substantially complete from a litigation perspective at that point in time but have not fully satisfied revenue recognition accounting standards and our policies. It is subject to change and relates to substantially completed investments with conditional settlements or judgments on appeal which may be recognised in future periods.
Internal rate of return (IRR)
IRR is calculated including all full and partial completions of investments for the relevant period, excluding fund 1 sales, withdrawals and Extraordinary Investments. IRR at fund level is calculated using actual sequencing of investments and associated cashflows within a fund. IRR for subsets of investments across funds (including vintages, LTD, or other time periods) is calculated using zero-based IRR methodology, which has each investment start at T=0 within the subset.
Invested capital
refer to Capital deployed.
Knowledgeable Employee
As per the SEC’s Rule 3c-5 under the US Investment Company Act of 1940, Knowledgeable Employee with respect to any Covered Company means any natural person who is: (i) an Executive Officer, director, trustee, general partner, advisory board member, or person serving in a similar capacity, of the Covered Company or an Affiliated Management Person of the Covered Company.
LatAm (Latin America)
The geographic region spanning Central and South America.
LTIP
Long-Term Incentive Plan.
Malus and clawback event provisions
These are provisions whereby participants in the LTIP may in the event of certain specified conduct such as fraud, forfeit all or a portion of their performance rights or the resulting shares or be required to repay all or a portion of their sale proceeds from such securities.
Managed Investment Scheme (MIS)
An investment structure regulated under Australian Corporation Law regulations.
Management fees
Management fees are received for the provision of investment management services provided and are paid quarterly in arrears calculated on the net invested capital.
Material litigation events (MLE)
Objectively verifiable events leading to changes in assumptions or inputs in the calculation of the FV of investments. There are many possible material litigation events, with some generally applicable to most litigation investments and others more investment specific. A material litigation event is always objectively verifiable and not based on a subjective reassessment of an investment. Typical material litigation events include: i. Judgments, arbitral decisions, new relevant case law, mediations, partial settlements or recoveries, new external legal opinions (eg. as a result of changes to fact base or legal discovery), new expert opinions (eg. on damages) ii. Changes to expected duration (eg. following case management hearings, court timetables or observed delays), book-building results, budget changes, asset freezes, new recoverability intelligence, etc.
MENA
Middle East & North Africa.
Merits investment
Refers to investments where the underlying dispute involves ongoing questions about facts, damages or legal outcome and there is a risk around a judicial decision.
MOIC
Multiple on invested capital.
NCI
Non-controlling interest. This represents the interests of external Fund investors in funds that are consolidated within the Group, in accordance with each of the respective Funds’ return waterfall.
OBE Group
Omni Bridgeway Holdings BV and subsidiaries; it includes Fund 6.
OBL
Omni Bridgeway Limited (ABN 45 067 298 088).
OBL-only
A non-IFRS term reflecting the amounts attributable to equity shareholders excluding the external Fund investors’ interest.
OCA
OBL On-line Client Administration Proprietary Database.
Other costs
Includes unrecoverable due diligence costs and for Funds 2&3 and Fund 5 it additionally includes the cost of the After–the–Event insurance policy premium.
Performance fees
Refer to Carried Interest.
Annual Report 2026
99
Glossary continued PPA
Purchase price adjustment is the adjustment in value ascribed to the investments purchased with OBE compared to their carrying cost at the time of the business combination in 2019. Adjustment occurs at the OBL and consolidation level, not within OBE Group and does not affect portfolio or Fund performance, waterfall or fees.
Principle protection cover
Insurance cover to protect against risk of losing the Capital deployed to an investment.
Qualified Purchaser
Has the meaning given in Section 2(a)(51) of the US Investment Company Act of 1940 and the rules and regulations of the US Securities and Exchange Commission.
Resolution Sum
Means the total amount of any money, services, benefits and/or any in-kind assets that becomes due or is collected in accord with the underlying litigation or enforcement. It is before allowing for any amounts due to the funder, lawyers or other advisors or participants. The funder earns a share of this Resolution sum in accord with the funding arrangements.
Rest of world (RoW)/non–USA
Includes all regions, excluding the United States of America, in which OBL has or may have investments, LatAm.
Return on invested capital (ROIC)
Is the ratio of profit made above the investment cost calculated on Completed Investments across their entire life (not on an annualised basis). Unless expressly stated to the contrary, it excludes consideration of capitalised overheads, operating overheads, and withdrawals from investments. It is calculated as gross investment income less all total expenditure (excluding any adverse costs), divided by total investment expenditure (excluding any adverse costs).
SIAC
Singapore International Arbitration Centre
Sidecar
Sidecar Investments reflect third party capital, outside of fund capital, in investments managed by OBL, or investments in which OBL has an economic interest equal to greater than 60%. OBL is generally entitled to separately agreed management fees, transaction fees and/or Carried Interest on such sidecar investments.
Second Generation Fund
OBL’s Fund 4 Series I and Fund 5 Series II - established by the Group in 2019 with generally consistent terms.
Secondary market sale
A sale (in whole or part of) an existing litigation investment to another litigation investor at a point during the life of the investment before completion.
SPV
Special purpose vehicle
STIP
Short-Term Incentive Plan. Note that this is now replaced by Carried Interest and no new STIP is issued from FY25 onwards.
Success rate
Refers to % of investments where the underlying litigation has completed in a manner that causes the funder to have received more than it deployed.
Success – legal
Refers to investments where the underlying litigation has completed to the benefit of the funded party.
Success – financial
Refers to investments where the underlying litigation has completed in a manner that causes the funder to have received more than it deployed.
TFR
Total Fixed Remuneration
Third Generation Fund/Purchased fund
OBL’s Fund 6 and Fund 7; which were established by OBE Group and acquired as part of the 2019 acquisition of that group by IMF.
TSR
Total shareholder return.
US Person
Any natural person resident in the United States is a US person according to Rule 902(k)(1)(i) of Regulation S. In C&DI 276.01, the SEC staff clarified that a person that has permanent resident status in the US (a so-called Green Card holder) is presumed to be a US resident for purposes of Regulation S.
Withdrawal
Refers to investments where the funder has ceased funding before the underlying litigation has completed.
$ weighted average
Is the average of results allowing for the respective relative AUD values of the sample inputs.
Total addressable market information sources
- US: MarketLine Industry Guide, Reference MLIG250001-01 “Legal Services Global Industry Guide 2020-2029”, Marketline, January 2025, p 104.
- UK: MarketLine Industry Guide, Reference MLIG250001-01 “Legal Services Global Industry Guide 2020-2029”, Marketline, January 2025, p 86.
- NZ: “Legal Services in New Zealand”, IBISWorld, July 2025, p 3, 4.
- Europe: MarketLine Industry Guide, Reference MLIG250001-01, “Legal Services Global Industry Guide 2020-2029”, Marketline, January 2025, p 51.
- Asia: MarketLine Industry Guide, Reference MLIG230001-01, “Legal Services Global Industry Guide 2018-2027”, Marketline, January 2025, p 38
- Australia: MarketLine Industry Guide, Reference MLIG250001-01, “Legal Services Global Industry Guide 2020-2029”, Marketline, January 2025, p 38.
- Canada: MarketLine Industry Guide, Reference MLIG250001-01, “Legal Services Global Industry Guide 2020-2029”, Marketline, January 2025, p 107.
100
Omni Bridgeway
Non-IFRS financial information and disclosure Non-IFRS financial information included in OBL’s Annual (and Half-year) Report, associated result presentations, quarterly investment portfolio announcement and other materials has been prepared in accordance with ASIC Regulatory Guidance 230 – Disclosing Non-IFRS financial information, issued December 2011. Such information has not been audited or reviewed by external auditors. Non-IFRS financial information is financial information that is presented other than in accordance with all relevant accounting standards. The Group believes that given the unique nature of its business the inclusion of non-IFRS information is useful for investors and other users. In our disclosures it includes, FV, IEV, LTCR, commitment, deployed, completion, PCP, preferred return, income yet to be recognised, investment income and other terms bespoke to OBL. In certain instances, it is simply redisplaying IFRS information differently (e.g. ”cash table” or “completion table” is readily reconcilable to the IFRS disclosures.) Whilst our statutory financial reports provide historical financial information that are prepared in accordance with accounting standards and other financial reporting requirements of the Corporations Act and have the objective of ensuring consistent and comparable reporting of historical financial performance, position and cash flows over and between entities; our Non-IFRS material contains information aimed to assist in informed assessment of the Group’s operations, financial position, business strategies and prospects. It is provided to more fully explain the performance and financial position of the Group so as to provide an understanding of the underlying business and the drivers of profit. The Group’s non-IFRS financial information is calculated consistently from period to period; is unbiased and does not remove ‘bad news’. Definitions and assumptions around calculations, are provided as appropriate. Where such information is a re-presentation, reclassification or a subset of IFRS material, the identifiable IFRS components are provided in order to prove a link to the statutory financial reports. The primary rationale for the majority of our non-IFRS information is to provide an indicative view of the size, value and diversification of the Group’s litigation investments (however accounted for); our past economic performance regarding litigation investments and the interplay between OBL and NCI attribution. We feel that this is necessary due to the complex (and not readily understood or comparable) nature of our accounting and structural treatment. This is amplified by the overriding requirement of most of our litigation investments being required to be carried at cost (less any impairment). Additionally, in certain disclosures we include 100% of Fund 5; this approach aggregates the external investors’ interests with those of OBL to facilitate direct comparison between all Funds (as the other Funds are consolidated & hence disclosed at 100%).
Annual Report 2026
101
Americas
Asia Pacific
Europe, Middle East & Africa
Houston
Washington, D.C.
Melbourne
Amsterdam
+1 713 965 7919
+1 771 213 5181
+61 3 9913 3301
+31 20 809 7788
LyondellBasell Tower 1221 McKinney Street Suite 2860 Houston TX 77010 United States
2101 L Street, N.W. Suite 925 Washington, D.C. 20037 United States
Level 2 377 Lonsdale Street Melbourne VIC 3000 Australia
Schiphol Boulevard 121 1118 BG Schiphol Amsterdam The Netherlands
Los Angeles
Montreal
Perth
Cologne
+1 514 257 6971
+61 8 9225 2300
+49 221 801155-0
For assistance with funding, please contact [email protected]
240 rue Saint-Jacques Suite 906 Montréal QC H2Y 1L9 Canada
Level 10 66 St Georges Terrace Perth WA 6000 Australia
Juelicher Straße 5 50674 Cologne Germany
Miami
Toronto
Sydney
+1 786 891 2228
+1 416 583 5720
+61 2 8223 3567
+41 22 818 6300
+1 213 550 2687
For assistance with 250 The Esplanade funding, please contact Suite 127 [email protected] Toronto ON M5A 1J2 Canada
New York
+1 212 488 5331 437 Madison Avenue 36th Floor New York NY 10022 United States
San Francisco +1 415 231 0363 50 California Street Suite 2930 San Francisco CA 94111 United States
Level 7 35 Clarence Street Sydney NSW 2000 Australia
São Paulo
Hong Kong
For assistance with funding, please contact our Latin America team [email protected]
+65 6964 7646 11/F Tower 2 Admiralty Centre 18 Harcourt Rd Admiralty Hong Kong
Singapore +65 6964 7646 Level 13-03 6 Battery Road Singapore 049909
Auckland +64 21 990 620 Level 12 2 Commerce Street Auckland 1010 New Zealand
Geneva Place du Bourg de Four 4, 1204 Genève Switzerland
London Link House 78 Cowcross Street London EC1M 6EJ United Kingdom
Milan +39 339 448 3907 Via Fatebenefratelli, 5 20121 Milano MI Italy
Paris +33 6 5159 4359 128 rue La Boétie 75008 Paris France
Dubai +971 4 514 4608 Gate Village 10 Level 07 Business Centre, Office 32 Dubai United Arab Emirates
Tel Aviv For assistance with funding, please contact our team [email protected]
omnibridgeway.com
FY26 results 27 August 2026
Presenting today
Raymond van Hulst
David Breeney
Managing Director & CEO
Global Chief Financial Officer
FY26 RESULTS | 27 August 2026
2
Contents 01
Highlights
02
Portfolio performance
03
Financial results
04
Strategic update
05
Annexures
Please refer to the notes and footnotes contained in Annexures, which are an integral part of this presentation.
FY26 RESULTS | 27 August 2026
3
01
Highlights
FY26 RESULTS | 27 August 2026
4
Key messages FY26 Summary
Fee income increased
Opex controlled
(A$m)
(A$m)
• Cash investment proceeds of A$350.5m Up 49% on FY25.
2
35.4
97.6
ction
89.7
84.1 67.1
16.6
FY23
FY24
FY25
FY26
FY23
FY24
(A$m)
R
AG %C
37
5.9
4.5
350.5
235.5
FY26
FY24
FY25
• Managing extensive growth opportunities within parameters of capital-light strategy and cost coverage targets.
FY26
FY26 RESULTS | 27 August 2026
Annexures
FY25
• Global industry consolidation reflected in growing opportunity set, increased pipeline, and appropriate risk-adjusted pricing.
• Celebrating 40-year company anniversary and 25-year ASX listing as leading global alternative asset manager dedicated to legal assets.
186.4
FY24
• Further capital raising for multiple sidecar arrangements.
Strategic update
5.2
FY26
Completions momentum
(A$bn) AGR 14% C
FY25
• Together with controlled opex, on track for FY28 cost coverage target.
Financial results
AUM growth 2
• A$72.5m in additional sidecar capital raised. • FY26 OBL-only investment proceeds below anticipated range at 30/6, materially bridged 6 weeks after.
• Continued increase of fee income, driven by AUM growth and improving fee terms.
st redu
25.4
• Cost coverage of 53% Up from 36%, FY26 target exceeded. • US$1bn capital raising target reached for Funds 4/5 series II – US$543.5m added in FY26. 1
• Mature portfolio driving momentum in cash completions.
Portfolio performance
• Fee income of A$35.4m Achieved target, up 17% on FY25.
31% co
AGR 9% C
30.3
• New commitments of A$712.2m Up 38% on FY25. • Cash opex at A$67.1m Down 16% below A$80m budget.
FY27 Outlook Highlights
• Disciplined strategy execution Key targets achieved or exceeded.
FY26 Highlights
5
Highlights – Investment performance (for the 12 months ended 30 June 2026) Realisations
Assets under management (AUM) 2
Total proceeds
Up 12% from 30 June 2025
A$54.1m of OBL-only proceeds
Portfolio fair value 3, 4
Fair value conversion 5
A$725m of OBL-only fair value
Across all 80 full and partial investment completions during the period
New fair value added
5-Year trailing IRR 6 ,7
FY26 MOIC 8
from A$712.2m in new commitments
Across all full and partial investment completions
Across all 80 full and partial investment completions
A$5.9bn
105%
FY26 RESULTS | 27 August 2026
Annexures
2.3x
Strategic update
40%
Financial results
A$564.4m
A$350.5m
Portfolio performance
A$3.8bn
Highlights
Investments
6
Highlights – Business performance (for the 12 months ended 30 June 2026) OBL-only (Non-IFRS)
Equity metrics
Total income
Total income
Total book value per share (IFRS) 10
A$182.2m
A$116.5m
A$2.96
per share
Up 17% on FY25
Attributable to OBL shareholders
Cash opex
Earnings per share (IFRS) 12
A$35.4m A$67.1m
8.0%
A$0.19
per share
Down 20% on FY25
FY26 RESULTS | 27 August 2026
Annexures
A$45.9m
Return on equity 11
Strategic update
NPAT
Fee income
Financial results
A$48.2m
Portfolio performance
Down 1% on FY25
NPBT
Highlights
Statutory accounts (IFRS) 9
7
02
Portfolio performance
FY26 RESULTS | 27 August 2026
8
Continued strong investment performance metrics
• This compares to 2.4x MOIC 13 full life-to-date across all vintages, over multiple decades and economic cycles, and within the normal range of variation. • The 80 full and partial investment completions had a fair value conversion ratio of 105%.5
Highlights
• Generated a strong uncorrelated return of 2.3x MOIC from a diversified set of 80 full and partial completions, with record cash proceeds, up 49% on FY25.
Portfolio performance
Investment completion metrics for the 12 months ended 30 June 2026 MOIC
Fair value conversion 5
Proceeds (A$m)
OBL-only proceeds (A$m)
Completed
39
2.2x
102%
190.8
45.8
Partially completed
41
2.5x
109%
159.7
1.7
Subtotal
80
2.3x
105%
350.5
47.5
6.6
Total
54.1
FY26 RESULTS | 27 August 2026
Annexures
Cash carried interest
Strategic update
Financial results
FY26
9
Portfolio construction and diversification 14
• Low concentration of fair value and commitments on the 10 largest investments, further mitigates risk of negative binary outcomes. • Market leading diversification reflects the multi-strategy legal assets approach, global origination platform, and disciplined portfolio construction.
Fair value by investment type
23%
4%
77% 13%
Commitment by investment concentration
21%
EMEA
14%
Arbitration
Class Actions
Enforcement
Group Claims
Intellectual Property
Law Firm
Single Party
Other
85% 10 largest investments
FY26 RESULTS | 27 August 2026
Balance
Annexures
APAC
15% 9%
35%
Strategic update
5%
Americas
Financial results
35%
19%
15%
30%
Fair value by investment concentration
Portfolio performance
Fair value by region
Highlights
• The portfolio is uniquely diversified, both geographically and by area of law, across over 300 active investments.
10
Portfolio fx diversification 14
• Our portfolio is diversified by geography, resulting in exposure to different currencies.
FY26 FX movement against AUD (% change during the year)
• Fair value by currency reflects the currency of entitlement of all investments in the portfolio, which typically is the claim currency.
100
17% (4.6)%
95
(7.4)% (8.1)%
18%
2Q26
1Q26 EUR
GBP
Other
AUD
USD
EUR
4Q26
• However, there is a non-cash impact when USD denominated funds are translated to AUD for financial reporting (as noted on pages 13 and 14).
GBP
FY26 RESULTS | 27 August 2026
Annexures
USD
3Q26
85
• Majority USD entitlement provides a natural hedge with fund returns as the majority of fund capital is USD denominated.
Strategic update
90
• The entitlement currency is typically similar to funding currency, providing a natural hedge.
Financial results
51%
Portfolio performance
9%
5%
Highlights
Fair value by currency
11
Continued strong portfolio growth
A$2.4bn
A$3.8bn
18%
R AG
A$2.4bn
CAGR
A$3.6bn
A$3.8bn
Portfolio performance
C 17%
Total portfolio fair value
Highlights
Total commitments and deployments on active investments 15
A$2.0bn
A$2.8bn
A$1.8bn
Financial results
A$2.5bn
A$1.5bn A$1.3bn A$1.2bn A$1.1bn
Strategic update
A$0.9bn A$0.6bn
A$1,042m
A$928m
Jun-23
Jun-24
Deployments
Jun-25 Commitment
Jun-26
Dec-23
16
Fund 9 A$669m
A$725m
Jun-24
Jun-25
Jun-26
OBL-only
Third-party capital
FY26 RESULTS | 27 August 2026
Annexures
Jun-22
A$0.7bn
12
Total portfolio fair value movement
• Fair value movement of the portfolio is mainly driven by:
(A$179m)
- Discount unwind;
- Material Litigation Events (MLEs);
A$3,559m
New commitments
Investment deployments
Fair value movement of portfolio17
Investment completions
• MLEs reflect the net effect of positive and negative MLEs on 217 investments over the period, which is indicative of a diversified portfolio. The total effect of MLEs in FY26 was negative A$333m. • FX had a non-cash impact of negative A$317m on the fair value movement in the period.
Annexures
Jun-25
- FX effects.
Strategic update
A$3,836m
Financial results
(A$351m)
Portfolio performance
A$564m
Highlights
• Overall A$277m increase in portfolio fair value.
A$242m
Jun-26
FY26 RESULTS | 27 August 2026
13
OBL-only portfolio fair value movement
A$149m
(A$68m) (A$54m)
A$725m
• The total OBL-only effect of MLEs in FY26 was negative A$38m.
New commitments
Investment deployments
Fair value movement of portfolio17
Investment completions
Annexures
Jun-25
Strategic update
• FX effects in FY26 had a negative A$64m impact on the OBL-only fair value movement in the period.
Financial results
A$669m
• The OBL-only attribution of deployments equally varies with the fund terms involved, with Funds 8 and 9 generally having a lower OBL-only attribution of deployments.
Portfolio performance
• The OBL-only attribution of new commitments depends on the general and carry terms for the relevant funds and sidecar arrangements.
Highlights
• Overall, the OBL-only value of the portfolio has increased by A$56m.
A$28m
Jun-26
FY26 RESULTS | 27 August 2026
14
03
Financial results
FY26 RESULTS | 27 August 2026
15
Consolidated P&L IFRS walk
235.5
Fee income
35.4
30.3
Interest and other revenue
2.4
33.2
–
294.7
Total gross revenue
388.3
593.7
Third party interest
(244.9)
(106.8)
Total revenue
143.4
486.9
Investments derecognised 18
(15.0)
(119.2)
Fair value movement investment portfolio
61.9
293.6
Fee income (non-IFRS cash income)
(8.1)
(9.9)
Total income
182.2
651.4
Investment costs and amortisation 18
(47.8)
(58.5)
Platform expenses
(72.6)
(85.9)
Other
(13.6)
(11.5)
NPBT
48.2
495.5
Tax
(2.3)
(78.7)
NPAT
45.9
416.8
Fund 9 transaction
• Due to these accounting changes in FY25, not all FY25 financials can be compared like-for-like with FY26 financials. FY26 delivered record investment proceeds of $350.5m, up 49% on FY25. • Fee income increased 17% to A$35.4m, meeting the full-year target. • Platform expenses down $13.3m to $72.6m reflecting continued cost discipline.
Annexures
350.5
Strategic update
Investment proceeds
• FY25 includes the Fund 9 transaction, comprising deconsolidation/ derecognition of Funds 2, 3 and 4 and recognition of OBL residual interests as financial assets at fair value.
Financial results
FY25
Portfolio performance
FY26
Highlights
A$m
FY26 RESULTS | 27 August 2026
16
OBL-only fair value P&L Non-IFRS management accounts
54.1
42.7
Fee income
35.4
30.3
Realised income (A)
89.5
73.0
Platform expenses (cash opex)
(67.1)
(84.1)
Realised EBIT
22.4
(11.1)
Gross fair value increase investment portfolio
109.4
141.5
Netting out investment completions
(54.1)
(42.7)
Netting out investment deployments
(28.3)
(43.8)
Unrealised income (B)
27.0
55.0
Total income (A + B)
116.5
128.0
Total EBIT
49.4
43.9
• Investment proceeds include proceeds from full and partial investment completions and carried interest. • Realised income was materially positive in the period, based on successful investment completions with strong metrics, and increased fee income. • Gross fair value movement consists of new commitments, investment deployments, and the fair value movement (see pg 14). • Investment deployments are netted out, as they reflect the cost of the fair value increase of investment portfolio. • Unrealised income was likewise positive reflecting strong value generation through new investments.
FY26 RESULTS | 27 August 2026
Annexures
• Total EBIT was materially positive, notwithstanding the negative A$64m impact of FX movements in the period. On a constant currency basis, total EBIT was A$114m.
Strategic update
Investment proceeds
• The OBL-only fair value P&L (non-IFRS management accounts) provides for a better understanding of the overall net value generation, realised and unrealised in the period.
Financial results
FY25
Portfolio performance
FY26
Highlights
A$m
17
OBL-only cash P&L
Non-IFRS management accounts
Investment proceeds
54.1
42.7
Proceeds from secondary market transactions
–
320.0
Net interest
–
(19.0)
Investment Income
54.1
343.7
Management and other fee income
35.4
30.3
Fee income
35.4
30.3
• Investment deployments reflect OBL's co-investment into ongoing portfolio investments, which will drive future investment proceeds.
Cash opex
(67.1)
(84.1)
• Positive net cash generation during the period of A$22.4m.
Platform expenses
(67.1)
(84.1)
• Negative total cash movement of A$15.6m.
Net cash generation
22.4
289.9
–
(250.0)
Investment deployments
(28.3)
(43.8)
Working capital movement
1.8
22.1
Non-recurring cash items
(11.5)
(10.7)
Total cash movement
(15.6)
7.5
Strategic update
Repayment of debt
• Investment proceeds include proceeds from full and partial investment completions and carried interest.
Financial results
FY25
Portfolio performance
FY26
Highlights
• The non-IFRS OBL-only cash P&L provides a further understanding of the net cash generation for the period, excluding the impact of the fund consolidation and fair value movements.
A$m
Annexures
FY26 RESULTS | 27 August 2026
18
Continued improvement in cost coverage
• Continued strong growth in fee income; achieved A$35m target for FY26, with a 29% CAGR since FY23.
GR 29% CA A$30m
A$40m to A$45m
A$35m
A$17m
Disciplined cost management FY24
FY25
FY26
• FY26 cash opex of A$67.1m, materially below the A$80m budget for FY26, reflecting the effects of cost management measures in prior periods, and some one-offs.
FY27E
• Cash opex target for FY27 at A$72.5 – 75m, reflecting primarily inflation. No further material cost savings anticipated.
Opex and cost coverage 53%
A$72.5m to A$75m
17%
• Continued improvement of cost coverage, at 53% for FY26.
Strategic update
28%
Increasing cost coverage
36%
Financial results
FY23
• Fee income target for FY27 at A$40 – 45m, supported by AUM growth and improving fee terms.
Portfolio performance
A$25m
Increasing fee income
Highlights
Fee income
• On track to achieve the target of 70% cost coverage by FY28. 89.7
84.1
67.1
FY23
FY24
FY25
FY26
12M trailing opex
FY27E
• Operating leverage has increased significantly, with opex reduced by 20% while commitments increased by 38% and AUM increased by 12%.
12M trailing cost coverage
FY26 RESULTS | 27 August 2026
Annexures
97.6
19
OBL-only cashflow and liquidity
• In aggregate, A$125m is available for OBL-only investment deployments, opex and payables, with an additional A$33m due from agreed settlements, which had been largely received by mid-August.
Highlights
• OBL-only cashflow and liquidity 19 has overall developed within expectations.
• This is before cash proceeds from any investment completions, fee income, carried interest, and possible further secondary market transactions. Portfolio performance
A$35m Financial results
A$54m A$35m (A$67m) A$105m
A$125m (A$10m)
Opening cash
A$89m
Jun-26
Investment proceeds
Fee income
Cash opex
Investment deployments
Other
Closing cash
Jun-26
Receivables
Total accessible liquidity
FY26 RESULTS | 27 August 2026
Annexures
Jun-25
Strategic update
(A$28m)
20
OBL-only cashflow and liquidity profile
Probabilistic 12-month forward-looking OBL-only cashflow and liquidity
Highlights
• The candlestick chart for investment activities shows the expected range of 12M forward cashflows for the portfolio. It highlights the average forecast and the likely spread of OBL-only cash proceeds, based on the range of possible portfolio completion scenarios (P80/P20 or 60% confidence interval). Given the uncertainty and dynamics of legal assets duration, any probabilistic analysis of completions for a period less than 12 months would not be meaningful. • Supported by the elimination of interest, increasing management fees, decreasing opex, lower deployments following Fund 9, and the increased portfolio maturity and momentum, the portfolio is currently on track to deliver positive free cash flow for the year.
Portfolio performance
A$182m
Financial results
A$43m
(A$74m)
A$98m
(A$40m) Strategic update
A$125m A$77m
Dec-25 Total accessible liquidity 19
Jun-27 Investment proceeds
Fee income
Potential secondary
Cash opex
Investment deployments
Pro-forma closing liquidity
FY26 RESULTS | 27 August 2026
Annexures
Jun-26
21
04
Strategic update
FY26 RESULTS | 27 August 2026
22
Strategic update Capital formation
• US$1bn capital raising target reached for Funds 4/5 series II, making Omni Bridgeway the positive standout in global legal finance.1 • Commitments split circa 40/60% between Fund 4 and Fund 5 to better align with the portfolio, team and opportunity set by region (US / Rest of World).
• Sidecar funding is an increasing source of flexible capital for legal assets outside the investment criteria of our funds.
Cumulative capital commitments (A$m) 21
4,354m Financial results
3,330m
GR
30% CA
2,828m
2,072m
2,079m
2,104m
FY20
FY21
FY22
FY23
Strategic update
2,063m 1,338m 417m
589m
FY18
FY19
Third-party capital
FY24
FY25
FY26 1
Annexures
FY17
Portfolio performance
• Added multiple new institutional investors as long-term capital partners, who have indicated an intention to materially increase their commitments to Omni Bridgeway through sidecars, new funds and new verticals.
Highlights
• New third-party capital raised in FY26 of A$862m.1
OBL FY26 RESULTS | 27 August 2026
23
Strategic context OBL is well positioned to benefit from the evolution of the legal finance industry
• The only listed institutional-grade investment manager globally focused exclusively on legal assets.
• Continued and increasing demand by large institutional capital allocators for legal assets, driven by the non-correlated returns and attractive investment characteristics.
• Consistently voted by industry participants and clients as the leading and most diversified platform for originating, underwriting and managing legal assets.
Market
• Unmatched industry track record of delivering strong uncorrelated returns over multiple decades, economic cycles and industry cycles.
• Market for legal finance has been growing at double-digit growth rates globally. • Continued growth through increasing adoption and balanced regulation in relevant markets globally. • Current capital products offering for the legal industry is nascent and limited compared to overall total addressable market.
• Since inception nearly 40 years ago, the industry has gone through several phases and is currently in a period of consolidation.
• Validated fair value framework for legal assets.20 • Strong and debt-free balance sheet, well positioned for current global economic and industry dynamics.
Annexures
• Capital consolidating around scaled players with proprietary origination, with work-out capabilities, and a track record of underwriting discipline across multiple economic cycles.
• Listed on the ASX since 2001, with high governance, compliance and transparency standards.
Strategic update
Industry
• Largest and most diversified industry dataset of completed investments, including across non-transparent jurisdictions, driving further AI and underwriting advantages.
Financial results
• Unique asset class with attractive investment characteristics and the ability to generate strong asymmetric returns uncorrelated to financial markets.
Portfolio performance
Omni Bridgeway
Highlights
Legal Assets
• Reduced competition supports further growth and incremental market share at appropriate risk-adjusted returns.
FY26 RESULTS | 27 August 2026
24
Executing the plan
Execution
Sustainable growth
Phase 1 - Completed
Phase 2 - In progress
Phase 3 - Early stages
− Repaid A$250m debt in full and eliminated ~A$30m of annual interest expense. − Moved from net-debt to net-cash. − Settled last A$28m legacy balance sheet liability.
Capital-light asset management model
− Growth through further expansion of existing strategies and markets.
Continued acceleration of cash completions − Continued growth of investment completions
CORPORATE GOVERNANCE STATEMENT 27 August 2026
CONTENTS
OVERVIEW .................................................................................................................................................... 3
1.1.
Omni Bridgeway’s Values ........................................................................................................................... 3
BOARD OF DIRECTORS ............................................................................................................................... 3
2.1.
Board Roles and Responsibilities .............................................................................................................. 4
2.2.
Role of the Company Secretary ................................................................................................................. 5
2.3.
Structure of the Board ................................................................................................................................ 5
2.4.
Board Skills................................................................................................................................................... 7
2.5.
Board Diversity ............................................................................................................................................ 7
2.6.
Board Committees ...................................................................................................................................... 8 Audit and Risk Committee ............................................................................................................................... 9 Nomination and Remuneration Committee ................................................................................................... 9 Corporate Governance Committee ............................................................................................................... 10
PERFORMANCE EVALUATION AND REMUNERATION ........................................................................... 11
3.1.
Performance Evaluation ........................................................................................................................... 11
3.2.
Director, Executive and Investment Professionals Remuneration...................................................... 11
RISK MANAGEMENT .................................................................................................................................. 12
4.1.
Risk Management...................................................................................................................................... 12
4.2.
IT and Cybersecurity ................................................................................................................................. 13
4.3.
Artificial Intelligence .................................................................................................................................. 13
4.4.
Certification and Board Approval ............................................................................................................ 14
BUSINESS ETHICS AND INTEGRITY .......................................................................................................... 14
5.1.
Code of Conduct ........................................................................................................................................ 14
5.2.
Anti-bribery and Corruption .................................................................................................................... 15
5.3.
Whistleblowing .......................................................................................................................................... 15
5.4.
Continuous Disclosure ............................................................................................................................. 15
5.5.
Shareholder Communication .................................................................................................................. 15
5.6.
Dealing in Shares....................................................................................................................................... 16
2
CORPORATE GOVERNANCE STATEMENT 1.
OVERVIEW
Omni Bridgeway Limited (Omni Bridgeway or the Company) is pleased to publish its 2026 Corporate Governance Statement (Statement). As a listed company, Omni Bridgeway must comply with Australian laws including the Corporations Act 2001 (Cth) (Corporations Act) and the Australian Securities Exchange Listing Rules (ASX Listing Rules). In accordance with ASX Listing Rule 4.10.3, ASX-listed entities are required to benchmark their corporate governance practices against the ASX Corporate Governance Principles and Recommendations (4th Edition) (Recommendations). This Statement outlines the key principles and practices the Board has adopted for its corporate governance during the financial year ending 30 June 2026 (FY26). These principles and practices are reviewed regularly and revised as appropriate to reflect changes in legislation and developments in corporate governance.
-
Press Release
Share
Omni Bridgeway Releases 4Q26 Portfolio Update with Record FY26 Commitments and Investment Proceeds
SYDNEY, 31 July 2026 / -- Omni Bridgeway Limited (ASX: OBL), a leading global alternative asset manager specialising in legal assets, has released its Investment Portfolio Report as at 30 June 2026. FY26 delivered record new commitments and record cash investment proceeds, alongside strong completion metrics, disciplined cost management and continued growth in fee income, reflecting the scale and diversification of the Group's global legal assets platform.**
Key Highlights**
- Record new commitments: FY26 new conditional and unconditional commitments reached A$712.2 million across 43 new investments, a record for the Group and approximately 38% above FY25. A$343.0 million was committed in the June quarter alone, as the exceptional pipeline reported at 3Q26 converted into contracted investments.
- Record investment proceeds, with strong completion metrics: Total cash investment proceeds of A$350.5 million in FY26, a 49% increase over FY25 excluding secondary sales, and a record high for the Group. 80 full and partial completions delivered an overall MOIC of 2.3x and a combined fair value conversion ratio of 105. A further A$45.3 million in proceeds has been received since 30 June at an estimated 5.7x MOIC.
- Pipeline remains elevated: Following the record June quarter, the pipeline comprises 43 agreed exclusive term sheets representing an estimated A$407.8 million in new commitments if contracted, significantly above the historical quarterly average and supporting continued origination momentum into 1Q27 and beyond.
- Operating leverage: FY26 cash operating expenses of A$67.1 million were materially below the A$80 million budget, while management fees of A$35.4 million exceeded the upgraded FY26 target of A$35 million.
- Fund Capital Formation: The full and final close of the US$1 billion Funds 4/5 Series II raise is anticipated in August, following the additional US$228 million closed in 1H26. A$72.5 million in fee-paying sidecar capital was raised during FY26, with approximately A$175 million of further sidecar capital currently in diligence, reflecting the expansion of structured finance solutions and alternative investment structures.
Managing Director and Chief Executive Officer Raymond van Hulst commented:
"FY26 was a year of disciplined execution. We set records in both new commitments and investment proceeds while holding costs materially below budget and exceeding our fee income target, evidence that the platform is scaling as intended.
With A$45.3 million in proceeds already received in FY27 at an estimated 5.7x, we enter the new financial year well positioned.”
FY26 Results Webcast
Omni Bridgeway will release its results for the 12 months to 30 June 2026 and host a market briefing at 10:30am AEST on Thursday 27 August 2026. Registration: https://webcast.openbriefing.com/obl-fyr-2026/
**
Investor and Media Contacts**
Media
Naomi Barber
, Director, Business Development & Marketing
+61 421 371 844, [email protected]
**
Investor Relations**
Nathan Kandapper
, Global Head of Investor Relations
+61 403 941 502, [email protected]
**
ABOUT OMNI BRIDGEWAY**
Omni Bridgeway is a global alternative asset manager specialising in legal assets, with over A$5.5bn assets under management across 11 funds. Listed on the ASX since 2001, and with a 40-year [track record, Omni Bridgeway has pioneered the industry and has a unique track record of consistent outperformance across multiple economic cycles. With a team of c.160 professionals operating in over 20 locations and 15 countries, Omni Bridgeway is the largest and most diversified platform for originating and managing legal assets across all relevant jurisdictions and areas of law.
Back
All Press Releases
------------------
\
- Company Insights
\ - Blog
\ - Case Studies
\ - Press Releases
\ - Video Library
\ - Regulation and Case Law
\ - © OmniBridgeway
, 2026\ - All Rights Reserved
\ - Follow Us\
\- Terms of Use
\ - Privacy Policy
\ - Cookie Opt-out
\
Privacy Preference Center\
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. More information
Allow All
\
Manage Consent Preferences\
\
Performance Cookies\
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
\
Functional Cookies\
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
\
Targeting Cookies\
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
\
Strictly Necessary Cookies\
Always Active
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Confirm My Choices
Back Button
Back
\
Performance Cookies\
Vendor Search Search Icon Filter Icon
Clear Filters
Information storage and access
Apply
Consent Leg.Interest
All Consent Allowed
Select All Vendors
Select All Vendors
All Consent Allowed
\
-
\33Across\
\host description\
\View Cookies\
REPLACE-WITH-DYANMIC-HOST-ID
\- Name
cookie name
\
- Name
-
\33Across\
View Privacy Notice
3 Purposes
REPLACE-WITH-DYANMIC-VENDOR-ID
Arrow
Consent Purposes
Location Based Ads
Consent Allowed
Legitimate Interest Purposes
Personalize
Require Opt-Out
Special Purposes
Location Based Ads
Features
Location Based Ads
Special Features
Location Based Ads
Confirm My Choices
Omni Bridgeway Limited (Omni Bridgeway) (ASX:OBL) lodges the attached revised Security Trading Policy with the ASX in accordance with ASX Listing Rule 12.10. A copy of the Security Trading Policy is available in the corporate governance section of the Company’s website at www.omnibridgeway.com.
This announcement is authorised for release to the market by the Board.
INVESTOR ENQUIRIES: Nathan Kandapper Global Head of Investor Relations and Head of Corporate Development [email protected]
Omni Bridgeway Limited | ABN 45 067 298 088 | GPO Box 5457 | Sydney NSW 2000 | Freecall 1800 016 464
Corporate Governance Manual SECURITIES TRADING POLICY
Application of Policy:
Global This Policy applies to all Employees and every member of the Group. Certain employees of the Group are also subject to the securities trading rules established by Omni Bridgeway Management (USA) LLC, a subsidiary of the Company which is a registered investment adviser with the Securities and Exchange Commission.
Definitions: Capitalised terms used throughout this Policy are defined in paragraph 9.
Purpose This Policy provides restrictions in dealing with the Company’s Securities and other restricted dealings so that Restricted Persons do not trade in securities in a way that breaches insider trading laws and provides confidence to the market that trading practices are ethical and honest. The Company will also consider restricting trading where transactions may reflect badly on the person or the Company. Whilst the Group encourages its Directors and Employees to hold Securities in the Company, all such Directors and Employees have a personal responsibility to ensure that they comply with the law and with this Policy. Employees also need to carefully consider when working on specific projects that they may have access to Inside Information in securities other than those issued by the Company and that they therefore cannot trade in such securities. All holders of Securities have an obligation NOT to Deal in those Securities if in possession of Inside Information. If in doubt, please contact the Company Secretary or Compliance for non-OBL securities immediately.
Dealings prohibited at all times
2.1.
Insider Trading Notwithstanding any other provision of this Policy, if any person possesses Inside Information, that person must not Deal, or get others to do so, or pass on the Inside Information to others. This prohibition applies regardless of how the person becomes aware of the Inside Information.
OMNI#1,269,341
Omni Bridgeway Limited – Securities Trading Policy
2.2.
Margin Lending and other secured financing arrangements Restricted Persons must not, without the prior written consent of a Designated Officer:
2.3.
(a)
enter into any margin loan arrangements in relation to a Dealing in the Company’s Securities;
(b)
use the Company’s Securities as collateral in any financial transactions, or grant or permit to exist any encumbrance over the Company’s Securities, including in connection with margin loan arrangements; or
(c)
engage in any lending arrangements in respect of the Company’s Securities.
Other Prohibited Dealings In addition to the prohibition on insider trading in paragraph 2.1, a Restricted Person must not: (a)
Deal in the Company’s Securities: (i)
where the Dealing is of a Short-Term Nature;
(ii)
where the Dealing by its timing, size or regularity will have the effect or likely effect of bringing the Company into disrepute amongst shareholders or potential investors; or
(iii)
where it is unlawful to do so; or
(b)
deal in the securities of any other entity where such Restricted Person, or the Company, is in possession of information that is not generally available to the market but which, if generally available, might materially impact the price or value of the applicable entity’s securities. Where the Company is in receipt of such information, the applicable issuers will be listed on the Company’s Restricted List.
(c)
directly or indirectly, enter into, trade in, acquire, dispose of, vary or otherwise deal in any Litigation Event Contract. This prohibition applies regardless of whether the relevant litigation, arbitration, regulatory proceeding or dispute resolution process involves the Company, any member of the Group, any fund, investment, client, counterparty or other matter in which the Group has, or may have, an interest. For the avoidance of doubt, this prohibition applies to any Dealing by an Associate of a Restricted Person, and a Restricted Person must not procure, encourage, advise or arrange for another person to enter into, trade in or otherwise deal in a Litigation Event Contract.
Dealing by Restricted Persons
3.1.
Dealings by a Manager A Manager may only Deal in the Company’s Securities during the following “Open Periods”: (a)
the four (4) week period commencing on the first Trading Day after the date of the Company’s annual general meeting;
omnibridgeway.com
|2
Omni Bridgeway Limited – Securities Trading Policy
(b)
the six (6) week period commencing on the first Trading Day after the release of the Company’s half-yearly results;
(c)
the six (6) week period commencing on the first Trading Day after the release of the Company’s preliminary final results and final results to ASX;
(d)
the four (4) week period commencing on the first Trading Day after the release of the Company’s quarterly Investment Portfolio Report to the ASX as at 31 March;
(e)
the four (4) week period commencing on the first Trading Day after the release of a disclosure document offering securities in the Company; or
(f)
such period commencing and ending on dates which may be determined by the Board (or its delegate(s)1) from time to time,
provided that the Manager is not in possession of any Inside Information relating to the Company’s Securities and complies with the requirements detailed in this paragraph 3. 3.2.
Dealings by Restricted Persons (other than a Manager) A Restricted Person (other than a Manager) may Deal in the Company's Securities at any time except for during the following "Closed Periods": (a)
the period commencing on and from 1 January of the relevant calendar year and ending two weeks after the release of the Company's half-yearly results to the ASX;
(b)
the period commencing on and from 30 June of the relevant calendar year and ending two weeks after the release of the Company's annual financial results to the ASX; and
(c)
such period commencing and ending on dates which may be determined by the Board (or its delegate(s)2) from time to time,
Trading is permissible provided that the Restricted Person (other than a Manager) is not in possession of any Inside Information relating to the Company's Securities and complies with the requirements detailed in this paragraph 3. 3.3.
Restrictions on Dealing by Restricted Persons (a)
Before a Restricted Person may Deal with the Company's Securities in accordance with paragraph 3.1 or 3.2 (as applicable), a Restricted Person must comply with the applicable requirements in paragraph 3.4.
(b)
Dealing in Securities notified in accordance with the procedure in paragraph 3.4, will not be permitted if any of the following factors exist: (i)
the Company is currently not in compliance with its continuous disclosure
1 The Board has delegated authority to the Chair of the Board and the Chair of the Audit & Risk Committee to make a
determination under paragraph 3.1(f). 2 The Board has delegated authority to the Chair of the Board and the Chair of the Audit & Risk Committee to make a determination under paragraph 3.2(c).
omnibridgeway.com
|3
Omni Bridgeway Limited – Securities Trading Policy
obligations under Listing Rule 3.1;
3.4.
the Restricted Person possesses any Inside Information in relation to the Company’s Securities; and
(iii)
in respect of a Manager, the Company is withholding any material information from disclosure by reason of the exceptions to Listing Rule 3.1A (namely under Listing Rules 3.1A.1, 3.1A.2 and 3.1A.3).
Pre-Dealing Requirements (a)
3.5.
(ii)
Before Dealing, or giving instructions for Dealing or causing anyone else to Deal, in the Company’s Securities, the Restricted Person must: (i)
request approval from the relevant Designated Officer(s) in writing (including email or via the Company’s online portal) to Deal (or to cause someone else to Deal) in the Company’s Securities. Such request to include confirmation that the Restricted Person does not hold any Inside Information;
(ii)
have received an approval from the relevant Designated Officer in writing (including email or notification via the Company’s online portal) which may attach conditions to any clearance as determined by the Designated Officer; and
(iii)
have complied with any conditions on Dealing imposed by a Designated Officer relevant to that Restricted Person.
(b)
The Board, Chair, Managing Director or Company Secretary may seek appropriate legal advice to ensure the proper provision, or otherwise, of a clearance under this paragraph, and the cost of such advice shall be borne by the Company.
(c)
Approvals once granted are valid for ten (10) Trading Days, unless otherwise notified by the applicable Designated Officer and do not constitute an endorsement or recommendation by the Company of the proposed Dealing. Restricted Persons remain responsible for their own investment decisions and compliance with the insider trading provisions of the Corporations Act and this Policy.
Notification of Dealing (a)
A Restricted Person must notify the Company Secretary or delegate where that Restricted Person Deals in the Company’s Securities within one (1) Business Day of such Dealing having taken place.
(b)
The above notification must be in writing and include: (i)
the name of the Restricted Person;
(ii)
whether the interest in the Company’s Securities held by the Restricted Person was direct or indirect (and if it was indirect, the circumstances giving rise to the interest);
omnibridgeway.com
|4
Omni Bridgeway Limited – Securities Trading Policy
(iii)
the date of the Dealing, and the number of Securities involved;
(iv)
the consideration given or received for the Securities; and
(v)
the number of Securities held by the Restricted Person, directly and indirectly, before and after the trading in Securities.
Permitted Exceptions
4.1.
Exceptions A Restricted Person who is not in possession of Inside Information in relation to the Company may be given prior written clearance by a Designated Officer (“Prior Written Clearance”) to sell or otherwise dispose of Company Securities during a Restricted Period where:
4.2.
(a)
the Restricted Person is in severe financial hardship, as described in paragraph 4.3; or
(b)
there are other exceptional circumstances, as described in paragraph 4.4.
Prior Written Clearance (a)
To apply for Prior Written Clearance under paragraph 4.1, a Restricted Person (“Applicant”) must apply to the relevant Designated Officer(s) by sending an application in writing (“Application”) at least 5 Business Days prior to the date of the proposed Dealing, providing the following information: (i)
the name of the Applicant;
(ii)
whether the interest in the Company’s Securities held by the Applicant is direct or indirect (and if it is indirect, the circumstances giving rise to the interest);
(iii)
a description of the proposed Permitted Dealing;
(iv)
the proposed date of the Permitted Dealing;
(v)
a declaration that the Applicant does not hold any Inside Information; and
(vi)
either: (A)
if paragraph 4.1(a) applies, a description of the circumstances of severe financial hardship, as described in paragraph 4.3; or
(B)
if paragraph 4.1(b) applies, a description of the other exceptional circumstances which apply, as described in paragraph 4.4,
and, in either case, why the proposed Dealing is the only reasonable course of action available to the Applicant. (b)
A Designated Officer will consider the Application and respond by giving notice in writing to the Applicant, confirming whether or not the clearance sought has been
omnibridgeway.com
|5
Omni Bridgeway Limited – Securities Trading Policy
granted or rejected, together with details of any applicable conditions applied to a clearance, within two (2) Business Days of receipt of the Application. (c)
4.3.
4.4.
The grant of Prior Written Clearance in accordance with this paragraph 4.2 is not an endorsement or recommendation by the Company of the proposed Dealing. Restricted Persons remain responsible for their own investment decisions and compliance with the insider trading provisions of the Corporations Act and this Policy.
Severe Financial Hardship (a)
For the purposes of paragraphs 4.1(a) and 4.2(a)(vi)(A), the Designated Officer may consider a Restricted Person to be in severe financial hardship if he or she has a pressing financial commitment that cannot be satisfied otherwise than by selling or disposing of the relevant Company Securities.
(b)
A tax liability of a Restricted Person will not normally constitute severe financial hardship unless the Restricted Person has no other means of satisfying the liability.
Other Exceptional Circumstances (a)
For the purposes of paragraphs 4.1(b) and 4.2(a)(vi)(B), a Designated Officer may consider the proposed Dealing of the Company’s Securities by a Restricted Person in accordance with: (i)
a court order;
(ii)
a court enforceable undertaking; or
(iii)
some other overriding legal or regulatory requirement for the Restricted Person to do so,
to be exceptional circumstances, as well as any other circumstances the Designated Officer deems to be exceptional circumstances for the purposes of paragraph 4.4(b). (b)
A Designated Officer may consider other circumstances to be exceptional circumstances for the purposes of paragraphs 4.1(b) and 4.2(a)(vi)(B) if the Designated Officer is satisfied that the proposed Dealing is the only reasonable course of action available to the Restricted Person.
Breach of Policy (a)
The Policy must be strictly complied with both in spirit and intent.
(b)
From time to time, Restricted Persons may be asked to confirm that they have complied with this Policy or, if they have not, to disclose where this is not the case. Such a request must be responded to promptly.
(c)
The Company monitors compliance with this Policy and may access Restricted Persons' trading activities in Company Securities or other securities (including access through the CHESS sub-register) in order to confirm compliance with this
omnibridgeway.com
|6
Omni Bridgeway Limited – Securities Trading Policy
Policy. (d)
In the event of a breach of this Policy by a Restricted Person, a written warning will be issued by the Chair (or, where the relevant Restricted Person is the Chair, by the Managing Director) to the Restricted Person specifying the breach. A warning will be recorded against the Restricted Person unless the majority of the Board (excluding any Director being the subject of the breach) resolves that a warning should not be given. For the avoidance of doubt, a breach of this Policy by an Associate of a Restricted Person will be treated as a breach of this Policy by that Restricted Person for the purposes of this paragraph 5.
(e)
In the event of a Restricted Person receiving a second notice of breach, after a recorded warning, then, unless the majority of the Board (excluding any Director being the subject of the breach) resolves that a second breach should not be recorded, then: (i)
if the Restricted Person is a Director they will resign immediately from the Board or if such Director refuses to resign then, to the extent permitted by law, the Director’s directorship will be terminated by the Board with immediate effect; or
(ii)
if the Restricted Person is an Employee they will resign immediately from the Company or if such Employee refuses to resign then, to the extent permitted by law, the Employee’s employment will be terminated by the relevant Group entity with immediate effect,
without any claim by the relevant Director or Employee, other than for unpaid but due fees or salary (as applicable) and other accrued entitlements up to the date of termination, including any documented out of pocket expenses.
Training and Monitoring The Group will provide initial training in relation to this Policy and thereafter on a periodic basis. The Group will put in place compliance and monitoring programs to review the Group’s compliance with the requirements of this Policy. Restricted Persons may also be asked to confirm, including by periodic attestation, that they have not entered into, traded in or otherwise dealt in any Litigation Event Contract or other restricted securities.
Review and Amendment of this Policy This Policy will be reviewed periodically by the Board to check that it is operating efficiently and whether any changes are required. Any amendments to this Policy, other than updates for changes in the Company's branding or position titles, and any non-material amendments (which may be approved by the Company Secretary), must be approved by the Board.
Docusign Envelope ID: 1E18B7AD-4B8C-8155-80DF-8D4E9E5FFC87
605
Page 1 of 2 15 July 2001
Form 605 Corporations Act 2001 Section 671B
Notice of ceasing to be a substantial holder To Company Name/Scheme
Omni Bridgeway Ltd
ACN/ARSN
ACN 067 298 088
- Details of substantial holder (1) Name
Brightlight Capital Partners LP (Brightlight Capital)
ACN/ARSN (if applicable)
N/A
The holder ceased to be a substantial holder on
15/07/2026
The previous notice was given to the company on
16/04/2026
The previous notice was dated
16/04/2026
- Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Date of change
Person whose relevant interest changed
15/07/2026
As above
Nature of change (4)
Off market transfers of FPO
Consideration given in relation to change (5)
Class (6) and number of securities affected
Person's votes affected
Nil
-11,400,307
-11,400,307
- Changes in association The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable)
Nature of association
n/a
- Addresses The addresses of persons named in this form are as follows: Name
Address
Brightlight Capital
33 Woodside Ave Westport, CT 06880 USA
Signature print name
Vadim Rubinchik
capacity
Managing Partner
Docusign Envelope ID: 1E18B7AD-4B8C-8155-80DF-8D4E9E5FFC87
605
sign here
date
Page 2 of 2 15 July 2001
16/07/2026
DIRECTIONS (1)
If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.
(2)
See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(3)
See the definition of "associate" in section 9 of the Corporations Act 2001.
(4)
Include details of: (a)
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
(b)
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001. (5)
Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest w as acquired.
(6)
The voting shares of a company constitute one class unless divided into separate classes.
(7)
Give details, if appropriate, of the present association and any change in that association since the last substantial holdin g notice.
Docusign Envelope ID: 63168F87-B406-8708-8022-3F6B031940A8
604
Page 1 of 3 15 July 2001
Form 604 Corporations Act 2001 Section 671B
Notice of change of interests of substantial holder To Company Name/Scheme
Omni Bridgeway Limited
ACN/ARSN
067 298 088
- Details of substantial holder (1)
Retail Employees Superannuation Pty Limited (in its capacity as trustee of the Retail Employee Superannuation Trust)
Name ACN/ARSN (if applicable)
001 987 739
There was a change of interests of the substantial holder on
09/_ 07 / 2026_
_
The previous notice was given to the company on
10/_ 06 / 2026_
_
The previous notice was dated
05/_ 06 / 2026_
_
- Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:
Class of securities (4)
Previous Notice Person’s votes
Ordinary
Present Notice Voting Power (5)
Person’s votes
Voting power (5)
11.40%
38,413,435
13.26%
33,020,938
- Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial shareholder was last required to give a substantial holding notice to the company or scheme are as follows: Date of change
As attached
Person whose relevant interest changed
Retail Employees Superannuation Pty Limited (in its capacity as trustee of the Retail Employee Superannuation Trust)
Nature of change (6)
As attached
Consideration given in relation to change (7)
As attached
Class and number of securities affected
As attached
Person’s votes affected
Retail Employees Superannuation Pty Limited (in its capacity as trustee of the Retail Employee Superannuation Trust)
Docusign Envelope ID: 63168F87-B406-8708-8022-3F6B031940A8
604
Page 2 of 3 15 July 2001
- Present relevant interests Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows: Holder of relevant interest
Registered holder of securities
Retail Employees Superannuation Pty Limited
State Street Australia Limited (as custodian of Retail Employees Superannuation Pty Limited in its capacity as trustee of the Retail Employee Superannuation Trust)
Person entitled to be registered as holder (8)
State Street Australia Limited
Nature of relevant interest (6)
Power to control voting and/or disposal of securities
Class and number of securities
Person’s votes
38,413,435
38,413,435
(Ordinary Shares)
- Change in association The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable)
Nature of association
- Addresses The addresses of persons named in this form are as follows: Name
Address
Retail Employees Superannuation Pty Limited State Street Australia Limited
Level 21, 50 Bridge Street, Sydney NSW 2000 420 George Street, Sydney, NSW, 2000
Signature print name
Edmund Waters
capacity
sign here
Company Secretary
date
13
/
07
/ 2026
DIRECTIONS (1)
If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.
(2)
See the definition of "associate" in section 9 of the Corporations Act 2001.
(3)
See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(4)
The voting shares of a company constitute one class unless divided into separate classes.
(5)
The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
(6)
Include details of: (a)
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
Docusign Envelope ID: 63168F87-B406-8708-8022-3F6B031940A8
(b)
604
Page 3 of 3 15 July 2001
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001. (7)
Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
(8)
If the substantial holder is unable to determine the identity of the person (e.g. if the relevant interest arises because of an option) write “unknown”.
(9)
Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
Docusign Envelope ID: 63168F87-B406-8708-8022-3F6B031940A8
Trade Date Security Long Name 02/07/2026 OMNI BRIDGEWAY LTD COMMON STOCK 02/07/2026 OMNI BRIDGEWAY LTD COMMON STOCK 09/07/2026 OMNI BRIDGEWAY LTD COMMON STOCK 09/07/2026 OMNI BRIDGEWAY LTD COMMON STOCK
CUSIP Number BM95XH908 BM95XH908 BM95XH908 BM95XH908
Transaction Category Name BUY BUY BUY BUY
Shares/Par Value 2,169,387.00 3,074.00 3,014,598.00 205,438.00
Base Net Amount 3,493,043.62 4,949.61 4,846,413.19 330,272.04
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Omni Bridgeway Limited
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| DXIV | 0.01% | 10,905 | $ 13.033K | Nov 12, 2026 |
| DFIS | 0.00% | 158,596 | $ 189.547K | Nov 12, 2026 |
| DFAX | 0.00% | 112,239 | $ 134.143K | Nov 12, 2026 |
| DFIC | 0.00% | 136,977 | $ 163.709K | Nov 12, 2026 |
| DFAI | 0.00% | 57,612 | $ 68.855K | Nov 12, 2026 |
| AVDE | 0.00% | 49,909 | $ 56.893K | Nov 16, 2026 |
| AVSD | 0.00% | 7,551 | $ 8,607.63 | Nov 16, 2026 |
| AVDS | 0.00% | 11,151 | $ 12.711K | Nov 16, 2026 |